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Abstract 
 
The understanding of the underlying mechanisms of the persistence of atrial fibrillation 
remains poor. Key to this is the relationship between structure - myocardial architecture, 
and function - electrical activity, and how these can be measured, interpreted and correlated 
clinically. We sought to address the hypothesis that the local electrogram morphology is 
determined by local atrial myocardial activation patterns, which are in turn determined by 
local atrial myocardial architecture.  
In addressing this hypothesis, we utilised improved techniques of atrial segmentation and 
detection of wall enhancements to more accurately delineate underlying de novo atrial 
myocardial fibrosis, with late-gadolinium enhanced cardiac magnetic resonance imaging (LGE-
CMRI). Here, we demonstrated a predilection of native structural remodelling on the 
posterior left atrial wall. The electrophysiological changes underlying late-gadolinium 
enhancements were interrogated with high-density electroanatomic 3D mapping using a 
Kernel as a unit of measure, in the varying rhythms of AF, sinus and pacing, with drop in 
tissue voltages and conduction velocities in regions of fibrosis, but counter-intuitively, a 
higher extent of electrogram fractionation in healthy myocardium. We observed the rate 
and wavefront-activation dependency of voltage, emphasizing the importance of voltage 
maps being interpreted in the context of its rhythm. We have also described a novel 
technique of AF voltage mapping, with the metric of mean AF voltage sampled over 8 secs 
correlating well with LGE-CMRI defined fibrosis, and surprisingly better than that of sinus 
rhythm voltage suggesting that this metric may be more representative of the underlying 
atrial substrate.  
Lastly, reverse translational cell monolayer experiments in novel co-cultured neonatal 
ventricular rat myocytes and fibroblasts were carried out to corroborate clinical in vivo 
observations under the control of the basic science laboratory.  These emphasized the 
contributions of the structural and functional changes to electrogram morphology (voltage 
and fractionation).  
The contact electrogram is the result of a complex dynamic functional electrophysiology, 
and its interactions with the underlying atrial myocardium. This increased understanding of 
structure and function (electroarchitecture) provides mechanistic insights essential if we are 
to progress beyond the current empiricism of catheter ablation strategies of persistent AF.  
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1 Review of Literature 
 
	
“I have tremor cordis on me: My heart dances; But not for joy; not joy”. 
[William Shakespeare] 
1.1 Introduction 
Atrial fibrillation (AF) is the most common sustained clinical arrhythmia. In the UK, 
approximately 1 in 100 of the population have AF, and its prevalence increases to more than 
1 in 10 in the elderly.1,2 It is associated with increased morbidity and mortality, especially 
from strokes and heart failure.3,4 It hence presents a significant public health problem and 
accounts for 1% of the National Health Service budget.5 
In conjunction, or as an alternative to pharmacological therapy, catheter ablation is an 
effective therapeutic option in the treatment of AF.6 Pulmonary vein isolation (PVI) to 
eliminate pulmonary venous triggers is the mainstay of ablation of paroxysmal AF, because 
AF in this group of patients is highly trigger dependent.7 However, PVI alone in persistent AF 
(where AF is maintained for more than 7 days) has poorer outcomes because the 
progressive atrial structural, electrical and mechanical remodelling which contributes of the 
maintenance of AF in this group of patients.8-10 Ablative treatments of persistent AF 
therefore requires modification of a highly remodelled atrial substrate, and this have been 
largely based on a “learning by burning” approach involving targeting areas of fractionated 
electrograms,11 placement of linear atrial lesions,12,13 and the combination of these strategies 
in a step-wise manner14 with incremental benefit.15,16 These approaches have been largely 
based on empiricism, without furthering our mechanistic understanding of the highly 
complex myocardial atrial substrate, accounting for the lack of an optimal therapeutic 
strategy and stagnating success rates in the catheter ablation of persistent AF.  
Until recently, the focus has been on eliminating triggers, and isolation of the pulmonary 
veins, and this has taken attention away from the mechanisms of triggering in AF, and the 
substrate for sustaining AF. The recent explosion in the literature on rotors in human AF 
has re-invigorated a more mechanistic approach to addressing the underlying mechanisms of 
persistence of AF. Focal sources or rotors have been for the first time described in humans 
utilizing complex non-propriety post-processing of recordings from multi-electrode array 
catheters placed bi-atrially17 (Focal Impulse and Rotor Modulation [FIRM] mapping) with 
phase analysis to identify signals best representing local activity as opposed to ‘far-field’ 
signals from other atrial regions.17 The elimination of these sources can acutely modify AF, 
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and improve long-term outcomes from catheter ablation.18 Non-invasive panoramic mapping 
of AF has also identified active sources including unstable rotors and pulmonary vein foci, 
and its validation with improved catheter ablation outcomes when these regions are 
targeted.19,20 These observations seem to corroborate with Jalife’s initial description of 
rotors using optical and electrical mapping in Langendorff-perfused sheep hearts,21 and all 
adds to the evidence supporting the hierarchical model dependent on localised high-rate 
electrical activation as drivers perpetuating AF.  
Moe’s multiple wavelet re-entry hypothesis has not been discarded with recent observed 
phenomenon of endocardial-epicardial dissociation22 resulting from rearrangement of atrial 
bundles,23 complex fibrillatory waves24 and longitudinal dissociation of myofibrils25 using high-
density mapping, congruent with the anarchical model of AF being sustained by multiple self-
perpetuating activation wavelets propagating in a random fashion through heterogeneous 
atrial tissue.26 This model would support an ablative strategy of creating boundary lines 
confining and extinguishing wavelets.   
The mechanisms that sustain human AF, once triggered, remain ill defined today. Part of the 
reason for this incomplete understanding of the progression to persistent AF is the sheer 
difficulty in identifying either (or ideally both) the structural or functional myocardial 
determinants of the arrhythmic substrate because of the complexities of mapping the 
spatiotemporally varying electrical activity and myocardial architecture in AF in the human 
heart. 
1.2 Atrial fibrillation 
1.2.1 Definition of atrial fibrillation 
AF is a supraventricular tachyarrhythmia characterized by uncoordinated atrial activation with 
consequent deterioration of mechanical function. On the electrocardiograph (ECG), rapid oscillations, 
or fibrillatory waves that vary in amplitude, shape, and timing, replace consistent P waves, and there 
is an irregular ventricular response that is rapid when conduction is intact. The ventricular response 
depends on electrophysiological properties of the AV node and other conducting tissues, vagal and 
sympathetic tone, the presence or absence of accessory pathways, and the action of drugs. 
ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation.27 
1.2.2 First descriptions of atrial fibrillation 
An irregular pulse, referred to as rebellious palpitations, delirium cordis and pulsus 
irregularis perpetuus, was a cause of speculation by physicians since early times.28 But it 
 32 
seems that the earliest description of AF appears in the Yellow Emperor’s Classic of Internal 
Medicine, where Emperor Huang Ti, believed to have ruled China from 2696 and 2598 BC, 
noted the poor prognosis associated with the chaotic irregularity of the pulse.29  
William Harvey made the earliest recorded description of AF in 1628 where he noted the 
undulation/palpation of the right auricle (atrium) in a dying horse long after all normal 
beating had ceased.30 In 1827, following the invention of the stethoscope, Robert Adams 
reported the association of irregular pulses with mitral stenosis. Etienne Marey in 1863 
published a pulse tracing using a sphygmograph of an irregular arterial pulse which was 
consistent with rapid atrial fibrillation31 (Figure 1.1). In 1894, Mackenzie, whilst studying the 
character of the venous pulse with the aid of a polygraph, demonstrated that the initial wave 
(‘A’ wave) was secondary to atrial contraction, and the second due to ventricular 
contraction. In patients with severe mitral regurgitation, when the irregular pulse supervenes, 
no signs of atrial contraction can be detected in the venous pulse, which subsequently 
returns when the pulse regularizes. The main diagnostic breakthrough arose with the 
invention of the electrocardiograph (ECG) by William Einthoven in 1900, and Sir Thomas 
Lewis was the first to record an ECG in a patient with AF. Mackenzie’s observations were 
corroborated with the publication of electrocardiographs of AF, and led to the additional 
diagnostic criteria of AF as the presence of an irregular baseline on the surface 
electrocardiographs, occasionally demonstrating irregular f-waves, but without any organised 
atrial activity and irregularly times QRS complexes32 (Figure 1.2).  
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Figure 1.1 First described arterial tracing with a sphygmograph 
Etienne Marey in 1863 published a pulse tracing using a sphygmograph of an irregular arterial 
pulse which was consistent with rapid atrial fibrillation. Adapted from Marey.31 
 
 
Figure 1.2 The first electrocardiograph of AF 
Electrocardiograph showing the presence of f-waves and absent p waves. Adapted from 
Hering.32 
 
1.2.3 Epidemiology of atrial fibrillation 
AF is a global healthcare problem. Its prevalence is rising, and increases with age and 
underlying cardiovascular disease. This was demonstrated in the ATRIA (the 
AnTicoagulation and Risk Factors In Atrial Fibrillation) study,33 amongst others, a cross-
sectional study of about 1.9 million individuals in a health maintenance organization in the US 
where the overall prevalence of AF was 1%, but ranged from 0.1% in the under 55 year olds 
to 9% in those above 80 years old. The prevalence was also higher in men than women 
(1.1% vs. 0.8%), and this was seen in every age group. They projected that more than 5.6 
million US adults will develop AF by the year 2050, with more than 50% of affected 
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individuals aged 80 years old and above (Figure 1.3). The incidence of AF, like its prevalence, 
increases with increasing age and underlying cardiovascular disease.34-37  
It has been established that the key risk factors for the development of AF include increasing 
age, hypertension, myocardial infarction, cardiac failure, and valvular heart disease,34,37,38 
although up to one-third of individuals developed AF in the absence of cardiovascular disease. 
As part of the Framingham Heart Study,39 the lifetime risks for the development of AF are 1 
in 4 for men and women above the age of 40. Even in the absence of antecedent cardiac 
failure or myocardial infarction, the lifetime risks are relatively high at 1 in 6. As a follow-up, 
the mortality of the individuals who developed AF in the same cohort was examined.3 The 
presence of AF doubles the risk of mortality even after adjustment for the cardiovascular 
conditions with which AF was related. AF remained associated with significant excess 
mortality even in individuals without valvular heart disease and pre-existing cardiovascular 
disease, with about a doubling of mortality in both men and women.  
A stroke is often the most devastating clinical consequence of atrial fibrillation. AF is 
associated with a near 5-fold increase risk of a stroke, with a greater mortality impact 
amongst the elderly.40 Ischemic strokes associated with AF were nearly twice as likely to be 
fatal as non-AF stroke41. With our increasingly aging population, and increased longevity as a 
result of improved medical care, AF is an emerging epidemic with huge socio-economic 
implications.  
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Figure 1.3 Projected number of adults with AF in the US between 1995 
and 2050 
More than 5.6 million US adults will develop AF by the year 2050. Adapted from Go.33 
Upper and lower curves represent the upper and lower scenarios based on sensitivity 
analyses. 
 
1.3 Early concepts of atrial arrhythmogenesis 
1.3.1 The Multiple Heterotopous Centres theory 
The multiple heterotopous theory states that each cardiac fibre could become independently 
rhythmic, forming a focus with its own impulse formation as a result of increased 
excitability.42 This was based on experiments of electrical currents on strips of myocardium. 
Lewis and Schleiter reasoned that activity from one or more heterogeneous centres would 
account for single premature beats, for regular tachycardias and, ultimately, for the 
completely uncoordinated activity seen in auricular fibrillation.43		
1.3.2 The Critical Mass of Fibrillation theory 
In 1914, Garrey made several observations which form the basis of the Critical Mass of 
Fibrillation theory.44 He noted that the ease with which a chamber could fibrillate was 
proportional to its mass. Large mammal ventricles would fibrillate with considerable ease 
and rarely spontaneously terminate, whereas small mammal ventricles or the smaller 
“auricular” chambers of large mammal hearts would rarely fibrillate and often stopped 
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fibrillating spontaneously. When a fibrillating chamber was cut into four pieces, each 
fragment continued to fibrillate, but a critical amount of muscle mass was necessary. The 
multiple wavelet hypothesis (discussed below) provided a quantitative framework for these 
observations that the persistence of fibrillation depends on a critical mass of tissue large 
enough to support multiple re-entrant waves that prevent simultaneous termination of all 
underlying re-entrant activity, in addition to the concept of wavelength, which is the product 
of the refractory period and conduction velocity of an impulse.45,46 West et al in 1962 
corroborated this theory with their work on isolated atrial segments.47 
1.3.3 Re-entry: A mechanism for cardiac arrhythmias 
It was generally accepted that the mechanism for cardiac arrhythmogenesis was due to 
enhanced impulse initiation de novo from hyper-excitable myocardium. However, these 
theories were subsequently replaced with the demonstration of “circus movements” or re-
entry as an alternative mechanism for cardiac arrhythmogenesis. McWilliam in 1887 was the 
first to suggest that a circulating impulse could re-excite the same tissue over and over again 
by this observations on the nature of ventricular fibrillation.48  
This suggestion was revived 20 years later with Alfred Mayer’s study of the causes of 
rhythmic pulsations in the bell of the medusa.49 The disks of Cassiopea deprived of marginal 
sense organs was made to pulsate indefinitely in seawater. The subumbrella tissue was cut 
into a ring, and stimulated the ring at one point. He observed that if two waves of excitation 
of equal magnitude start at the same point, and progress in opposite directions around the 
ring, only one contraction of the ring occurs. However, when pressure near the site of 
stimulation was applied, a wave of excitation could be induced to progress in one direction 
around the ring, with the area of pressure preventing a wave of excitation from progressing 
in the other direction. The wave conducting in one direction would return to its point of 
origin, and then conducted around the ring again, with the observation of the “single wave 
going constantly in one direction around the circuit may maintain itself for days at uniform 
rate”.  A further crucial observation as that “the point which was stimulated and from which 
the contraction wave arises was no more important in maintaining the rhythmical movement 
than any other point in the ring”, suggesting that the stimulation did not initiate a rhythmic 
focus at the site which it was applied and it stopped instantly when the circuit was 
interrupted. Mayer recognized the importance of the path length, conduction velocity and 
the refractory period, referred to “the need for the tissue to rest”, for the ability of the 
circulating excitation to persist. He repeated these experiments on large rings cut from the 
hearts of loggerhead turtles. 
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Figure 1.4 Ring preparation from Cassiopea xamachana 
(A) Aboral view of the intact animal. (B) Oral view after the stomach and mouth-arms 
removed. (C) Ring of sub-umbrella tissue made by cutting off the marginal sense organs and 
removing the centre of the disk. When this ring was stimulated at one point, a contraction 
wave travelled around it and returned to the point of origin. Adapted from Mayer.49 
 
George Ralph Mines in 1912-1914 performed a course of experiments on the two-
chambered hearts of cold-blooded animals, and observed the phenomenon of reciprocating 
rhythm which further contributed to the development of the concept of re-entry in cardiac 
arrhythmogenesis.50 Mines’ summary of his theory of circulating impulses in the heart (parts 
of which were derived also from the studies performed by Mayer and Garrey) is reproduced 
in Figure 1.5. Mines suggested that conditions, which result in fibrillation and other 
arrhythmias, slow conduction and shorten refractoriness, and thereby favouring re-entry, 
which reflect many changes which occur in diseased tissue. Even at this stage, it was 
suggested that theses circus movements could be the underlying mechanism of AF.  
The observations in these ring preparations went on to lay down the fundamental principles 
that govern re-entry.51  
1) Unidirectional block is required for the initiation of a re-entrant circuit. 
2) A refractory state exists, when the tissue cannot be re-excited. 
3) The refractory period is shortened and the conduction rate is slowed down by 
increased stimulation rate. 
4) The ability to form a re-entrant circuit is dependent on the length of the muscle 
path, conduction rate and duration of the refractory period.  
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Figure 1.5 Re-entry: Early experiments by Mines 
Top: Mines’ diagram of his ring preparation comprising of the auricle (atrium) and ventricle 
of the tortoise, in which he observed reciprocating rhythm. During this rhythm, contraction 
proceeded in the order V1, V2, A1, A2. Bottom: Mine’s explanation of the mechanism for 
the circulating excitation. A shows the events that occurs if the impulse travels too rapidly 
in one direction around the loop, unidirectional block being present in the other direction. 
The conducting impulse, represented by the darkly shaded area, is initiated by a stimulus and 
travels rapidly around the loop, only to return to the point of origin prior to the recovery of 
excitability of this region (3rd and 4th diagrams from the left). As a result, the impulse dies 
out as shown in the 5th and 6th diagrams, and the tissue remains refractory (stippled area). In 
the 7th diagram, the tissue begins to regain excitability as shown by the disappearance of the 
stippled area. B shows that re-entry will occur if conduction is slowed and the refractory 
period is decreased. The stimulated impulse conducts slowly in one direction, leaving a trail 
of refractory tissue. Since conduction is slow, and the refractory period is short, by the time 
the impulse has returned to its site of origin (5th and 6th diagrams from the left), the region 
has recovered and impulse can continue to perpetuate (7th diagram). Adapted from Mines52. 
 
Between 1914 and 1921, Thomas Lewis conducted pioneering work linking experimentally 
induced ‘circus movements’ and clinical arrhythmias in animals. He was the first to 
demonstrate that re-entrant activation was a cause of the specific clinical arrhythmia atrial 
flutter. He had earlier believed that “flutter may consist of simple paroxysmal tachycardia 
arising in a pacemaker”.53 With the aid of a string galvanometer (usually used for recording 
surface ECGs) connected to glass tubes plugged with kaolin and saturated with copper 
sulphate solution, in vivo excitation waves from the surface of the atria in open-chested dogs 
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were recorded. The activation times and directions from these early intracardiac 
electrograms in different parts of the atria during induced atrial flutter were calculated to 
deduce the direction of the wavefront propagation (Figure 1.6). With this, he concluded that 
atrial flutter was a re-entrant arrhythmia54, characterised by a central wave rotating around 
anatomical boundaries, activating the rest of the atria by centrifugal waves of excitation 
emitted by this central wave. The central wave was noted to be located in various parts of 
the atria in this canine model of atrial flutter, but the cycle length of the tachycardia was 
constant and the atrial activation corresponds to the surface p waves. The conclusion that 
re-entry was the mechanism which underlay atrial flutter in humans was based on the 
observation that the p-waves from the surface electrogram in a patient in atrial flutter 
closely resembled that of the surface electrogram in induced atrial flutter in dogs55. 
 
Figure 1.6 Diagrams from atrial excitation from Lewis’ canine atrial 
flutter study 
Numbers on each diagram indicate the time of activation on that site, in seconds, as 
determined with a local electrogram, relative to the beginning of a flutter wave on the 
surface ECG. (Left) Readings obtained during a period of atrial flutter. Dashed lines and 
arrows represent the path Lewis believed the circulating excitation wave pursued around 
the venae cavae. (Right) Readings and path of excitation wave during sinus rhythm. Adapted 
from Lewis.54 
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Figure 1.7 Electrocardiographs of induced canine and clinical human atrial 
flutter 
ECGs from induced canine atrial flutter (Experimental) and clinical atrial flutter (Human). R 
and T are ventricular deflections and f represents oscillations arising from auricles in atrial 
flutter.  
 
1.3.4 Re-entry: A mechanism for atrial fibrillation  
It has often been suggested that circulating excitations causes AF, but due to the 
complexities of the spread of electrical activity over the atrium during AF, it is practically 
impossible to satisfy any of the criteria necessary to prove re-entry. Hence, the prevailing 
view was that AF occurred as a result of multiple foci discharges. Garrey44,56 was the first to 
suggest that AF was caused by circus movement based on a few of his observations. Whilst 
watching the exposed fibrillating atrium of an animal heart, he commented “Riotous and 
chaotic as this fibrillation appears to be, analysis indicates that it me be aptly spoken as a 
contractile maelstrom, for it appears that contractions are not independent of each other 
but that the contractile impulse travels in a ring-like circuit repeatedly retuning to and 
involving a given region after completion of each circuit”.56 Garrey was also able to induce 
fibrillation with a single stimulus, as he was able to start circus movement in a ring 
preparation. His third observation, which supported circus movement over single or ectopic 
foci driving AF, was based on experiments where fibrillating chambers were cut into smaller 
pieces and determining the critical size required for fibrillation to be sustained. The 
observation of fibrillating tissue continuing to fibrillate when cut into four equal parts when 
“only one of the pieces can contain the original hypothetical tachysystolic pacemaker” 
provides evidence against Rothberger’s tachysystole theory57 which states that AF is caused 
by a single ectopic focus firing at very high rates. Englemann proposed in 1894 the theory 
that AF is caused by multiple foci. To refute this theory, Garrey cut many small pieces of 
fibrillating muscle from the atrium, and observed that each severed piece ceased to fibrillate, 
concluding that the individual fibers were not independently rhythmic. With these 
experiments, a critical mass was required to maintain fibrillation, and therefore, he felt that 
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circus movements has to be the mechanism but had to be more complex to account for the 
rapid chaotic atrial activation.  
Lewis eventually adhered to the circus movement theory of AF, but though that fibrillation 
was caused by a single circulating wave. During further studies of induced flutter in his 
canine model, Lewis observed a group of atrial tachycardias that had flutter like p waves on 
the surface electrocardiogram but with cycle length variability. There were termed “impure 
flutter”.58 This was thought to be due to either local aberration of the centrifugal waves as 
they exit the central wave, or alterations to the path of the central wave.  
 
Figure 1.8 Atrial flutter and fibrillation 
(Left) A diagram illustrating the successive paths followed by the excitation wave in flutter. 
The path is sinuous but is in general accurately repeated from cycle to cycle. (Right) A 
similar diagram of successive paths taken in fibrillation. The path is coarsely sinuous and ever 
varying, though it continues to progress in a clock-wise fashion around a central area. 
Adapted from Lewis.55  
 
In it most extreme form, this “impure flutter” resembled AF on the surface 
electrocardiograph. In conjunction with the understanding of the rate-related changes of 
tissue refractoriness and conduction velocity, Lewis proposed a model of AF based on a 
meandering central or mother wave, moving in multiple directions but along its course, 
giving rise to, daughter waves whose conduction properties are determined by local tissue 
properties.51 The surface electrocardiograph provided further evidence to support this 
model with changes in the electrical axis of the minor fibrillatory deflections measured in 
several different planes (through the computation of a roving electrical axis) in patients with 
chronic AF could represent a central wave moving in multiple directions, and even reversing 
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direction (Figure 1.8). A similar observation is seen with the electrical axis of the surface 
electrocardiograph p wave during flutter revolving during the progress of each cycle. 
 
Figure 1.9 Impure flutter: a mechanism for AF 
(A) Surface electrocardiograph from a patient with AF. The appearance of p waves in some 
leads (1 and 2) and not in others (3) directed Lewis to suggest that this may be impure 
flutter. (B) By creating curves of the axis of deflection, Lewis suggested that there was 
evidence of circuits of activations. Adapted from Lewis. 58 
 
This prevailed as the dominant theory of the underlying mechanism of AF for until half a 
century later.  
1.4 Contemporary mechanisms underlying atrial fibrillation 
1.4.1 Multiple wavelet hypothesis and leading circle re-entry 
Until 1947, multiple ectopics and the meandering central wave (“Mother wave”) theory 
remained the two plausible mechanisms of atrial fibrillation, with limited supporting evidence. 
Scherf performed a series of experiments that supported the theory that the mechanism of 
AF was due to an ectopic focus when injected aconitine into canine atria, which led to rapid 
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excitation and initiation of AF. Cooling in this area resulted in cessation of AF, which re-
started after discontinuation of cooling.59 He made a crucial observation stating “as the 
impulse moved into the larger mass of auricular muscle, islands of refractory tissue appear 
which cause a weaving and interweaving of the contraction process that is characteristic of 
fibrillation”, and suggested that the subsequent possible re-entry waves of excitation were 
not the cause, but a concomitant feature of AF. Although this ectopic focus theory appears 
plausible, especially in the context of our modern understanding of AF, it was overshadowed 
by the observations of Moe et al. 26,60 The significant challenge at this stage was to dissect the 
mechanism of initiation of AF from those which sustain AF. 
High rate pacing in animal models could induce AF. However, these episodes of AF would 
not persist beyond a few seconds. Therefore, it was assumed that a similar continued high 
rate of focal discharge was a required to sustain AF. However, Moe developed a canine 
model of AF that could be sustained for much longer periods, using simultaneous vagal 
stimulation, which shortened the refractory period, and pacing from the right atrial 
appendage.26 During AF, the right atrial appendage was electrically excluded with a clamp, 
and when the atrial pacing was discontinued, the AF was no longer apparent in the right 
atrial appendage but persisted in the rest of the atria. This suggested that even though the 
AF may have originated from one focus, it did not depend on the continued high rate of 
discharge to sustain AF. Having separated the initiating source from sustained AF, the 
meandering central wave hypothesis seemed a likely explanation. However, Moe argued that 
with vagal stimulation, which dramatically increased the dispersion of refractoriness, it was 
unlikely that a large wave would stay intact in the inhomogenously repolarizing milieu of the 
repeated activated atrium. This led to the proposal of the “Multiple wavelet” hypothesis 
where the central wave fragments into multiple “independent daughter” wavelets as it 
divides about strands of refractory tissue, and provided that an adequate number of wavelets 
were present, the atria would continue to fibrillate.61 While supporting re-entry as a major 
mechanism of AF, it was noted that the irregular activation of the atria could be produced 
by several factors including a single rapidly discharging focus, multiple discharging foci, or 
rapidly circulating circus movement. Unfortunately, Moe concluded, “the direct test of this 
hypothesis is difficult, if not impossible in living tissue”. Hence, this was subsequently tested 
in a 2-dimensional computer model, where the theoretical substrate had a variable 
repolarization time and conduction velocity according to the level of excitability of the 
tissue.60 In this simulation, following initiation, the electrical activity was self-sustaining with 
resultant turbulent activity resembling fibrillation. They key factor which determined the 
sustainability of the fibrillation the number of electrical wavelets, estimated to be between 
23-40, re-entering random regions of the substrate, and is favoured by slow conduction, 
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shortened refractory periods and increased atrial mass. Enhanced spatial dispersion of 
refractoriness promotes perpetuation by heterogeneous conduction delay and block.  This 
model provided indirect evidence for the multiple wavelet hypothesis, but also raised the 
possibility that re-entrant circuits could exist as a result of purely functional mechanism 
without a structural anatomical substrate being present. The development of the surgical 
Cox maze III procedure was predicated on this model of AF.62 
The theoretical concepts proposed by Moe were subsequently supported with experimental 
evidence with the advent of mapping technology. Allessie, in a series of experiments using 
multiple micro-electrodes on rabbit atria, demonstrated that re-entrant circuits could be 
independent of any anatomical substrate63,64, a concept first raised in Moe’s computer 
simulations.60. This led to the “leading-circle” concept of re-entry, in which the initiation of 
re-entry is dependent on the non-uniformity of refractoriness of atrial fibres in close 
proximity to one another, and the activation wavefront continually emits wavelets centrally 
to produce and sustain a central refractory core (Figure 1.10). The wavefront, by 
immediately re-entering excitable tissue at the tail, form a re-entrant circuit rotating around 
the central functional refractory obstacle.65 This differed from the earlier concepts of re-
entry defined by Lewis, Garrey and Mines where an anatomical circuit with regions of fully 
excitable tissue, later termed the “excitable gap” were not always necessary. The functional 
circuit described by Allessie only required a minimal excitable gap, and could operate 
anywhere in the heart under the right local conditions.  
Later experiments performed by Allessie using an epicardial multi-electrode array in 
Langendorff-perfused canine hearts with sustained AF with acetylcholine demonstrated 
wavelets propagating randomly through each atrium from derived isochronal activation 
maps.66 Figure 1.11 shows a series of activation maps of the canine right atrium during 0.5 
second of acutely induced AF, illustrating a continuous beat-to-beat change in activation 
patterns including functional turning, collision, fractionation and extinction in functional lines 
of block. The critical number of wavelets in both the right and left atria necessary to sustain 
AF was about 3 to 6.66 Allessie then went on to conduct further work on chronically 
instrumented conscious dogs which re-emphasized the importance of conduction slowing 
and shortened refractoriness, cumulatively resulting in a shortened wavelength in 
determining the onset of AF.67  
With the experimental validation by Allessie, Moe’s multiple wavelet hypothesis gained 
widespread acceptance. This was further strengthened with observations in humans using 
the same multi-electrode simultaneous mapping technology used by Allessie in his canine 
experiments. Canavan first described the potential benefit of intra-operative global atrial 
 45 
activation recorded from 156 epicardial electrodes in humans.68 This same group went on to 
map epicardially electrically induced AF in young patients undergoing cardiac surgery for 
Wolf-Parkinson-White syndrome.62 AF was induced by burst pacing, the both atria where 
mapped using several epicardial templates consisting of approximately 160 electrodes, with 
an inter-electrode distance varying between 5 and 10mm. Activation sequences showed the 
presence of multiple wavelets fragmenting, meandering, fusing and propagating in different 
directions with variable degrees of complexity. Anatomical obstacles such as the pulmonary 
and caval veins were involved in some reentrant circuits, but these circuits also occurred on 
the absence of anatomical obstacles. Although no complete circuits were mapped, re-entry 
was still suggested as the underlying mechanism of AF. In addition, only single maps were 
presented, and beat-to-beat changes in activation were not analysed. Detailed epicardial 
mapping in human induced AF was then performed by Konings et al in patients undergoing 
open-chested surgery for Wolf-Parkinson-White syndrome69. The right and left atrial free 
walls demonstrated a high intra- and inter individual variation, with both well-organised 
activations consisting of a single planar wavefront and completely disorganized activation 
with multiple wavefront propagations in different directions seen. Shorter median AF cycle 
lengths were associated with a higher degree of wavefront disorganization. Based on the 
complexity of atrial activation, 3 types of AF were defined dependent on the predominant 
number of wavefronts in the mapping field (Figure 1.12). Type 1 AF is characterised by single 
uniformly propagating waves. This type of AF probably reflects the presence of macro-
reentry around anatomical obstacles. During type II AF, single non-uniformly conducting 
waves or 2 wavelets are present. Type III AF is characterised by the presence of 3 or more 
wavelets associated with multiple areas of slow conduction and arcs of conduction block. 
During type III AF, leading circle and random re-entry were frequently observed. 
Conduction velocity decreased progressively from type I to III AF, and the fibrillation interval, 
the surrogate marker of refractoriness, was shorter in type III AF compared to type I. 
Therefore, the re-entrant mechanism in AF appeared to be associated with decreasing 
conduction velocity and refractory period, with increasing complexity of activation. 
Occasional focal activation was seen on the right atrial free wall, and these occurred as 
solitary events and never repetitively. The electrograms at the site of earliest activity during 
these patterns of focal activation were preceded by a small R wave suggesting an epicardial 
breakthrough was responsible. Although occasional focal activation was seen, the dominant 
mechanism for sustaining AF was that of multiple re-entrant wavelets in this study.  
The above descriptions of AF wave dynamics have all be in acutely induced AF. In a goat 
model of AF, acute AF was found to be predominantly of type 1, whereas chronic AF was of 
type III.70 This was similarly observed in a canine model during acute and chronic AF, where 
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the atrial rate was higher and activation was more disorganized during the former. The left 
atrial AF cycle length was enhanced during chronic AF. The activation pattern in the right 
atrium was similar in acute and chronic AF. However, during acute AF, linking of successive 
fibrillation waves was seen in the left atrium, whereas in chronic AF, the more complex 
activation patterns were seen.71 
 
Figure 1.10 “Leading circle” concept of re-entry: Circus movement in the 
rabbit atria 
(Top right) Map of spread of activation in a piece of isolated left atrial muscle during a period 
of sustained tachycardia as constructed from time measurements of the action potentials of 
94 different fibres. The impulse is continuously rotating in a clockwise direction with a 
revolution time of 105ms. The membrane potentials of seven fibres (marked A, D and 1-5) 
located in a straight line through the centre of the circus movement is shown. These 
records demonstrate that the central area is activated by centripetal wavelets. (Left) 
Transmembrane potentials of the seven fibres. The fibres in the central point of the circuit 
(fibres 3 and 4) show double responses of sub-normal amplitude. Both responses are unable 
to propagate beyond the centre, thus preventing the impulse from shortcutting the circuit. 
(Bottom right) A schematic representation of the activation pattern showing the leading 
circuit with the converging wavelets in the center. Block is indicated by double bars. 
Adapted from Allessie.65  
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Figure 1.11 Endocardial excitation maps of the right atrium in the isolated 
canine heart.  
Isochronal maps of activation during 0.5 second of self-perpetuating AF. These maps were 
reconstructed from 192 electrograms from a template containing 480 electrodes. The 
propagation pattern is visualized by colours, each representing 10ms. In the lower right 
panel, an activation map in sinus rhythm is shown for comparison. During AF, multiple 
wavelets can be easily identified. The asterisks indicate sites of endocardial breakthrough of 
impulses probably originating form the left atrium (panel C, F and G). Adapted from 
Allessie.66  
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Figure 1.12 Mapping criteria for the classification of AF. 
High density mapping of human AF where an epicardial plaque containing 144 unipolar 
electrodes recorded atrial activation patterns over the right atrial free wall. Type 1 is 
characterised by single uniformly propagating waves. During type II, single non-uniformly 
conducting waves or 2 wavelets are present. Type III is characterised by the presence of 3 
or more wavelets associated with multiple areas of slow conduction and arcs of conduction 
block. Adapted from Konings.69 
 
With the growing acceptance of the Multiple Wavelet hypothesis, and the observations 
discussed previously in 1.3.2, which supports the Critical Mass theory of AF, the Cox maze 
III procedure was devised and first performed in 1988. The operation creates a maze-like 
series of incisions in both atria (Figure 1.13) to prevent the formation of macro re-entrant 
circuits preventing a critical mass of contiguous atrial tissue from sustaining atrial fibrillation 
whilst maintaining atrial contractility.  Sinus impulses are then channeled through a path or a 
“maze” to reach the atrio-ventricular node.72 As part of this procedure, the pulmonary veins 
are completely isolated, and both appendages removed. This was fortuitous, as the role of 
the pulmonary veins in the initiation of AF has only been appreciated in relatively recent 
years.7 Although the Cox maze III procedure was effective in the treatment of AF, the 
invasiveness and complexity of the procedure, with its associated morbidity due to the 
prolonged period of cardiopulmonary bypass required restricted its widespread adoption. 
The development of alternative energy sources have recently enabled surgeons to create 
lines to ablation to replace most incisions of the original Cox maze III procedure.73 
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Figure 1.13 Lesions in the original Cox maze III procedure 
Typical lesions depicting the surgical maze procedure where the atria is dissected into 
multiple segments and re-sutured, leaving a “corridor” from the sinus node to the atrio-
ventricular node”. Adapted from Damiano.74 
 
1.4.2 Focal sources in the Initiation and Maintenance of AF 
Rothberger and Winterberg in 1909 first postulated that AF was the result of a single 
electrical focus3, but this theory was overshadowed initially by Lewis’ persuasive 
electrocardiographic that supported the circus movement theory. Scherf’s experiments in 
1949 (discussed in 1.4.1.) re-kindled the idea of the mechanism of AF being more compatible 
with an ectopic focus.59 However, the mechanism of impulse formation within the ectopic 
focus remained debatable, some favouring repetitive discharges in cells75,76, others a localised 
circus movement. 77,78 In 1959, following Moe’s observations, the multiple wavelet 
hypothesis was accepted as the dominant theory governing AF wave dynamics and the focal 
source theory fell by the wayside.   
However, there has been more recent experimental animal models, and observations in 
human AF, which suggest focal sources, or drivers may be critical in maintaining the 
fibrillatory process.79,80 These may be either high frequency focal sources with radial 
activation, or a rotational wave of excitation (rotor).79 According to the multiple wavelet 
hypothesis, the constant generation of secondary daughter wavelets moving randomly 
throughout the atrium which eventually extinguishes as they collide with other wavelets or 
other obstacles (anatomical or functional) would create a totally random phenomenon akin 
to Brownian motion, which may explain the disorganization in AF. However, whether the 
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disorganization results form organised sources or whether the disorganization is the primary 
driver of AF has been debated for decades.81  
In the time domain, optical mapping and intracardiac recordings of AF reveal atria electrical 
activity that is spatio-temporally variable, which seems disorganized and unpredictable. The 
application of rigorous statistical and signal processing techniques in the frequency domain 
has provided evidence that the nature of AF is not entirely random, both in animal models 
and human AF demonstrating well-defined spatially distributed gradients of local excitation 
frequency.  
Schuessler et al first described localised sources in an isolated canine right atrial preparation 
where high concentrations of acetylcholine converted multiple circuits into a single relatively 
stable high-frequency source.82 In a sheep Langendorff preparation during electrically induced 
acetylcholine-AF, Jalife, with the use of spectral analysis through fast Fourier transformation 
of optical recordings determined the presence of dominant circuits. The use of the fast 
Fourier transforms disperses the power spectral components of the local (or derived) 
electrogram. The dominant frequency component is the frequency with the highest peak in 
the power spectrum.83 The activation patterns in the left atrium were more regular than the 
right atrium (Figure 1.14).21 Sources of periodic activity were noted, appearing as functional 
re-entry in the form of spiral waves rotating around microreentrant circuits approximately 
1cm in diameter (or sites of epicardial breakthrough) with cycle lengths of oscillation 
corresponding to the underlying local dominant frequency (Figure 1.15). The rapidly 
successive wavefronts emanating from these sources propagates through both 
heterogeneous atria substrate, and interact with anatomical/functional obstacles, leading to 
fragmentation and wavelet formation, which have short lifespans of <1 rotation. Wavebreaks 
were frequently noted at the left atrial appendage and right atrial free wall.84 Similar 
observations have been made in a similar model in which AF is induced by stretch. 85,86 
Simultaneous bi-atrial optical mapping with concomitant bipolar electrogram recordings 
along Bachmann’s bundle, coronary sinus, right atrial free wall, left atrial appendage and the 
pulmonary vein regions demonstrated a left-to-right reduction in dominant frequencies with 
a substantial left-to-right gradient.87 This supported that maintenance of AF in the sheep 
model resulted from high-frequency periodic sources located in the left atrium, with 
fibrillatory conduction towards the right atrium. Indeed, Morillo et al had earlier reported 
restoration of sinus rhythm and prevention of inducibility of AF after focal cryoablation in an 
area in the posterior left atrium at the base of the pulmonary veins which exhibited the 
shortest AF cycle length and highest frequencies in a canine model of pacing induced AF.88 
These observations are not compatible with Moe’s multiple wavelet hypotheses, but may be 
congruent with Lewis’ theory of a single re-entrant mother wave giving rise to high 
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frequency excitation and resulting in complex wavefront activation patterns depending on 
the local tissue electrophysiology.  
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Figure 1.14 Optical mapping in a sheep AF model. 
Isochrone maps and pseudo-electrograms (EG) constructed from the left and right atrium 
optical recordings of episode of AF. (A) Isochrone map of single rotation of stable rotor 
located in the left atrium. (B) Pseudo-EG of this signal, which is monomorphic. (C) Two 
sequential right atrial isochrone maps during AF. Right atrial pseudo-EG is shown in D. 
Despite uniform activation in the left atrium, the right atrium is highly heterogeneous in 
both activation sequence (see isochrone maps) and electrical activity (see pseudo-EG). 
Bipolar EG seen in E is consistent with AF. 
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Figure 1.15 Focal sources in a sheep model of AF. 
(Upper panel) 3 sequential isochronal maps of the left atrium from an isolated sheep 
heart constructed from optical recordings demonstrating a repetitive focal spread of 
activation. (Lower panel) Fourier transforms of the transmembrane potentials at sites 1, 
2 and 3. At all sites, temporal periodicity is demonstrated by the presence of a dominant 
peak between 15 and 20 Hz. Remote from the dominant source, the activation pattern 
became more complex reflected by the appearance of additional frequency peaks at sites 2 
and 3. Adapted from Skanes.21 
 
Similarly, these stable dominant frequency gradients between and within the atria has also 
been consistently demonstrated in humans.89 The presence of consistent and reproducible 
directions of propagation in AF consistent with linking90 (the term linking relates to the 
tendency for wavefronts to follow paths of previous excitation)  in the atria of the majority 
of patients with AF adds to the evidence that the pattern of circulating wavelets during 
human AF is not entirely random, supporting localised drivers as the underlying mechanism 
of the maintenance of AF. Unfortunately, measures of organization and spatial gradients in 
AF, such as dominant frequency (discussed in 1.7.3), organizational index and Shannon 
entropy have proven unstable and have not improved catheter ablation results when 
targeted, and are of no significant clinical utility. 91,92  
Previous epicardial mapping studies of AF in both humans by Konings93  and Cox62 have 
failed to demonstrate a repetitive focal activation as the underlying mechanism driving AF, 
although these studies have examined induced acute AF rather than chronic AF. Subsequent 
to these studies, Harada et al performed a detailed human study of chronic AF activation in 
10 patients with chronic AF undergoing isolated mitral valve surgery.94 Repetitive and regular 
activation originating in the left atrium were observed in all 10 patients, whereas activation 
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in the right atrium was predominantly chaotic. The number of electrodes limited their 
mapping technique, and hence, discrete re-entrant circuits or ectopic foci were not 
demonstrated. Nevertheless, it was suggested that the left atrium acted as an electrical 
driving chamber for atrial fibrillation in the majority of patients, and the right atrial 
fragmented activity was merely a by-stander effect of fibrillatory conduction. In a separate 
study, 16 patients with chronic AF underwent epicardial recordings at the right atrial 
posterior free wall, and the preferable activation pattern, propagation direction, cycle length 
and conduction velocity of each activation waves were determined.95,96 The activation 
patterns ranged from disorganized with multiple co-existing activation waves to 
predominantly organised activation characterised by either uniform activation consistent 
with the presence of large re-entry circuits (although complete circuits suggestive of leading 
circle re-entry were not identified) or repetitive activation of unknown mechanism and focal 
spread. Yamauchi et al performed epicardial mapping to guide cryoablation of AF sources97 
in 40 patients. Sustained re-entrant activations or repetitive firing from foci located in the 
right atrium was never observed. Foci or re-entry circuits located in the left atrium were 
clearly observed in 11 out of 40 cases, and in 9 out of the 11 cases, AF was terminated by 
placing cryolesions at these sites. In these patients, the left atrium, and focal sites played an 
important role as the electrical driving chamber for AF.  
Interestingly, Waldo recently re-studied, in vivo, Moe’s original canine experiments with vagal 
nerve stimulations using an electrode array consisting of 512 electrodes.98 Multiple wavelets 
were not observed, but multiple foci of different cycle lengths widely distributed over the 
atria were thought to be driving the AF. During AF, the primary activation sequences 
showed wavefronts originating from different foci that resulted in colliding and merging of 
wavefronts. With the cessation of vagal nerve stimulation, the rate of discharges from the 
multiple foci slowed, allowing for periods of non-activation of the atria, but continued to 
drive atrial activation. When all focal firing ceased, there was a prolonged pause before sinus 
rhythm resumed. This sequence supports that AF, in an identical model to that in Moe’s 
initial descriptions, is due to a driver mechanism and not random re-entry. He argued that 
Allessie’s model of cholinergic AF in a Langendorff-perfused canine atrial preparation which 
was accepted as validation of Moe’s multiple re-entry hypothesis, was not the Moe model, 
and the differences could be due to the effect of acetylcholine on the atria in an in vivo and 
an ex vivo study.  
More contemporary epicardial mapping studies performed however have not replicated the 
findings of focal repetitive activation as the underlying mechanism driving chronic AF. 
Allessie et al used wave mapping to describe AF wave dynamics from data acquired from 
epicardial recordings (244 electrodes) in patients with long-standing persistent AF with 
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structural heart disease25,99. There was no evidence of stable foci, but frequent narrow 
wavelets of simultaneous propagations were observed through the atrial wall which led to an 
alternative hypothesis (Double Layer hypothesis), which is discussed in more detail below in 
1.4.3. The Kalman group corroborated the findings of this study when they performed high-
density epicardial mapping in 18 patients with persistent AF undergoing open heart 
surgery.100 A total of 2904 activation patterns were analysed from mapping of the posterior 
left atrial wall, left and right atrial appendages, and right superior pulmonary vein-left atrium 
junction. The activation patterns observed were highly heterogeneous, mostly unstable and 
fleeting from one to another during each recording. Focal activations accounted for up to a 
third of the fibrillation waves, but all were short-lived (</= 2 beats) with no site 
demonstrating sustained focal activity. 
In parallel with observations in the studies of animal models, and during surgical epicardial 
mapping, numerous clinical observations of human AF with endocardial mapping has 
provided support in the focal source hypothesis, and in identifying local triggers for AF. In 
1997, Jais described a series of nine patients with paroxysmal AF with focal sources of 
activation.101 In these patients, the surface electrocardiograph ECG pattern of AF was due to 
focal rapidly firing source of activity, exhibiting a consistent and centrifugal pattern of 
activation. These sources can be eliminated with discrete radiofrequency energy applications, 
with subsequent non-inducibility of AF. The sites of the foci were largely found in the left 
atrium, around the pulmonary vein ostia. Haissaguerre et al, in the following year, reported 
the seminal observations which provided definite proof that the pulmonary veins were an 
important source of ectopic beats capable of initiating paroxysms of AF.7 Roving quadripolar 
catheters were placed within the pulmonary veins of patients with drug refractory and 
frequent paroxysms of AF. AF was initiated by single ectopic foci in a minority of patients, 
and a short burst of 2 or more repetitive discharges. 94% of the 69 ectopic foci found to 
initiate AF in the 45 patients were within the pulmonary veins. Radiofrequency ablation of 
these same foci kept 62% of the patients free from anti-arrhythmic drugs at a mean of 8-
months follow-up. Haissaguerre was able to demonstrate that the ectopic foci were 
travelling form a distal to proximal direction in relations to the mapping electrodes placed 
within the pulmonary veins, whereas during normal sinus rhythm, the same regions of 
pulmonary vein musculature could be seen to be activated passively, from proximal to distal 
(Figure 1.16). This all leads to the increasing popularity of the concept of focal ectopy 
causing AF.  
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Figure 1.16 Angiogram of a Left Inferior Pulmonary Vein Depicting the 
Source and Exit of Ectopic Activity. 
The electrogram showed characteristic changes in timing depending on the position of the 
recording catheter in the specific pulmonary vein. With an increasingly distal catheter 
position (toward the source), the spike was recorded progressively later during sinus 
rhythm (left-hand panel, arrows) and correspondingly earlier during ectopic activity 
(arrowhead). Conversely, in a proximal position at its exit into the left atrium (right-hand 
panel), the spike was not as delayed during sinus rhythm (arrows) nor as precocious during 
ectopic activity (arrowhead). The application of radio-frequency energy at the source of 
ectopic activity eliminated the local spike during sinus rhythm and ectopic beats and atrial 
fibrillation on a short-term basis. The dotted lines mark the onset of the ectopic P wave, and 
1–2 and 3–4 are bipolar recordings from the distal and proximal poles of the mapping 
catheter. A indicates near-field atrial activity. The radiograph (center panel) shows the 
position of electrographic recordings inside the pulmonary vein at the source and exit. 
 
1.4.3 The Double Layer Hypothesis 
It must however be noted that epicardial mapping can only present data in two-dimensions, 
and transmural conduction may be interpreted as focal activation. Allessie et al used wave 
mapping to describe AF wave dynamics from data acquired from epicardial recordings (244 
electrodes) in patients with long-standing persistent AF with structural heart disease, 
reported as a 2-part study. 25,99 This algorithm divides the fibrillatory process into individual 
elements to allow for quantitative analysis of the heterogeneous activation patterns in AF. 
4430 maps of persistent AF were acquired. There was no evidence of stable foci, and instead, 
many narrow wavelets of simultaneous propagations were observed through the atrial wall 
(as opposed to broad fibrillation waves, which often collided or fused during acute AF). Lines 
of interwave conduction block bound these waves, which were predominantly oriented 
parallel to the atrial musculature. These lines of block were not fixed, but changed on a 
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beat-to-beat basis but were not randomly distributed but their orientation seemed to be 
determined by the underlying atrial architecture.  
The authors purport that electrical dissociation of neighboring atrial muscle bundles is 
crucial to the development of the substrate of persistent human AF, but accepts that these 
changes may not be directly responsible for the maintenance of AF. It was also observed 
that a large proportion of the fibrillation waves were of “focal” origin. However, these “focal” 
fibrillation waves were not repetitive and occurred over the entire epicardial surface. They 
often has a coupling interval which was longer than the dominant AF cycle length, and the 
unipolar electrograms are the epicardial origin of these waves exhibited small but clear R 
waves which strongly suggested the “focal” fibrillation waves were as a result of endo-
epicardial breakthrough rather than due to ectopic focal discharges (Figure 1.16). In patients 
with persistent AF, the total lengths of lines of intra-atrial block were more than 6-fold 
higher than during acutely induced AF, with a more than 4-fold increase in epicardial 
breakthroughs. There were narrower and more numerous fibrillation waves in persistent AF.  
The width of the fibrillation waves correlated with the underlying architecture of the atrial 
wall, and varied from 3-6mm in the right atrium with thick pectinate muscles and to 1-2mm 
in the posterior left atrial wall between the pulmonary veins.  
This led to the Double-Layer hypothesis where they suggested that the atria are 
transformed into a double layer of electrically dissociated muscle bundles through a 
progressive process of longitudinal and endo-epicardial dissociation, stabilizing the fibrillation 
process. Instead of re-entrant or focal activity, the frequent “cross-overs” of fibrillation 
waves between these two layers provide a constant source of “new” fibrillation waves. Each 
time a fibrillation wave is extinguished, it provides an opportunity for the multiple fibrillation 
waves to conduct transmurally and replace the extinguished wave by one of more focal 
breakthrough waves.  
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Figure 1.17 The Double-Layer Hypothesis 
Epicardial wave maps displaying evidence of longitudinal dissociation and endo-epicardial 
dissociation in a patient undergoing mitral valve surgery in the right (top) and left 
(bottom) atria. The separate arrows in the wave maps indicate fibrillation waves with the 
color indicating sequence of activation. Asterisks show site of epicardial breakthrough, and 
diagrams on right show spatial distribution and incidence (proportionate to size of star) of 
these during 12 s of AF.  
 
1.5 The Rotor revolution 
The evidence of localised sources driving AF has been limited to animal models described 
above.  These localised sources may be in the form of discrete foci with centrifugal spread of 
activation, small anatomical re-entry or functional rotor.93,102 These sources may be 
identified during organised periods of AF using conventional mapping techniques, but are 
challenging to detect in persistent AF due to variable and short fibrillation cycle length 
resulting in diffuse fractionation of atrial electrograms and continuous electrical activity.103,104 
Much of the progress to date in identifying rotors as active AF drivers have been due to the 
use of complex signal analysis known as phase mapping (which plots a signal against a time 
shifted version to display the different stages within one cycle), when initial attempts using 
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conventional activation (isochronal) mapping failed to detect stable rotational circuits in 
AF.21,105 In a recent canine model (Beagle heart failure model), epicardial ablation of rotors 
suppresses inducibility of acetylcholine-induced AF.106 Localised sources in human AF has 
been described as early as 1993, but the “hunt for rotors” has been re-invigorated recently 
with the demonstration using Focal Impulse and Rotor Modulation (FIRM) mapping that 
rotors act as human AF sources107 and observations of unstable rotors with the use of 
panoramic non-invasive mapping.20,108 These have revitalized a more mechanistic approach to 
addressing persistence in human AF.  
1.5.1 What are rotors?  
Spiral waves were first described in cardiac fibrillation by Davidenko using optical mapping in 
animal tissue.109 Rotors are a special type of localised functional re-entrant circuits which 
differ from the leading circle re-entry by exhibiting a central zone/core of extreme wave 
curvature that results in very slow conduction, allowing precession into excitable tissue, 
with emanating spiral waves which disorganize. The definition of rotor is highly dependent 
on the extreme wavefront curvature, which increases as conduction slows towards the 
central zone/core, and the small (curved) excitable gap that exists between the head and tail 
of the wavefront. The re-entrant singularity, the central zone/core from which the spiral 
waves emanate is termed the “rotor”, and meanders as it pivots around “unexcited but 
eminently excitable tissue”.79 (Figure 1.17) 
Rotors are thus defined using the following key characteristics: 
(1) Extreme wavefront curvature at the core in which head meets tails. 
(2) An excitable and precessing core. 
(3) A highly variable re-entrant wavelength, with an often-undetectable excitable gap. 
There are crucial differences between the theory of rotors and the leading circle re-entry. 
Most importantly, the leading circle assumes full refractoriness at the core, produced by the 
continual invasion of centripetal waves which creates a ring of excitation around a 
functionally unexcitable obstacle, similar to the anatomic obstacle of circus movement re-
entry described by Mines.52 Hence, whether functional or anatomic, the obstacle in the 
centre would render it impossible for the re-entrant circuit to meander or precess. On the 
contrary, rotors meander because they pivot round unexcited but excitable tissue.110  
A rotor may be initiated in various ways including unidirectional conduction block in cardiac 
tissue as a result of tissue heterogeneities in excitability, repolarization or conduction 
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velocity,111 or even dynamic change in properties such as action potential alternans.112 The 
underlying basis for rotor initiation is that of “vortex shedding”,113 which occurs when a 
wave encounters an obstacle with sharp edges, analogous to the formation of eddies and 
turbulence, when a water flow reaches a bifurcation, and is rooted in the concept of critical 
curvature.114 
 
 Figure 1.18 Rotors – basic concepts 
(A) Color phase map of a two-dimensional (2D) spiral wave, which, as in a pinwheel, spins 
around a singular point in the center, that is, in which all phases, converge. (B) Features of a 
rotor. Near the core conduction velocity falls (see shorter vectors, arrowed) and action 
potential duration shortens (examples from positions 1, 2, and 3), thus shortening 
wavelength [distance from the wavefront (black line) to the wave tail (dashed line)]. 
Wavefront curvature becomes more pronounced near the rotor, which is a phase singularity 
at the point in which the wavefront and the wave tail meet (*). Adapted from Pandit et al.115 
1.5.2 Rotors in human fibrillation 
Computer modelling involving simplified 2D sheets and complex geometrically realistic 3D 
models of human atria and ventricle has demonstrated the possibility of inducing sustained 
rotors to drive both AF116,117 and VF. 118,119 Rotors have been observed during VF with in 
vivo and epicardial surface mapping studies in human, as well as in optically mapped 
Langendorff-perfused hearts. 120,121 Although similar epicardial mapping studies have been 
performed in the atria during open chest cardiac surgery, and focal AF drivers observed, no 
sustained rotors have been demonstrated. 80,100 Later, AF sources in the form of rotational 
activity were demonstrated by non-contact balloon,122 and high-density endocardial mapping 
with multipolar catheters. 123,124  
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More recently, Narayan et al, undertook FIRM mapping, where bi-atrial endocardial mapping 
was performed with a multi-spline basket catheter and a novel computational mapping 
approach using a specific non-proprietary software to delineate localised sources (including 
rotors), which were then targeted by radiofrequency ablation.17,107 The detection of rotors 
was optimised with the use of phase analysis (identifying phase singularities), and through the 
identification of signals best representing local activity as opposed to ‘far-field’ signals from 
other atrial regions using noise-filtered electrograms.125 (Figure 1.19) Electrical rotors and 
focal sources were present in almost all patients (98 out of 101 cases with sustained AF), 
each subject demonstrating 2.1±1.0 sources, of which 70% were rotors and 30% focal 
impulses. These AF sources were in diverse bi-atrial sites with 40-50% near the pulmonary 
veins and left atrial roof, and 20-30% in the right atrium, with AF source locations being 
more widely distributed for persistent as compared to paroxysmal AF (Figure 1.20).  
In the CONFIRM (Conventional Ablation With or Without FIRM) trial,18 rotors and focal 
sources were present in the vast majority of patients with AF. These were targeted with 
catheter ablation, and their elimination acutely modified AF, and substantially improved 
outcomes on long-term follow-up. 
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Figure 1.19 Focal impulse and rotor modulation mapping demonstrates 
right atrial rotor. 
(a) Basket and ablation catheters in the right atrium. (b) Counterclockwise rotor in the 
posterolateral right atrium (centered at electrode C3), with collision beyond the spiral arms 
(double lines). (c) Electrograms around the right atrial rotor site, indicating 
counterclockwise rotation that precesses at cycle length approximately 177 ms. (d) FIRM 
ablation at right atrial rotors alone terminates atrial fibrillation to sinus rhythm within 30 s. 
ABL, ablation electrogram; AF, atrial fibrillation; CL, cycle length; CSP, proximal coronary 
sinus; FIRM, focal impulse and rotor modulation; RA, right atrial. Adapted from Narayan.17 
 
 
Figure 1.20 AF focal impulse and rotor locations in the CONFIRM trial 
Locations as a percentage of all sources for each AF type: (A) paroxysmal and (B) 
persistent. Focal impulses - stars; rotors - circles. CONFIRM = Conventional 
Ablation for AF With/Without Focal Impulse and Rotor Modulation; IVC - inferior 
vena cavae; LAA - left atrial appendage; LIPV - left inferior pulmonary vein; LSPV - 
left superior pulmonary vein; RAA - right atrial appendage; RIPV - right inferior 
pulmonary vein; RSPV - right superior pulmonary vein; SVC - superior venae cavae. 
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In addition, the advent of body surface mapping and computer signal processing have also 
allowed for the non-invasive mapping of atrial activation with increasing resolution.126,127 
Cuculich et al presented continuous bi-atrial epicardial activation sequences in AF using non-
invasive electrocardiographic imaging (ECGI) and demonstrated a variety of mechanisms and 
complexities of patterns of activation in AF- the most common patterns being multiple 
wavelets (92%) with pulmonary vein (69%) and non-pulmonary vein (62%) focal sites with 
rotor activity seen, but rarely (15%).108 More latterly, Haissaguerre et al have demonstrated 
that persistent AF is maintained predominantly by drivers clustered in few regions, most of 
them being unstable re-entries.20 
1.5.3 Structural determinants of rotor sites 
Atrial fibrosis has been theorized to play an important role as a potential anchor for the 
anatomical reentrant circuits. 128-130 Optical mapping has demonstrated that rotors can 
anchor to structural barriers in the form of anatomic discontinuities or fibrosis.131,132 Patient 
derived computational modelling of the atria has also suggested that regions of fibrosis may 
anchor fibrillatory rotors, consistent with the concept the discontinuities in the fibre 
architecture and unexcitable regions are structural features which can trap rotors transiently 
or permanently.  Increasing the extent of fibrosis and scar may eventually convert fibrillation 
to excitable gap re-entry tachyarrythmias.129  
Slow conduction in diseased myocardium may be necessary for sustaining rotor activity, and 
localised rotational activity observed with multipolar endocardial mapping tends to co-
localise with regions with very low voltages in AF (<0.1mV).133 Similarly, rapid focal- and 
rotor-activity have also been noted in regions of low voltage in AF (<0.5mV).134 Electrogram 
amplitude has also been observed to be reduced at rotor sites critical to the maintenance of 
persistent AF, as determined by FIRM-mapping.135 
Late-gadolinium cardiac magnetic resonance imaging (LGE-CMRI) has now been used to 
detect atrial fibrosis. The burden of atrial fibrosis as determined by LGE-CMRI positively 
correlated with the number of sites exhibiting high rotor activity (rotor driving regions) 
using non-invasive mapping, and rotor trajectories showed a clustering around borders of 
fibrotic areas.136 However, Chrispin et al, using FIRM-mapping to identify rotor incidence 
with global and regional late-gadolinium enhancement (using distinct post-processing 
algorithms to the Bordeaux group), failed to demonstrate an association between the rotor 
sites and fibrosis as determined by LGE-CMRI.137 
Authors from the DECAAF study have coined the concept of “residual fibrosis” where the 
overlap of ablation-induced scar with underlying atrial fibrosis predicts response to catheter 
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ablation in atrial fibrillation, i.e., patients with less “residual fibrosis” had better clinical 
outcomes.138 This has formed the basis of the DECAAF-2 where atrial scar as determined by 
LGE-CMRI will be targeted during catheter ablation for AF.  
1.6 Substrate in atrial fibrillation 
The concept of trigger, initiators and perpetuators advanced by Allessie et al requires that 
for AF to exist, it must be initiated by some trigger, and then maintained by favourable 
electrophysiological and electroanatomical properties of substrate. They proposed that AF 
itself may cause progressive changes to the atria and subsequently, promote its perpetuation 
which describes remodelling of the AF substrate.  
1.6.1 The Electrophysiological substrate of AF 
The potential importance of spatial variability in atrial electrophysiology for the induction 
and maintenance of AF has long been recognized. In early animal studies, high rate pacing in 
isolation was inadequate to induce sustained periods of AF. AF only persisted in the 
presence of concomitant vagal stimulation which raised the possibility that the persistence of 
AF is only possible under specific electrophysiological conditions.26  
1.6.1.1 Variable refractoriness 
Cellular depolarization has been appreciated to be fairly consistent in the atria, whereas 
repolarization could be variable. The heterogeneity of repolarization and the consequent of 
dispersion of refractoriness was essential for the generation of AF in Moe’s classical 
computer model.60 This model used time-dependent functions to represent excitability, 
conduction and refractoriness in cellular automata arranged in a polygonal array to 
represent the medium. The independent survival of AF was possible only in the presence of 
inhomogeneous atrial repolarization as an impulse propagate through the medium at a time 
when some of its components have recovered while others remain partially or fully 
refractory as a result of a preceding activation. Accordingly, some elements of in the 
medium may be activated while their neighbours may not. Experimental evidence for the 
role of dispersion of refractoriness was demonstrated in Allessie’s induced re-entry in the 
rabbit atria,64 and later, in canine experiments. Dogs with AF induced by a single extra-
stimuli after cardio-pulmonary bypass have increased refractoriness dispersions, as with dogs 
with idiopathic AF, and the ability of flecainide to terminate idiopathic and vagally induced AF 
in dogs is associated with reductions in the dispersion of effective refractory period 
(ERP).139,140 Increased dispersion of the ERP also appears to play a central role in vagally 
induced experimental AF.141,142 
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Rapid atrial activation increases the spatial variability in AF cycle length,143 which has been 
suggested to present a surrogate of atrial refractoriness.144,145 The variation of AF cycle 
lengths as measured by the standard deviation at different sites correlates well to the 
duration of AF in dogs subjected to rapid atrial pacing.143 Patients with paroxysmal AF have 
an increased spatial variability of AF cycle lengths compared to patients with no history of 
AF during electrically induced AF, 145,146 and atrial tissues from patients with AF have an 
increased heterogeneity in ERP.147  
As discussed earlier, the re-entry wavelength is crucial in determining the susceptibility to 
re-entrant arrhythmias, including AF. Interestingly, in some studies, the AF duration and 
inducibility did not seem to be correlated with wavelength, but appeared to be more related 
to ERP dispersion.139,142 More recently, functional re-entry observed during AF may 
correspond to spiral wave re-entry79. This concept may explain, at least in part, how 
interventions that increase refractoriness dispersion can promote AF maintenance without 
altering the re-entrant wavelength.  
1.6.1.2 Shortening of refractoriness 
Wijffels et al148 made the observations that induction of atrial fibrillation in normal goats was 
relatively difficult, and only lasted for a few seconds. However, with repetitive induction, 
through progressively increasing the duration of the artificially maintained AF, the inducibility 
and ability of the atria to sustain AF increased (Figure 1.18). This was associated with 
shortening of the ERP, and the loss of rate adaptation (findings corroborated in observations 
in humans149).  These changes, collectively termed “electrical remodelling”, were maximal 
after 2-3 days of AF, and were entirely reversed within a week of restoration of sinus 
rhythm. The shortening of atrial refractoriness has also been described in a rapidly-paced 
canine model of AF, and was highly predictive of increased AF inducibility.88 This led to the 
notion that “AF begets AF”, where AF itself may cause progressive changes to the atria, and 
would promote the initiation and perpetuation of the arrhythmia.   
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Figure 1.21 AF begets AF 
Prolongation of the duration of episodes of electrically induced atrial fibrillation (AF) 
after maintaining AF for respectively 24 hours and 2 weeks. Adapted from Wijffels.148 
 
These changes in atrial refractoriness reflect the alterations in activation profiles of major 
repolarizing currents, in particular, a reduced L-type calcium current, and outward 
potassium current, namely ITo and IKur.150,151 The decrease in the L-type calcium current 
results in shortening of the action potential, whereas the decrease in ITo is considered to 
result in loss of the physiological rate adaptation of the action potential.  
These findings corroborate clinical observations during the natural history of AF whereby 
paroxysmal AF often progressing to persistent AF, with the transition rate varying with the 
underlying aetiology.152 However, up to a-fifth of patients with lone paroxysmal AF develop 
persistent AF, occurring in a greater proportion of patients with longer durations of 
paroxysms of AF.153 These epidemiological data supports the “AF begets AF” theory, 
suggesting independent of the underlying disease process, AF in itself is a progressive disease. 
The term “domestication of atrial fibrillation” by M. Rosenbaum illustrates the clinical 
scenario that with time, it becomes more and more difficult to keep a patient with AF in 
sinus rhythm.  
1.6.1.3 Conduction delay 
Tissue conduction velocity plays an important role in arrhythmogenesis. In patients with 
paroxysmal AF, premature atrial stimuli conducted more slowly and produced more 
fractionated electrograms.154 The p-wave duration as a surrogate marker of atrial 
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conduction times were found to be prolonged in patients with chronic lone AF following 
electrical cardioversion to sinus rhythm, compared to that in controls (atrial enlargement 
was absent in patients with AF), implying slowed conduction. Differences on conduction 
delay were only manifest with premature stimuli, and there was no difference in the intra-
atrial conduction times of non-premature beats.155 Yu et al demonstrated shorter ERP with 
impaired rate adaptation and decreased conduction in patients following cardioversion for 
long-standing persistent AF, with the ERP increasing after 4 days of maintenance of sinus 
rhythm.156 Macroscopic propagation velocity appeared to be unchanged in chronic AF 
compared to compared to sinus rhythm but there is an increase in complexity of activation 
during epicardial mapping in patients undergoing cardiac surgery.157  
Conduction velocity was investigated as a “second” or an independent pro-arrhythmic factor, 
which would determine the perpetuation of AF based on the observations in a canine model 
of AF where the time course of changes in atrial refractoriness did not parallel the 
propensity of the remodelled atria to fibrillate. Although significant shortening of atrial 
refractoriness was observed within the first 24 hours of pacing and complete after 2-3 days, 
AF was only sustained indefinitely after one week.148.  
Abnormalities in atrial conduction was not seen consistently in both canine and goat models 
of AF. Several groups observed no delay in conduction in rapid atrial pacing goat models of 
AF.158-160 However, Gaspo et al demonstrated that progressively longer episodes of AF in a 
canine model resulted in conduction slowing.143 Attenuation of conduction velocity was 
maximal at 6 weeks, and lagged behind the drop in atrial ERP and rate adaptation which 
peaked within 7 days suggesting there abnormalities are medicated by different mechanisms, 
and that conduction slowing could serve as the “second factor” in the “domestication” of AF.  
The shortening of refractoriness, in combination with decreases in conduction velocity 
results in shortening of the atrial wavelength. In accordance to the Multiple Wavelet 
hypothesis, a shorter atrial wavelength would result in smaller wavelets given a fixed atrial 
surface. However, AF inducibility was not solely based changes in refractoriness and/or 
macroscopic conduction slowing. In canines, when the mode of AF induction was switched 
from rapid atrial pacing to rapid ventricular pacing to induce concomitant AF and heart 
failure, both atrial refractoriness and conduction velocities remain unchanged. The 
arrhythmogenic substrate was represented by extensive interstitial fibrosis resulting in 
increased local heterogeneity of conduction by no overall change in macroscopic conduction. 
These observations suggests that changes other than that of conduction delay or atrial 
refractoriness may play a crucial role in the AF substrate.  
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1.6.2 The structural substrate of atrial fibrillation – atrial fibrosis  
Davies and Pomerance in 1972 first described the structural changes associated with AF in a 
post-mortem examination of 100 patients with AF.161 They described the loss of the atrial 
myocardium in the region of the sinus node, nodal artery stenosis in patients with long-term 
AF.  
Prolonged rapid atrial pacing induces changes in atrial myocytes such as an increase in cell-
size, myolysis (loss of myofibrils), perinuclear accumulation of glycogen, alterations in 
connexin expression, fragmentation of sarcoplasmic reticulum and changes in mitochondrial 
shape.160 Atrial fibrosis has been well documented in patients with lone AF involving severe 
hypertrophy and vacuolar degeneration, lymphomononuclear infiltrates with necrosis of 
adjacent myocytes and non-specific patchy fibrosis.162,163 Structural remodelling can result in 
electrical uncoupling and slow conduction, facilitating AF continuation without inducing 
changes in atrial action potential properties. In contrast to electrical remodelling, structural 
changes are less reversible and they tend to persist even after the re-establishment of sinus 
rhythm.164 
Fibrosis certainly plays a role in animal models of AF, with quantitative relationships linking 
the development on the atrial substrate through its effects of conduction slowing. 165-167 
However, it is unclear from many of these studies associating fibrosis with increased 
predilection to AF whether this is the cause or effect of AF. Several studies investigating the 
left atrial substrate have suggested that AF may be a self-perpetuating disease wherein 
chronic fibrillatory activation of the atria leads to progressive electrical and structural 
remodelling which facilitates ongoing arrhythmogenesis. Although at the cellular level these 
structural changes are complex, the electrical manifestation of the remodelling is that of a 
reduction in myocardial voltage and a decrease in the effective refractory period.  
1.7 Contemporary evaluation of the atrial substrate in persistent AF 
In the era of catheter ablation for AF, the identification of the substrate has been crucial in 
the identification of sites which are deemed to be crucial in the maintenance of AF. Many of 
these involve the morphology of the contact electrogram, with its subsequent analysis which 
can categorise the atria into distinct spatial and temporally regions which can be targeted 
during catheter ablation. As much of this work has been performed in humans, and 
validation of the various parameters defining the AF substrate is challenging, and hence, have 
given rise to the concept of “learning-by-burning” which have dominated much of the AF 
literature over the last decade.  
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1.7.1 Voltage mapping 
Endocardial voltage is often used as a surrogate marker for scar, largely from data 
extrapolated from mapping in the ventricles, and in identifying diseased myocardium as part 
of a substrate based approach in catheter ablation of ventricular tachycardia. By virtue of this, 
atrial voltage mapping may represent an electrophysiologic function of the underlying atrial 
substrate in AF. There is evidence to support that the underlying atrial substrate in the form 
of the presence of low voltage areas can predict the outcomes of catheter ablation of AF168. 
Low-voltage areas in the atrium may represent regions of slow conduction as a 
manifestation of underlying fibrosis, and/or wave collisions representing more functional 
electrophysiologic change and these regions have been purported to be crucial in the 
maintenance of AF.  
Current substrate modification strategies targeting potential AF drivers involve targeting 
these low voltage regions. The spatio-temporal variability of voltages in AF underlie the 
challenges of voltage mapping in AF, and some have adopted an approach of mapping in sinus 
rhythm or during pacing to more accurately study the underlying substrate. Low voltage 
areas are more represented in persistent AF than in paroxysmal AF, in studies utilising 
voltage in the paced-rhythm,169 and in AF.170 Consistent with histological studies, there is 
also regional variation of low-voltage areas in patients with AF exhibiting significantly more 
low-voltage areas in the septum and posterior wall of the left atrium.171 The basis for this 
anatomical predilection of scar, and its association with AF drivers is still yet to be 
elucidated.  
The notion of scar homogenization, once again, extrapolated from catheter ablation of 
where multiple ablation lesions are created within myocardial scar to eradicate all potential 
channels that support the arrhythmia172 has now been described as part of a substrate 
modification approach. Rolf et al described a novel individualized approach for catheter 
ablation of AF based on low-voltage areas in the left atrium.173 Left atrial voltage maps were 
created in sinus rhythm after circumferential PVI, and low-voltage areas defined to regions 
with bipolar endocardial voltages of <0.5mV. Low-voltage areas were present in a-third of all 
patients, and as expected, were more predominant in patients with persistent AF, compared 
to that of the paroxysmal AF cohort (35% vs. 10%). The septum and posterior left atrial 
walls had increased tendencies to harbouring these low-voltage areas, corroborating with 
previous observations.171 An ablation strategy was adopted with the aim of preventing 
substrate-based initiation and perpetuation by elimination of all reduced potentials o smaller 
areas, or by applying strategic linear lesions through larger low-voltage zones. The 12-month 
arrhythmia-free rate was 62% for patients without low-voltage areas, and 70% with patients 
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with low-voltage areas who underwent tailored substrate modification (P=0.3).  The success 
rate in a comparison group of 26 patients with low-voltage areas without further substrate 
modification was 27%. These results suggest that patients with low-voltage areas left 
untreated had reduced outcomes after only PVI, but with additional voltage-based substrate 
modification, they had similar clinical outcomes when compared with patients with normal 
voltages with PVI alone. The same group has subsequently validated a clinical risk score - 
DR-FLASH (based on diabetes mellitus, renal dysfunction, persistent form of AF, LA 
diameter >45mm, age >65 years, female sex and hypertension) for the left atrial 
arrhythmogenic substrate based on low voltage analysis. The score effectively identifies the 
low-voltage area substrate, and the risk of AF recurrence following pulmonary vein isolation.  
The authors suggests that the score may be useful in the identification of patients who may 
require more extensive substrate modification in addition to pulmonary vein isolation.174 
Jadidi et al adopted a similar approach of targeting low-voltage regions, but in a cohort of 85 
patients with persistent AF, high-density endocardial mapping was performed in spontaneous 
or induced AF to delineate low-voltage areas (mean bipolar peak-to-peak over 1-2secs of AF 
<0.5mV). Patients with low-voltage regions of <10% of the total left atrial surface only 
underwent PVI (27%), and the remainder with sustained AF following PVI underwent 
selective atrial ablation at low-voltage areas resulting in termination of AF in 45/62 (73%) 
after 11±9min of radiofrequency ablation (a value significantly lower than the control group 
undergoing PVI and conventional CFAE ablation 21±13min, P<0.05). The extent of left atrial 
low-voltage was significantly lower in patients requiring only PVI than those requiring 
additional left atrial ablation to achieve AF termination (9±5% vs. 39±22%, P<0.01). With a 
mean follow-up of 9±2 months after a single procedure, 66/85 (78%) of patients remained 
arrhythmia-free compared to 58% in the control group. The authors concluded PVI alone 
achieves a high rate of arrhythmia freedom in patients with persistent AF with a low extent 
of left atrial voltage (<10%). However, in patients with a greater extent of low-voltage areas 
which persist in AF following PVI, targeting these low voltage areas results in a higher 
ablation success with significant reduction in the amount of ablation required to achieve AF 
termination compared to conventional PVI and CFAE ablation.134,175,176. 
Others have adopted an approach of identifying voltage gradients to define the atrial 
substrate and targeting low-voltage “bridges” between regions of higher-voltages.177 In this 
study, 54 patients (28 paroxysmal AF and 26 persistent AF) underwent bi-atrial high-density 
endocardial voltage mapping in either sinus rhythm or AF, with voltage levels then adjusted 
until low-voltage connections between higher-voltage regions were identified. The authors 
hypothesized that these low-voltage bridges represent abnormal atrial substrate represented 
by atrial fibrosis and loss of gap junctions seen in the atrium of patients with AF, and 
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targeting these would eliminate the endocardial fragmentation associated with AF. Ablation 
end-points were defined as termination of AF or non-inducibility of AF or atrial tachycardia, 
and completion of substrate guided ablation until there was an absence of low-voltage 
bridges connecting high-voltage regions (absent endocardial linking), and PVI via low-voltage 
bridges ablation (defined as the absence of PV voltage and activation). The primary clinical 
end-point of absence of AF (30 day-event monitors) was achieved in 86% and 79% of 
patients with paroxysmal and persistent AF respectively. They concluded that voltage 
gradient mapping is an effective tool for guiding ablation therapy, and ablation of the low-
voltage bridges connections disrupts wavelet propagation, and terminates AF acutely. 
Mapping small-scale voltage variations identifying critical endocardial linkages and offers 
insight into the underlying mechanism of AF persistence describing the nature of interactions 
between normal and diseased tissue suggesting that the relationship between the low-
voltage bridges and high-voltage regions akin to a syncytium of atrial tissue which act as 
regional wavelet reservoirs. This study discusses the use of endocardial voltage as a useful 
marker of the atrial substrate, and the relationship between voltage mapping in sinus rhythm 
and AF, and whether the recorded voltages represent a combination of activation and 
substrate. In a subset of patients, endocardial voltage mapping was performed in sinus 
rhythm and atrial fibrillation, although the actual methodology of voltage mapping in AF is 
not fully described. The voltage gradient maps in sinus rhythm and AF seem to correlate well 
with the relative values being consistent. The authors hence purport that the voltage 
mapping, regardless of the rhythm, does reflect the underlying atrial substrate. This however 
has not been observed in other studies whereby low voltage regions in AF frequently 
demonstrate normal atrial myocardial characteristics in terms of voltage and conduction 
velocity) during the paced or sinus rhythm.178 In this particular study, AF voltage was defined 
as the amplitude between the maximum peak positive and minimum peak negative 
deflections over 5 sec of recording. Studies with non-contact mapping in the left atrium have 
also described disparities in voltage during sinus rhythm and AF.179  
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Figure 1.22 Voltage mapping in sinus rhythm and AF 
The overall voltage was adjusted demonstrating lower voltage observed during atrial 
fibrillation. Low-voltage bridges are observed in similar locations regardless of the underlying 
rhythm. Because some variation in endocardial surface sampling exists, variation in the 
voltage gradient maps is unavoidable. However, the large-scale structures remain remarkably 
similar. Red arrows connect voltage regions that demonstrate the similarities recorded in 
sinus rhythm and atrial fibrillation. Adapted from Bailin et al.177 
 
Interestingly, and almost paradoxical to their above observation of mapping in AF and sinus 
rhythm, they also observed that these low voltage bridges activate the atrial endocardium 
selectively and ablations of these bridges results in a regional loss of voltage within the 
atrium. This suggests that at atrial endocardial activation is not homogenous, and is 
multidirectional and that endocardial activation has focal inputs identifiable by an adjacent 
low-voltage bridge. This observation may be supported by the phenomenon of “voltage 
discordance” which describes that voltage maps performed during macro-reentrant atrial 
arrhythmias often vary significantly from maps obtained in sinus rhythm. Shivkumar et al 
observed that the overall right atrial mean voltage was significantly higher in typical atrial 
flutter compared to sinus rhythm.180 These findings are preceded by observations seen 
during device implantations where the electrogram voltage on the atrial lead during sinus 
rhythm is typically larger than in atrial flutter or AF.181 Peak negative voltage in the right 
atrium has also been noted to be lower at faster pacing cycle lengths in patients with atrial 
flutter when assessed with non-contact mapping.182 The underlying basis for this 
phenomenon includes the cancellation of wavefronts and functional/anatomical blocks, 
factors such as fiber geometry/anisotropic cellular geometry183-185 and wavefront 
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curvature.179,186 It is important to take this phenomenon into consideration in understanding 
the true electroanatomic substrate for a patient, as failure to do so may result in inaccurate 
representations of the anatomic substrate and the mis-identification of critical isthmus and 
unnecessary ablation lesions.  
Some of the discrepancies in the interpretation of endocardial voltage mapping may well be 
explained by the basic principles of unipolar versus bipolar mapping where the electrode 
orientation and its interaction with the propagating wavefront have crucial effects in the 
electrogram voltage (and morphology).187 In almost all the studies, bipolar voltage mapping 
was employed, and the interaction of the activation wavefront and the bipoles (and their 
orientation) may result in the different values recorded.  
1.7.2 Complex Fractionated Atrial Electrograms 
One of the purported characteristic features of the underlying substrate is the presence of 
complex fractionated electrograms (CFAE). This phenomena has been observed in intra-
operative epicardial mapping of human AF, and have been described to coincide with areas 
of slow conductions and/or pivot points where the wavefront activation turn around at the 
end of arcs of functional block.69. This was corroborated in subsequent similar 
demonstrations suggesting that the morphology of electrograms during AF reflects the 
occurrence of various specific patterns of conduction as discussed above.188 The authors 
postulated that the electrogram morphology might be used to identify regions with 
structural conductions disturbances involved in the perpetuation of AF. Interestingly, Cosio 
et al had previously identified complex electrograms being crucial in the determination of 
abnormal conduction in typical atrial flutter.189 The regional distribution was described by 
Jais et al describing regional bi-atrial disparities in endocardial fractionation in paroxysmal AF, 
with complex fractionation had a predilection to the septal and posterior regions of both 
atria, and more regular activity seen in the trabeculated atria.190 As an extrapolation to AF, 
they concluded that fragmented electrograms often found in AF may be related to abnormal 
local conduction in relation to the re-entrant activation circuits (defined as either continuous 
re-entry of the fibrillation waves into the same area, or overlap of multiple different wavelets 
entering the same region at different times). There has also been an observed association 
between CFAE and the AF cycle length (AFCL), with a shortening in AFCL observed 
preceding the development of maximum fractionation at 91% of mapped sites, affirming the 
functional nature of these electrograms.191 These findings formed the basis of selective 
elimination of CFAE with catheter ablation as part of a substrate modification approach, 
whereby wavelet re-entry should stop, and prevent perpetuation of AF.  
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However, ablation of CFAE has achieved mixed clinical results. Nademanee et al reported 
70% of a balanced paroxysmal and persistent AF cohort of patients being arrhythmia-free off 
medical therapy a year following a single ablation procedure in 2004.11 More recently, long-
term outcomes from the study were published. For a mean of 1.68 procedures, 81% of 
patients were in sinus rhythm (average of 2.3 years follow-up), with only 13% remaining on 
medical therapy. Unsurprisingly, other operators and centres have not reproduced these 
impressive results. Oral et al solely performed CFAE-targeted ablation in 100 patients with 
persistent AF, and reported a mediocre success rate of 33% maintenance of sinus rhythm 
without medical therapy at a mean follow-up of 14 months.192 Most other investigators have 
incorporated CFAE-targeted ablation into a multifaceted ablation strategy, without the 
degree of benefit seen by Nademanee.193-195 A meta-analysis of CFAE ablation in addition to 
PVI demonstrated that adjuvant CFAE ablation increases the success rate of AF freedom in 
non-paroxysmal AF patients but does not provide additional benefit to in PAF patients.15 
Mostly recently, the STAR-AF II trial has reported no additional benefit of CFAE ablation in 
patients with persistent AF in addition to pulmonary vein isolation.196 Wong et al recently 
reported the non-incremental benefit of CFAE ablation when performed in conjunction with 
pulmonary vein isolation, and linear lesions (roof and mitral isthmus lines) in a multi-centre 
randomized study. With a mean follow-up duration of 35±5 months, both single and multiple 
procedure success rates were not significantly different (CFAE: 30/65 [46%] vs. control 
37/65 [57%], p=0.29 and CFAE: 51/65 [78%] vs. control 52/65 [80%], p=1.0 respectively). 
They noted a higher incidence of organised atrial tachycardias at the first-re-do procedure in 
patient who underwent CFAE ablation.197  
Hence, the role of CFAE ablation in modification of the substrate is still debated. Some 
discrepancies in clinical outcomes and the lack of reproducibility may be due to the 
subjective analysis of CFAE classification, which are varied and plentiful and results in non-
specificity of areas which are targeted.  In addition, there is also no widely accepted strategy 
of eradication of these electrograms once they have been identified. There has also been 
questions over the stability of CFAE in the context of a spatio-temporally variable rhythm 
has also been debated. An elegant study by Sanders et al using an automated algorithm 
(NavX “CFEmean”) for evaluation of CFAE reported that electrograms of greater than 5 sec 
duration were required to accurately characterise CFAE site, and recordings of less than this 
duration have unacceptable rates of error and may mislead in targeting appropriate sites.198 
However, other groups have made contrary observations where fractionation (which was 
expressed by significant dominant frequency variability) being detected only for 18.0±19.0% 
of the entire duration of recording at ganglionic plexi sites, and 12.7±13.4% at the posterior 
LA wall suggesting that fractionation was transient.199 
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Nevertheless, there are certainly observations that support that CFAE do describe and 
characterise the AF substrate such as the slowing of the AFCL or acute AF termination 
when CFAE regions were specifically ablated.14 Biophysical computer simulation models have 
suggested an inverse relationship between the number of focal sources maintaining AF and 
the AFCL.200 The relationship between CFAE and focal sources of AF remains poorly 
defined. Narayan et al, using FIRM mapping, that AF sources had diverse voltage 
characteristics and poorly correlated with CFAE. Most CFAE sites lie remote from AF 
sources and are not suitable targets for catheter ablation of AF.201 Others have also 
demonstrated that CFAE regions lies in healthy tissue regions, as determined by voltage 
mapping in sinus rhythm and LGE-CMRI suggesting their functional basis. 202,203 
1.7.3 Dominant Frequency 
Analysis of electrograms within the time domain has led to identification of features such as 
complex fractionation discussed above. However, due the apparently chaotic nature of 
electrical activity during AF, it may be challenging to see the underlying patterns of 
depolarization that may be crucial in the substrate maintaining AF. In order to overcome 
these limitations of CFAE mapping, spectral analysis, including dominant frequency (DF), has 
been used to detect areas of high frequency activation (with the assumption that such areas 
represent focal ectopic sources or local re-entry, which serves as AF drivers) with greater 
accuracy, through the analysis of electrograms in the frequency domain by fast fourier 
transform.204,205 Using this, the information on local activation may be distilled from an 
electrogram, which is otherwise too complex or noisy to be appreciated in the time domain.  
DF refers to the frequency with the largest amplitude at the power spectrum of the 
electrogram. The spatial hierarchical organization of local DF of the atria is thought to 
represent the fibrillatory conduction as a result of waves emanating from focal 
sources/drivers which subsequently interact with anatomic and functional obstacles. The 
origin of the DF is pathophysiologically distinct from that of CFAE, and morphologically, DFs 
have high-frequency activation but are devoid of the fractionation of CFAEs.206 Regions of 
high DF and CFAE show limited overlap when concomitantly mapped.207   
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Figure 1.23 Dominant frequency analysis 
Dominant frequency (DF) represents the main activation rate of the underlying tissue 
through spectral decomposition of the electrogram. A regular activation rate will give a 
narrow DF peak (left panel), whereas an irregular activation rate will lead to a wide peak. 
Adapted from Jarman et al.91 
  
Spectral analysis in animal208 and human209 paroxysmal AF have demonstrated high DF 
regions at the left atrial-pulmonary vein junctions, and gradients toward the left and right 
atria, with co-localisation of sources to these high DF sites. The distribution of high DF sites 
is more widespread in patients with persistent AF, mainly outside the region of the 
pulmonary veins, with higher DF values observed, compared to patients with paroxysmal AF. 
DF analysis has been thought to provide mechanistic understanding of the persistence of AF, 
and targeting of these sites and eradication of a left atrium-right atrium DF gradient predicts 
long-term freedom from both paroxysmal and persistent AF.89 However, other studies have 
shown mixed clinical outcomes, with no clear additional benefit over pulmonary vein 
isolation alone in either patients with paroxysmal or persistent AF.210  
This approach has encountered similar problems to CFAE mapping as regions of wavefront 
collision (collisions of multiple drivers can result in a pseudo-short frequency analysis) and/or 
rotational activity may lead to artificially high DF values that do not accurately represent the 
underlying activation rate. It is also vulnerable to phase shifts causing artefact in the 
frequency domain. As a result, dominant frequency ablation outcomes are conflicting, with a 
lack of spatiotemporal stability in high DF regions limiting the clinical utility of the 
parameter.91 These factors may account for the mixed clinical outcomes when sites of DF 
are targeted as part of a substrate modification approach. Further, there is also the technical 
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limitation of DF mapping and guided ablation as there is no currently available high-
resolution 3D mapping systems which can aid in localization of these DF sites in real-time.   
1.7.4 Late-gadolinium enhanced cardiac magnetic resonance imaging 
Cardiac MRI has shown promise in the detection of atrial structural remodelling. Late-
gadolinium enhanced cardiac magnetic resonance (LGE-CMRI) imaging appears a useful tool 
of delineating left atrial fibrosis in vivo, and evaluation of the structural re-modelled substrate 
in patients with AF. This technique has been extrapolated from the imaging of ventricular 
myocardium, where it has been shown to be an effective modality to identify in vivo fibrotic 
non-viable myocardium in coronary artery disease and cardiomyopathies.211 This technique 
of late-gadolinium enhancement takes advantage of the differential uptake and washout 
kinetics of gadolinium contrast in blood, healthy myocardium and myocardial scar. 212,213 The 
conception of this technique was initially in the identification of ablative scar post-pulmonary 
vein isolation, and the extent of post-procedural late-gadolinium enhancement was reported 
to correlate with the recurrence of AF.214,215 Since then, with the improvement spatial 
resolution of MRI and post-processing algorithms, its use has been extended to identify non-
iatrogenic or intrinsic/native left atrial fibrosis. Whereas ablative scar sites are represented 
by bright scar tissue (healed burn) with LGE-CMRI, native fibrosis is subtler. Accepting 
technical difficulties surrounding spatial resolution of MRI and susceptibility to partial volume 
effects from surrounding tissue, and the challenges of quantitative analysis of left atrial and 
pulmonary venous late-gadolinium enhancements, the extent of LGE-CMRI has now been 
shown to correlate to clinical parameters which has traditionally been use as surrogate 
markers of left atrial structural remodelling such as left atrial size and the persistence of 
AF.216 Clinical outcomes post-ablation are also influenced by the degree of structural 
remodelling (Utah stages I-IV) as determined by LGE-CMRI, where patients in Utah stage IV 
(>30% LA LGE) having the worst outcomes.  The same authors have validated their 
technique with endocardial voltage mapping, demonstrating that areas of left atrial late-
gadolinium enhancement correlate to low-voltage areas in pre-ablation patients,217 and have 
reported, in a small series of 10 patients with a history of AF where histological evidence of 
remodelling based on evaluation of collagen content with Masson trichrome staining 
correlated with structural remodelling on LGE-CMRI.218 Despite this optimism, its use in 
clinical practice has only been restricted to a few specialist centres, where the majority of 
the evidence supporting its use has been generated.  
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1.8 The contact electrogram  
The extracellular electrogram or the contact electrogram, routinely recorded clinically from 
2-4mm electrodes in contact with myocardium, is the signature of the interaction of 
electrical activation and architecture of the local myocardium. In terms of fundamental 
physics, the origin of the electrogram is the superposition (or summation) of the electric 
fields of ions in the vicinity of the electrode. Both the ion flux across cell membranes, 
producing the action potential, and the propagation of the action potential lead to variations 
in electric field strength at the electrode and the subsequent electrogram morphology.219 
The recorded electrograms contain 3 important pieces of information: (1) the local 
activation time (i.e. the time of activation of myocardium immediately adjacent to the 
recording electrode relative to a reference), (II) the direction of propagation of electrical 
activity within the field of view of the recording electrode and (III) the complexity of 
myocardial activation.  
1.8.1 Structural and functional determinants 
The extracellular electrogram is derived from the propagation patterns and morphology of 
the composite action potentials. Therefore, pathological changes to electrogram morphology 
can be due to either abnormalities in the transmembrane ion channels, changes in cell-cell 
coupling or the presence of non-conductive areas which may be reflected by different 
variables such as non-uniformed anisotropy and the presence/absence of scar (structural 
determinants).220 As a generalization, healthy myocardium gives rise to a simple electrogram. 
However, pathological conditions can lead to changes in electrogram characteristics 
rendering the morphology more complex. At present, clinical categorisation of electrograms 
is by largely binary descriptors – simple or fractionated, early or late, etc., with very little 
insight into the content of the signal itself. 
In addition, the manner by which the recordings have been acquires can have a considerable 
influence on the electrogram morphology: the recording technique: unipolar or bipolar, 
mapping catheters used (type and size of electrodes and their spacing), and the filter settings 
of the amplifiers used.221-223 These will be discussed in greater detail in the relevant chapters, 
but can affect electrogram morphology as a result of far-field effects and degrees of electrical 
noise suppression. Figure 1.24 summarises the various factors which may affect electrogram 
morphology.  
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Figure 1.24 Factors affecting electrogram morphology 
The morphology of electrogram can be affected by various factors. (A) Location of electrode 
during unipolar recording can result in changes in electrogram pattern (uniphasic Qs 
pattern/biphasic). (B) The presence of scar can result in local anisotropic conduction and 
electrogram fractionation. (C) A region being repeated activated by a rotor will result in 
continuous activation patterns. (D) Premature extra stimulus can result in electrogram 
fractionation as a result of functional conduction slowing. Adapted from de Bakker et al.223 
 
 
 
 
 
 
  
(A) Electrode location (B) Fibrosis 
(C) Activation pattern (D) Premature Extrastimuli 
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1.9 Scope of thesis 
This thesis sets out to address the hypothesis that the local electrogram morphology is 
determined by local atrial myocardial activation patterns, which are in turn determined by 
local atrial myocardial architecture.  Determining the relationship in these clinically 
accessible co-localisable measurables in human persistent AF, provides crucial mechanistic 
insights and attempts to understand the electroarchitecture of the arrhythmic substrate in 
persistent AF.   
Chapter 1 provides the background of AF, and the current understanding of the persistence 
of AF. It details the electrophysiologic substrate based on the contact electrogram-
morphological analyses - voltage, fractionation and time-domain and spectral analysis such as 
dominant frequency, and more contemporaneously, mapping of activation patterns including 
that of phase mapping. The representation of the structural substrate in-vivo and the role of 
atrial fibrosis in the maintenance of AF is discussed, with focus on the relatively new 
technology of left atrial late-gadolinium enhanced cardiac magnetic resonance imaging (LGE-
CMRI) in the detection of atrial fibrosis and its clinical implications. 
In addressing the hypothesis, the left atrium in patients with persistent AF was studied in 
detail (both in terms of structure and electrophysiology). A novel automated method of 
visualizing left atrial scar in patients with paroxysmal AF who have undergone left atrial 
ablation had been developed within our group using LGE-CMRI. This has been extended to 
the detection of native left atrial fibrosis in patients with persistent AF, who have a higher 
degree of structural remodelling. High-density endocardial electroanatomical mapping of the 
left atrium was performed to obtain electrophysiological parameters in both AF and the 
paced-rhythm, utilizing a “kernel” as a unit of measure. Registration of the left atrial scar 
maps derived from the LGE-CMRI and the 3D electroanatomical maps allows for co-
localisation of these parameters allowed us to address the hypothesis that LGE-CMRI 
detects changes in the atrial myocardial architecture which determines functional atrial 
electrophysiology. The methodology of the invasive electroanatomical and non-invasive LGE-
CMRI forms the basis of Chapter 2. Methodology involving reverse translational aspects of 
the work carried out – the co-culture of HL-1 atrial cardiomyocyte tumour cells, and 
neonatal rate ventricular myocytes (NRVM) with fibroblasts with multi-electrode array 
(MEA) in AF and the paced-rhythm to elucidate the functional and structural determinants of 
the electrogram morphology is also discussed here. 
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Chapter 3 presents the results of the quantification of the burden and distribution of left 
atrial scar as determined by LGE-CMRI in patients in persistent AF. The burden of left atrial 
scar, signifying the degree of structural remodelling, correlates with clinical parameters such 
as the duration of persistent AF and the CHADS2VASC score. As noted by other centres 
utilising LGE-CMRI, there is a predilection of left atrial fibrosis to the posterior left atrial 
wall, and in particular, the left inferior quadrant, adjacent to the left inferior pulmonary 
artery. The underlying basis for this anatomical distribution of left atrial scar is not known, 
although interference of the enhancement from extra-cardiac structures in close proximity 
to the posterior wall such as the descending aorta, oesophagus and vertebral column may 
play an important role on an individual patient basis. This chapter also discusses the need for 
rigorous segmentation of the left atrium from the raw LGE-CMRI sequences to ensure 
accurate projection of the enhancements onto the left atrial shell, and exclusion of extra-
cardiac enhancements, and the reproducibility of LGE-CMRI as a technique for atrial scar 
visualisation.  
The influence of left atrial enhancement on the electrophysiologic substrate was studied, and 
results presented in Chapter 5. Endocardial voltage, in AF and the paced rhythm, 
fractionation indices and conduction velocities at various pacing rates were correlated to the 
underlying degree of late-gadolinium enhancement. There was an unexpected inverse 
relationship between left atrial late-gadolinium enhancement and electrogram fractionation, 
suggesting a predominant functional component of EGM fractionation in AF. Conduction 
velocities were only significantly reduced at faster pacing rates in regions of patchy and 
dense left atrial scar as determined by LGE-CMRI, emphasizing the dynamic nature of 
changes in the electrophysiology and its interaction with the underlying atrial myocardial 
architecture.  
Endocardial mapping in AF is challenging due to the spatio-temporal variability of contact 
electrograms. Voltage mapping has been utilized to describe the underlying substrate, but 
mapping in AF has largely been ignored, in part due to the above, but also as a result of the 
limitations of current 3D mapping systems. More recently, low voltage areas in AF have 
been targeted as part of a substrate modification approach in the catheter ablation of AF. 
Although varying with time, AF voltage may inform us of the underlying AF substrate when it 
is systematically characterized over varying sampling windows, and increasing its sampling 
window allows for meaningful spatial differentiation. The relationship of this novel metric of 
mean AF voltage with late-gadolinium enhancement was studied, and compared to sinus 
rhythm voltage. These findings are summarized in Chapter 4, including the observations 
suggesting that mean AF voltage may more accurately represent the underlying atrial 
substrate.  
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As mentioned above, the complexities of mapping the spatiotemporal variations in AF limit 
the understanding of the functional electrophysiological determinants of AF. The assessment 
of the regional electrophysiologic relationship between AF and the paced rhythm sought to 
simplify the problem of understanding the electrical properties of AF, and the results 
presented in Chapter 6. Voltages in AF correlated to that in the paced rhythm and to 
fractionation of electrograms, but not CV. This suggests that the electrophysiologic 
substrate of AF can be interrogated in the paced rhythm, and this could provide crucial 
insights into the underlying mechanisms of AF.   
Chapter 7 summarises the ex-vivo reverse translational with the cell-monolayer model (HL1 
and NRVM) co-cultured with fibroblasts to study the effect of fibrosis on electrogram 
morphology. The introduction of fibroblasts leads to increased intrinsic fibrillation and 
fibrillation is associated with low peak-to-peak voltage electrograms. This model suggests 
that voltage may have a more dominant functional rather than a structural basis in AF.   
Increased fibroblast burden also led to an increase in electrogram fractionation, and 
conduction slowing via cellular uncoupling with carbenoxolone amplified this. This model 
validates clinical findings that electrogram fractionation may predict arrhythmia vulnerability, 
and may prompt the re-visiting of ablation of fractionated electrograms, but specificity of 
electrogram fractionation may still be problematic.   
Chapter 8 summarizes the major findings from this thesis, and expands on future directions 
for research. It advises caution in the interpretation of LGE-CMRI and suggests novel 
techniques in AF activation mapping which may allow better interpretation of the AF 
substrate and which may direct more meaningful catheter ablation strategies.  
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2 Methodology 
 
2.1 Patient selection 
Patients with symptomatic persistent AF (based on the classification of AF by published 
guidelines from the AHA/ACC/HRS/ESC224) presenting for their first ablation to Imperial 
College Healthcare NHS Trust were prospectively enrolled. The study was approved by the 
Local Research and Ethics Committee for Imperial College Healthcare NHS Trust and 
written informed consent were obtained from all patients. Patients with contraindications to 
undergoing late-gadolinium enhanced cardiac magnetic resonance imaging were excluded 
from the study.  
2.2 Left atrial late-gadolinium enhanced cardiac magnetic resonance 
imaging (LGE-CMRI) 
Imaging of the thin left-atrial wall is challenging, and inadequate resolution remains a 
significant problem. The majority of previous imaging approaches to identification of left 
atrial fibrosis and the structural substrate in AF are based on secondary effects such as 
changes in atrial dimensions and volume. Late-gadolinium enhanced cardiac magnetic 
resonance imaging (LGE-CMRI) is an effective well-established modality in identifying in vivo 
left ventricular fibrosis in coronary artery disease and cardiomyopathies. 225,226 The 
technique of late gadolinium enhancement takes advantage of the differential uptake and 
wash-out kinetics of gadolinium contrast in blood, healthy myocardium and myocardial 
scar.213 With improvements in the quality of magnetic resonance imaging, left atrial fibrosis 
has now been visualized with LGE-CMRI.227  
2.2.1 LGE-CMRI protocol 
All imaging was performed using a 1.5 T Philips Achieva MR system and a 5 or 32 element 
phased array cardiac coil. The technique used for LGE imaging has been described 
previously.228 Initial survey and reference scans were performed to determine cardiac 
position and orientation followed by an axial white blood anatomy image. A vertical long axis 
and a horizontal long axis were also acquired to help with positioning. A 50 phase 2D cine 
was acquired at the level of the atrioventricular groove to determine the time after the R 
wave with the least right coronary artery (RCA) movement and this time delay was used for 
subsequent ECG-gating.  
 84 
Further anatomic detail of the left atrium (LA) and pulmonary veins (PVs) was obtained by 
using non-ECG gated 3-D spoiled gradient echo contrast enhanced timing robust 
angiography (CENTRA) during the first pass of a 20 ml bolus of gadobenatedimeglumine 
contrast agent. This sequence was used at the time of the catheter ablation procedure for 
segmentation and registration with the mapping systems. 3D left ventricular LGE breath hold 
sequence was acquired at approximately 9 minutes post-contrast. To further delineate LA 
anatomy and acquire a high resolution LGE image, an ECG triggered, free-breath navigator 
gated, whole-heart 3-D spoiled gradient echo sequence was acquired in an axial orientation, 
with an acquired resolution of approximately 1.5 x 1.5 x 4 mm and reconstructed to 1.25 x 
1.25 x 2 mm. Complete LA coverage was obtained with 40-50 slices. Data were acquired 
within a window of 100-150ms within each R-R interval depending on heart rates, with a 
low-high k-space ordering and spectral pre-saturation with inversion recovery (SPIR) for fat 
suppression. The inversion recovery delay was determined from a Look-Locker sequence, 
with an inversion time chosen to null myocardial signal. 
2.2.2 Image processing methods to identify native atrial enhancement 
Interpreting 2D MR slices within a complex structure such as the left atrium and pulmonary 
veins is challenging and therefore most centres describe the generation of 3D atrial 
reconstructions to aid visualisation of atrial enhancement. This requires segmentation of the 
LA and PVs from the MRA with registration to the free-breathing, late-enhancement  
sequence, or manual slice-by-slice segmentation of the late-enhancement which is time-
consuming but may provide a more accurate anatomy, and crucially, exclude extra-cardiac 
enhancing structures. These steps introduce inherent inaccuracies to the process of 
visualising a thin-walled structure, which is moving with the cardiac cycle and respiration. 
ECG-gating and respiratory navigation considerably improve the accuracy of the sequence, 
however, atrial fibrillation (particularly uncontrolled heart rates) and inconsistent breathing 
patterns remain significant challenges in producing high-quality LE images of the LA.  
Current methods to identify regions with levels of enhancement defined as “scar” requires 
operator selection of a region of myocardium with normal appearance within the LA wall. 
To remove operator bias, we used the blood pool as a non-enhancing region against which 
the LA wall enhancement could be compared and normalised. The blood pool was identified 
automatically by shrinking the LA segmentation using mathematical morphology, and the 
mean and standard deviation (SD) intensity of the blood pool calculated. Intensity of the LA 
wall was determined automatically as the maximum intensity along the normal at each 
location or cell of the surface mesh, to a distance along this chord of 3mm inside and outside 
of the LA surface to allow for LA wall thickness and minor registration mismatch. LA wall 
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intensities were normalised (NLA) to the blood pool by expressing the directly measured 
value of LA wall intensities (ILA) as a multiple of the standard deviation (SDBP) above the 
blood pool mean (MBP) according to the following formula: 
NLA= (ILA- MBP)/SDBP 
NLA was expressed either as a continuous variable or categorically as multiples of SD such that: SD 0 
is NLA<0.5; SD 1 is NLA= 1 ± 0.5; SD 2 is NLA=2 ± 0.5; etc. 
2.2.3 Atrial segmentation from MRA sequence 
3D manual segmentation of the LA was performed using the Philips Workstation by an 
experienced cardiac radiologist from the MRA sequence, and hence essentially results in the 
atrial anatomy constructed from delineation of the endocardial LA border (Figure 2.1) The 
method of producing the atrial segmentation is not critical to the automated process of 
atrial scar mapping however the quality of the anatomical surface is important for accurately 
displaying regional atrial enhancement. The segmented atrial surface was used as the 
reference anatomy to which the normalized late-gadolinium enhancement is projected onto. 
Rigid or non-rigid registration was performed depending on the degree of overlap between 
MRA and LGE sequences, with manual verification of registration quality prior to analysis of 
LGE regions. 
 
Figure 2.1 Left atrial geometry from left atrial MR angiography sequences 
The reference atrial anatomy (right most image) is derived from manual segmentation of the 
MRA sequences on the Philips Workstation. 
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Figure 2.2 summarises the semi-automated process of the construction of the left atrial scar 
map from our group’s previously published method.228 
 
Figure 2.2 Left atrial “scar” map from LGE-CMRI 
Summary of the semi-automated process of the construction of the left atrial scar map from 
LGE-CMRI including the post-processing algorithms. 
 
2.2.4 Atrial segmentation from LGE-CMRI sequence 
Following our initial experience, we observed discrepancies in the registration of the 
reference anatomy created from segmentation of the MRA sequences to that of the late-
enhancement sequences which results in inaccurate representation and projection of the 
normalized late-gadolinium intensities (Figure 2.3). This error may arise as a result of 
inaccurate LA segmentation from the MRA sequences as a result of inadequate opacification 
of the left atrium. Further, segmentation of the anterior LA wall is often challenging as a 
result of its close association with the aortic root and a portion of the ascending aorta. It 
also has to be noted that the sequences acquired for the MRA and the late-enhancement are 
very different, with the former being performed during a single breath-hold during the 
gadolinium bolus, and the latter acquired during free-breathing with both ECG and 
respiratory navigator gated.  
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Figure 2.3 Discrepancy during registration of MRA and LE sequences 
Transverse slices of the left atrium from late-gadolinium enhancement sequences with 
overlying left atrial reference anatomy shells acquired from the MRA sequences (yellow 
outline). This illustrates the discrepancies in the registration of the MRA and LE sequences 
which results in inaccurate representation and projection of the normalized late-gadolinium 
intensities onto the reference anatomy.  
  
To overcome this, the reference anatomy was obtained from manual 2D slice-by-slice 
segmentation of the late-enhancement, which is time-consuming but offered a more accurate 
representation of the late-gadolinium enhancement intensities. This more precise 
segmentation also offered the advantage of accurately delineating the epicardial surface of 
the left atrium, and excluding late-gadolinium enhancing extra-cardiac structures which are in 
close proximity and often abuts the left atrium such as the oesophagus, ascending and 
descending aorta and vertebral column (Figure 2.4).   
These are all further discussed in greater detail Chapter 3.  
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Figure 2.4 Extracardiac late-gadolinium enhancing structures 
2D slice-by-slice manual segmentation of the left atrium allows for exclusion of extra-cardiac 
structures (red) which enhance on the late-gadolinium sequences such as the oesophagus, 
wall of the ascending aorta (AscAo) – left panel, and the vertebral column, wall of the 
descending aorta (DesAo) and mitral valve annulus (MVA). RA: right atrium, LA: left atrium, 
LAA: left atrial appendage, LIPV: left inferior pulmonary vein, LV: left ventricle and AoR: 
aortic root.  
 
2.2.5 Optimisation of LGE-CMRI post-processing 
Our previous method of atrial segmentation involved delineating the endocardial border of 
the left atrium from the MRA sequence. Hence, to assignment of left-atrial enhancement, the 
post-processing involved an automated algorithm whereby the maximum intensity along the 
normal at each location or cell of the surface mesh, to a distance along this chord of 3mm 
inside and outside of the LA surface to allow for LA wall thickness and minor registration 
mismatch. However, with the improved 2D slice-by-slice segmentation process, the 
maximum intensity along the normal at each location, to a distance along this chord of 3mm 
inside only as segmentation delineated the epicardial left atrial surface, and excluding the 
extension of the chord to 3mm outside ensured that enhancement from extra-cardiac 
structures are not erroneously included.  
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Figure 2.5 Optimisation of LGE-CMRI post-processing 
The maximum intensity along the normal at each location on the LA surface, to a distance 
along this chord of 3mm inside of the LA surface only is used for assigning a normalized left 
atrial intensity. 
 
2.3 High density endocardial electroanatomical mapping 
All anti-arrhythmic drugs were discontinued for at least 5 half-lives, and amiodarone was 
discontinued at least 60 days, prior to the ablation procedure. All procedures were 
performed in the post-absorptive state under general anaesthesia. Transoesophageal 
echocardiography was performed in all patients once under general anaesthesia to exclude 
left atrial appendage clot, and to subsequently guide transseptal puncture. A deflectable 
decapolar catheter (Inquiry, St Jude Medical, St. Paul, MN, USA) was positioned in the 
coronary sinus to record electrograms, pace the atrium, and serve as a spatial reference. A 
pentapole with a proximal reference electrode in the inferior vena cava was placed to allow 
for acquisition of unipolar recordings. Single transseptal punctures were performed using a 
Brokenbrough needle through a fixed curve long-sheath (SL0, St Jude Medical, MN, USA). 
Unfractionated heparin was administered to achieve an activated clotting time of 300-350s 
throughout the procedure. An impedance-based electroanatomical mapping system (NavX 
Ensite Velocity, St Jude Medical, MN, USA) was used. The left atrial geometry and all 
subsequent data were acquired using a 20-pole double-loop catheter (InquiryTM AFocusIITM, 
St Jude Medical, MN, USA) with 4mm electrode spacing. Bipolar electrograms were 
recorded and displayed at filter settings of 30-500Hz, and unipolar electrograms at 0.5-
100Hz during the procedure. Prior to any radiofrequency therapy, map data acquisition was 
performed according to the study protocol.  Subsequent to the study protocol, all PV's were 
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isolated, followed by a "stepwise approach" for modification of the AF substrate, at the 
discretion of the operator.  
2.3.1 The Kernel as a regional unit for comparative measurement 
The challenge of making regional comparisons of various electrophysiologic metrics such as 
conduction velocity, voltage and fractionation was resolved by establishing the "Kernel" as 
the spatial element of measure, a novel methodology used in this study. We defined a 
“Kernel” as the area of atrial myocardium mapped which is subtended by the high density 
mapping catheter, the AFocusII.   Any given “Kernel” consists of a set of 20 simultaneously 
acquired electrograms (both unipolar and bipolar).  As dictated by the dimensions of the 
electrode configuration on the catheter (and accounting for 5mm extrapolation beyond the 
boundary electrodes) the Kernel takes the shape of a circle, 3cm in diameter, resulting in an 
extrapolated surface area of ~10.6cm2.  20 unipolar recordings evenly spread across this 
surface yield a Kernel point density of 1.89pts/cm2.  Thus at any given “Kernel” location, the 
various electrophysiologic parameters in AF and sinus/paced rhythm could be compared 
against one another, in conjunction with the underlying atrial late-gadolinium enhancements. 
 
Figure 2.6 “Kernel” as a unit of measure 
All electroanatomic mapping was performed using a high-density mapping catheter, the 
AFocusII. The area mapped subtended by the AFocusII catheter is termed a “Kernel”, and is 
utilised as a unit of spatial measure allowing comparative evaluations of various 
electrophysiologic indices.   
 
AFocusII catheter!
Left atrial geometry!
“Kernel”!
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2.3.2 Voltage endocardial mapping in sinus- and paced rhythms 
All patients then underwent external electrical cardioversion to sinus rhythm. A 15 min 
interval was taken prior to mapping to avoid any acute post-cardioversion phenomenon. 
Localised electroanatomical maps (unipolar voltage and activation) were created during left 
atrial pacing. Unipolar signals were used for measurements of voltage to remove any 
discrepancies due to variation in bipole orientation on the AFocusII catheter, and its 
interaction with variable wavefront activations (Figure 2.7).  
 
Figure 2.7 Acquisition of unipolar paced electrograms 
Illustrative example of unipolar electrogram recordings from the mid-posterior left atrial 
wall during pacing from electrodes CS56 of the decapolar catheter placed in the coronary 
sinus (Left panel). The corresponding acquired electrograms are shown (Right panel).  
 
 
Pacing was performed from 2 separate left atrial sites (usually from the low posterior wall 
with pacing with the CS decapolar and from the left atrial roof with the ablation catheter), at 
cycle-lengths of 600ms, 400ms, 350ms, 300ms and 250ms. The AFocusII catheter was held 
stable, tangential to the LA surface, for up to 3 seconds during appropriately captured pacing 
before unipolar voltages (peak-peak) and activation timings (peak -dV/dt) were catalogued 
(Figure 2.8).  
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Figure 2.8 Measurement of voltage and activation time for paced 
electrograms 
2 illustrative examples of the measurement of the peak-to-peak voltage and local activation 
time referenced to a fixed electrode (in this instance a CS electrode) from the annotated 
unipolar electrograms (peak negative dV/dt). 
 
The electroanatomical data acquired subsequently generates a voltage and activation map. As 
a further safeguard against insufficient contact, the interior projection distance was set to 5 
mm.  During pacing at each independent site and rate, a mean number of 53±10 points were 
collected consisting of 2.6±0.5 acquisitions or simultaneously acquired "Kernels" evenly 
distributed across the posterior left atrial wall per patient. Due to the “flat” nature of the 
posterior wall, mapping of the posterior left atrial wall allows for the acquisition of a good 
complement of high quality electrograms as a result of the optimised tissue contact of the 
majority of the 20 electrodes of the AFocusII catheter, in contrast to whilst mapping of 
other left atrial sites. 
2.3.3 Voltage endocardial mapping in atrial fibrillation 
All patients were in AF on the day of the procedure. Baseline AF data was initially acquired 
and displayed in the form of a Complex Fractionated Electrogram (CFE) map. While bipolar 
electrogram data was used during the study, unipolar electrograms were also acquired for 
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some retrospective analysis.  The technique of acquiring CFE maps using an automated 
algorithm (NavX Ensite, St Jude Medical) has been previously described and validated. Atrial 
bipolar electrograms acquired using a multipolar catheter were analysed to compute the 
mean interval between the multiple deflections over an 8 second period of time (CFEmean). 
The CFEmean is then represented on the geometric shell as a colour-coded display. Based 
on previous studies, CFE areas were defined as sites having a CFEmean of <80ms. We used 
the following CFEmean tool parameters: CL 80-120ms; EGM width <10ms (to avoid 
detecting far-field signals); EGM refractory period 40ms; peak-to-peak sensitivity 0.04 mV (to 
avoid sensing noise); Interpolation was set to 10mm, and interior projection 5mm (as an 
exclusion criteria for insufficient contact). Contact bipolar electrograms were obtained in AF 
with the AFocusII catheter positioned tangentially with the endocardial surface to maximize 
electrogram fidelity for 8 seconds at each site. This data was then acquired, stored and 
displayed as part of the global CFE map. At the end of each case, this data is then exported 
into our own in-house custom written software – HEART (described in 2.5) and the mean 
peak-to-peak AF voltage is evaluated over varying sampling window periods discussed in 
Chapter 4.  
 
2.3.4  Quantification of tissue conduction velocity 
Conduction velocity is a quantitative electrophysiological measure that describes the speed 
of propagation of the action potential impulse across the myocardium, and provides 
important information (both structural and functional) about the underling myocardium. 
Areas with delayed conduction are thought to represent more diseased myocardium.229 
Clinical quantification of conduction velocity is challenging, and to overcome inaccuracies 
associated with measurement of conduction velocity over short distances where minor 
errors in timing measurements can be amplified, we adopted an approach of conduction 
velocity over a Kernel (or the area subtended by the AFocusII catheter).  
The location (x,y,z co-ordinates) and local activation times (-dV/dt) from each of the 20 
electrodes of the AFocusII catheter were exported from EnsiteTM  Velocity into Matlab, with 
a code written to calculate conduction velocity over the area encompassed by the Kernel. 
3D electrogram positions were first projected onto the 2D plane of best fit. The 2D 
positions along with their activation times, (Xi, Yi, Ti), were then fit to a planar model using 
ordinary linear least squares. The mean conduction velocity (represented by the slope of the 
plane) was then calculated using the gradient of the fitted activation time (Figure 2.9). This 
process was repeated twice at each kernel location and averaged for comparison. In addition 
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to mean conduction velocity, the degree of planarity of conduction r2 (i.e. coefficient of 
determination) was also computed.230 
 
Figure 2.9 Measurement of conduction velocity across a Kernel 
(Left panel)  An illustrative example of an isochronal map during left atrial pacing from 
electrodes CS56 with the AFocusII catheter placed on the mid-posterior left atrial wall. 
(Right panel) Schematic representation of the calculation of conduction velocity across the 
area subtended by the AFocusII catheter with each coloured dot representing an electrode 
on the 20 pole AFocusII catheter with local activation times (LATs) and 3D co-ordinates 
exported into Matlab.  
2.3.5 Scores of electrogram fractionation in atrial fibrillation 
The technique of acquiring CFE maps using an automated algorithm (NavX Ensite, St Jude 
Medical) has been previously described and validated. Atrial bipolar electrograms acquired 
using a multipolar catheter were analysed to compute the mean interval between the 
multiple deflections over an 8 second period of time (CFEmean). The CFEmean is then 
represented on the geometric shell as a colour-coded display. Based on previous studies, 
CFE areas were defined as sites having a CFEmean of <80ms. We used the following 
CFEmean tool parameters: CL 80-120ms; EGM width <10ms (to avoid detecting far-field 
signals); EGM refractory period 40ms; peak-to-peak sensitivity 0.04mV (to avoid sensing 
noise); Interpolation was set to 10mm, and interior projection 5mm (as an exclusion criteria 
for insufficient contact). Contact bipolar electrograms were obtained in AF with the 
AFocusII catheter positioned tangentially with the endocardial surface to maximize 
electrogram fidelity for 8 seconds at each site.  
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2.4 Correlation of electrophysiologic parameters and LGE-CMRI atrial 
scar maps  
The constructed atrial scar maps from the LGE-CMRI are required to the imported into the 
EnsiteTM Velocity system (St Jude Medical, Inc.) before registration of the atrial scar maps 
and the left atrial geometry acquired during electroanatomical mapping can occur.  
2.4.1 Image integration of LGE-CMRI derived atrial scar maps into 3D 
electroanatomical mapping software 
The atrial scar maps are constructed from the DICOM (Digital Imaging and 
COmmunication in Medicine) images derived from the LGE-CMRI sequences using out in-
house custom written software on C++. The output files are in the form of .vtk, and 
requires conversion into .xml files to allow for compatibility and subsequent integration into 
the EnsiteTM Velocity 3D electroanatomic mapping system. The conversion is performed as 
part of the semi-automated process, which outputs an atrial scar map in the form of a 
decomposed shell (atrial scar shell) into the EnsiteTM system, with varying degrees of late-
enhancement represented as different layers (i.e. colours).  
The left atrial 3D geometry is created using an AFocusII high-density mapping spiral catheter 
and consists of separate geometries for each of the PV, the LA body, and the LA appendage. 
This included all major features of the left atrium so that corresponding locations on the 3D 
geometry and the LGE-CMRI derived atrial scar shell were easily discerned in a side-by-side 
visual comparison (Figure 2.9). Field scaling was applied which refers to a computer 
algorithm that uses the known fixed separation of poles on the mapping catheter and the 
AFocusII catheter to calibrate the non-linear electrical field data (as a result of local changes 
in impedance fields) to real 3D space. Field scaling effectively reduces the apparent flattening 
and stretching of the LA geometry, making it easier to perform image integration.  
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Figure 2.10 Integration of atrial scar shells into EnsiteTM Velocity system 
The atrial scar shell (right) is imported into the EnsiteTM Velocity 3D mapping system from 
the LGE-CMRI and is represented as layers (each in a different colour representing different 
levels of late-enhancement i.e. >1SD, >2SD, etc. above the mean blood pool intensity). The 
3D geometry created during electroanatomic mapping (left) is then registered to the atrial 
scar shell. 
 
2.4.2 Registration of endocardial electroanatomical mapping with LGE-CMRI atrial 
scar mapping 
Registration describes the process of aligning the acquired atrial shell with the NavX 
chamber geometry model and coordinate system. This is performed using the integrated 
registration algorithm within EnsiteTM (NavX Fusion) prospectively. To integrate the image, 
15 to 30 fudicials points that correspond to landmarks clearly visible on both atrial scar shell 
and geometry are chosen. These often include, but are not limited to, venous bifurcations, 
the LAA, the intra-atrial septum, the mitral valve annulus as well as several points on the 
roof, posterior wall and floor of the left atrium. When fiducial selection is complete, fusion is 
attempted. The 3D geometry is rescaled to fit the atrial scar shell, using the fudicials to 
effectively allow ‘stretching’ of the geometry to match the atrial scar shell (Figure 2.10).  
The accuracy of NavX Fusion in aiding navigation of electrophysiologic mapping catheters 
has been validated in clinical studies.231,232  
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Figure 2.11 Registration of atrial scar shell to 3D geometry  
15 to 30 fiducial points (yellow “strands”) that correspond to landmarks clearly visible on 
both atrial scar shell and geometry are chosen. When fiducial selection is complete, fusion is 
attempted. The 3D geometry is rescaled to fit the atrial scar shell, using the fiducials to 
effectively allow ‘stretching’ of the geometry to match the atrial scar shell (lower panel). NB: 
Mitral valve annulus “cut out”.  
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2.5 Novel platform for co-localisation of atrial enhancement and 
electrophysiologic parameters – High-density Electrogram Analysis 
Research Tool (HEART) 
A modular software platform (HEART) was developed to post-process and rapidly analyse 
the large amounts of spatially-distributed electrical data acquired from electroanatomic 
mapping data using a range of existing and novel algorithms. Imaging data highlighting regions 
of scar can also be overlaid for comparison. 
This platform enables the post-processing of unipolar or bipolar electroanatomic datasets, 
exported from the Ensite Velocity system (St Jude Medical, Inc.). The chamber surface model 
is constructed during the mapping procedure and is exported from the mapping system as 
an endocardial surface triangulation. Multiple maps recorded during the procedure may be 
loaded concurrently for comparison of data recorded under different protocols. 
Additionally, pre-operative imaging data indicating regions of fibrosis may be simultaneously 
loaded with the externally registered electroanatomical data and overlaid for comparison. 
The graphical interface for the platform, shown below (Figure 2.5), is implemented in C++ 
using the Qt library for the user interface and the VTK libraries for the visualisation pipeline. 
The central component of the platform is the anatomical display showing the chamber 
geometry with a computed summary statistic, such as local activation time or peak-to-peak 
voltage amplitude, projected on the surface. Statistics are computed at the electrogram 
points and interpolated on the surface (up to a user-defined maximum distance) using a 
distance-weighted average of nearby points The geometry may be rotated and magnified by 
the user and areas of the chamber surface may be selected and removed from the analysis 
to focus on a region of interest. The displayed statistic is chosen from the drop-down list, 
and the panel on the left of the user interface allows for customisation of the algorithms 
used. Additional options enable the user to customise the rendered image, such as removing 
the electrogram points, colour bar and chamber surface, to aid analysis. 
When processing clinically recorded data it is important to filter out those recordings which 
are of insufficient quality to analyse confidently. This may be due to poor contact with the 
myocardium, interference due to far-field effects or electrical noise in the recorded signal. 
Individual electrograms may be examined in both the time domain and the frequency 
domain, and undesirable recordings may be disabled and subsequently excluded from further 
use in analysis. The numerical values of the summary statistics for each electrogram are also 
available for direct quantitative comparison. 
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2.5.1 Processing of electrophysiologic parameters on HEART 
A range of existing algorithms are implemented in the platform, including local activation 
time (LAT), maximum peak- to-peak voltage, fractionation scores (average cycle length, 
shortest cycle length) continuous atrial activity, dominant frequency, FFT ratio and 
organisational index. A number of novel algorithms including conduction velocity and time-
averaged peak-to-peak deflection voltage have also been implemented. Spatial comparison of 
scores may be achieved through blending or through threshold binarisation of the scores. In 
the latter, regions in which the value of a statistic falls within a restricted range are assigned 
a single colour, while those outside the range are not displayed. The resulting maps may be 
overlaid and regions of overlap identified and quantified in terms of area of coverage. This 
allowed for electrophysiologic parameters in different rhythms (sinus rhythm, pacing and AF) 
to be compared against one another with reference to underlying left atrial 
intensities/enhancements from LGE-CMRI data.  
 
Figure 2.12 HEART visualisation platform 
Graphical user interface for the analysis platform showing visualisation of the chamber with 
local activation time (LAT) projected on the surface. Electrogram recording points are 
indicated with blue dots. 
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2.5.2 Registration of endocardial electroanatomical mapping with LGE-CMRI atrial 
scar mapping on HEART 
Landmark registration provides a first estimate for surface registration and is usually based 
on the manual selection of corresponding fiducial points on the two surfaces or images 
which are to be registered. However, manual landmark selection can be highly subjective 
since it is dependent on the electrophysiologist choosing anatomically corresponding points. 
This process is restricted when using clinically available 3D mapping systems, and their 
integration and registration algorithms such as NavX Fusion (as discussed in 2.4.2). On 
HEART, the registration of the left atrial geometry during electroanatomic mapping with 
that of the LGE-CMRI derived left atrial scar was performed in a semi-automated fashion, 
where points are chosen only on the pulmonary veins on both geometries. Pulmonary vein 
boundaries were projected onto a plane of best bit, and fiducial points were placed at equal 
angle.  This method significantly reduces target registration error compared with direct 
manual selection of fiducial points.233  
 
Figure 2.13 Image registration on HEART 
Transformed electroanatomic surface using automated technique. Example LGE-CMRI 
non-fiducial points (red) and the corresponding electroanatomic non-fiducial points 
(blue) are shown. Adapted from Ali et al.233  
 
2.6 Cell-culture monolayer model 
As part of the reverse translational aspect of the study, a cell monolayer model of atrial 
fibrillation was adopted to investigate the role of fibrosis on the contact electrogram. In vivo 
clinical data obtained can be variable due to various external influences (catheter contact and 
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orientation, influence of anti-arrhythmic drug therapy), and the degree of manipulation that 
can be applied is limited. The reduction on complexity in an in vitro monolayer will allow for 
changes to be more directly correlated to a single phenomenon. It is important to note that 
in vitro models do represent a simplification and their limitations must be borne in mind.  
Primary cultures can be used for in vitro investigations, but do not survive long in culture and 
may introduce confounding factors due to the presence of heterogeneous cell populations in 
consistent proportions. A cell line allows for consistency of preparations of a single cell type 
which can be perpetually cultured. In this study, both a primary culture (neonatal rat 
ventricular myocytes) and a cell line (HL-1 atrial myocytes) were co-cultured with fibroblasts, 
each with justified reasons. However, as a result of inconsistent and unreliable co-cultures of 
the HL-1 cell line and fibroblasts, we were unable to perform sufficient numbers of 
experiments to generate statistically useful data, and hence, this was not included in the 
experimentation and data analysis in Chapter 7.  
2.6.1 Co-culture of HL-1 cell line with murine fibroblasts on multi-electrode arrays 
(MEA) 
The HL-1 cell line is an atrial cardiac myocyte cell line which retains a differentiated 
cardiac myocyte phenotype and maintains contractile activity over indefinite passages234. 
The HL-1 cell line was established from a culture of AT-1 cells by careful control of the 
culture environment. Morphological characterisation of the cell line showed the 
presence of cardiac-specific myosin and muscle-specific desmin intermediate filaments 
with normal myofibril development. Cells attach to adjacent cells via intercalated disc-
like structures. Gene expression characterisation showed that cultured HL-1 cells 
contain a pattern of gene expression similar to that of adult atrial myocytes, including 
transcripts for α-myosin heavy chain, α-cardiac actin and Cx43. Electrophysiological 
characterisation showed the presence of currents similar to sodium, potassium and L-
type calcium currents. This indicates that the cells contain all the necessary ion channels, 
gap junctional channels and contractile apparatus needed to use this cell line in the 
investigation of conduction propagation.  
2.6.2 Co-culture of neonatal rat ventricular myocytes with rat fibroblasts on multi-
electrode arrays (MEA) 
Schedule 1 was carried out within the guidelines of the EU Directive 2010/63/EU. Neonatal 
Sprague-Dawley rat pups (postnatal day 0-2) were sedated with isofluorane then sacrificed 
by manual cervical dislocation, death was confirmed by cessation of circulation. Sternotomy 
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and lateral thoracotomy incisions were made and the hearts dissected and collected in 
calcium and magnesium free Hanks’ balanced salt solution (HBSS).  The ventricles were 
isolated and cut into 1-2mm3 cubes. Samples were transferred to gentleMACs C tube, the 
neo heart enzyme mix and protocol was used with the gentleMACs automatic dissociator 
(Miltenyi Biotec GmbH)). Cell culture medium with 10% serum was added to the cell/ 
enzyme mix and applied to 70µm pre-separation filter then centrifuged at 1000g for 5 
minutes. Following supernatant aspiration, cells were re-suspended in M199 medium 
(supplemented with 10% neonatal calf serum (NCS) M19910%), 50U/ml penicillin, 0.05mg/ml 
streptomycin, 2mg/ml vitamin B12 and 0.68mM L-Glutamine) and pre-plated in T75 flasks for 
1 hr. Subsequent cell suspension was passed through 70µm pre-separation filter, to provide 
myocytes alone (97-99% myocyte). Cells retained within the T75 flask consist of 
mesenchymal cells, primarily fibroblasts. Cells obtained prior to pre-plating in T75 flask (pre-
plate), were considered to be a ‘natural composition’ of cells. 
Fibroblasts obtained during pre-plating stage were cultured for later experimental use. Cells 
were cultured under an atmosphere of 1% CO2 and 99% air in M19910% medium, changed 
every 48-72 hours. Fibroblasts were allowed to proliferate until confluent and then split as 
necessary. Cells were split by trypsinisation (without EDTA) for 15-20 minutes. Trypsin 
activity was blocked by trypsin inhibitor (soya bean) at a ratio of 10µL per 1 cm2 of cells. 
The dissociated cells were plated or used for experimentation.   
MEA plates were seeded with four experimental groups: ‘myocyte only’ (MO), ‘natural 
composition’ (NC) of cells (before pre-plate) and a combination of myocytes + 20 %(20%FB) 
or 40%(40%FB) fibroblasts (% by cell number). Fibroblasts obtained from previous NRVM 
isolations at P1-P2 were mixed as appropriate with myocytes from fresh isolations prior to 
seeding.  
2.6.3 MEA recordings during atrial fibrillation and pacing 
Extracellular unipolar electrogram recordings of neonatal rat-ventricular myocyte (NRVM) 
monolayers were measured using a microelectrode array (MEA) system (Multichannel 
Systems, Reutlingen, Germany). The MEA contains 60 gold electrodes (diameter-100µm 
with inter-electrode spacing of 700µm) in an 8x8 matrix (corner electrodes removed) 
allowing simultaneous stimulation and recording - total recording area- 4.9x4.9 mm.  
Using a dissection microscope, an inert polymer (Polydimethylsiloxane-PDMS) ring was 
positioned to encircle recording electrodes. 200,000 cells of each experimental group, 
suspended in 150µL M19910% medium, were seeded within the polymer ring which had 
been pre-coated with 100µL collagen.  Cells were left to attach for 30 minutes before 
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polymer ring removal and the plate flooded with 850 µL of M19910% medium. Medium was 
changed to M199 supplemented with 5% NCS 24 hours post seeding, then changed every 
12-24 hours. Recordings were made when the cells reached their previously determined 
maximum conduction velocity (3-4 days post-seeding) in HBSS with 1.5mM CaCl2 and 1 mM 
MgCl2. 
Monolayers were stimulated using bipolar voltage pulses ±1000mV for 2 ms at 2Hz (Cycle 
length = 500ms)(125% of the threshold) from two to four extra-cellular electrodes at the 
edge of each array. Pacing rate was increased incrementally in 1Hz steps until loss of capture 
or fibrillation. A monolayer was classed as fibrillating if the intrinsic cycle length was ≤250ms 
and ‘overdrive’ pacing was not possible. Plates were paced in orthogonal directions 
(North/South & East/West) at each rate. Ten second recordings of the extracellular field 
potentials of each electrode were acquired, with a sampling frequency of 25kHz using MC-
Rack (Multichannel Systems). When fibrillation was seen, a 30 second recording was 
acquired to analyse fibrillation stability. 
If there was no fibrillation following pacing the pacing rate was returned to 2Hz, and 
incremental additions of Carbenoxolone, a gap-junctional uncoupler was added (10µM-
100µM), to slow conduction velocity and facilitate arrhythmogenesis. Pacing protocol was 
repeated at each carbenoxolone concentration, unless fibrillatory activity was seen. 
 
Figure 2.14 MEA electrical recordings 
(1) 200,000 cells from each experimental group were seeded directly onto the MEAs, 
allowing cells to stabilize and achieve confluence for 3-4 days before electrical recordings 
were made in a 2hr long experimental protocol. (II) Monolayers were stimulated 
incrementally (2-5Hz) until loss of capture from orthogonal directions. (III) Incremental 
doses of carbenoxolone were administered, with the pacing protocol repeated at each dose, 
unless fibrillatory activity ensued. 
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3 Identification of native left atrial fibrosis using late-
gadolinium enhanced cardiac magnetic resonance 
imaging 
 
3.1 Introduction 
Left atrial structural re-modelling with fibrotic change is a fundamental determinant of AF, 
and its progression8,235, with sustained AF leading to changes that promotes arrhythmia 
persistence.  It contributes synergistically with electrical re-modelling to the AF substrate.236. 
In AF, atrial fibrosis is represented by excessive extracellular matrix synthesis and deposition 
by stimulated myofibroblasts, where the activated atrial cardiomyocytes secrete substances 
which enhance collagen synthesis.237 There is increased atrial fibrosis in patients with atrial 
fibrillation, and its burden is associated with the persistence of AF. 162,238,239  
 
The detection of atrial fibrosis clinically can be achieved via 2 approaches: invasive 
electrophysiology where voltage is utilized as a surrogate marker of scar, which will be 
discussed in Chapter 4; and non-invasively with imaging. However, imaging of the thin left 
atrial wall is challenging, and inadequate resolution of current imaging modalities remain a 
significant problem. The majority of current imaging approaches are based on secondary 
effects such as change in atrial dimensions and function. Left atrial enlargement has been 
proposed to the first detectable anatomical change which occurs before the onset of atrial 
fibrosis.240 Indices of left atrial size have been used to quantify left atrial structural 
remodelling. Newer echocardiographic myocardial deformation indices such as Doppler-
derived regional atrial strain have also been used to quantify atrial fibrosis.241,242 Although 
having better resolution than echocardiography, computed tomography (CT) is still limited 
to quantification of atrial dimensions and volumes in the clinical setting. Measurements of 
atrial wall thickness from multi-slice CT have been shown to be a predictor of transition 
from paroxysmal to persistent AF, and hence may be a marker of structural remodelling.243 
The resolution afforded by multi-slice CT in its current form provides inadequate 
visualisation for quantification fibrosis. However, there are emerging techniques utilising 
contrast enhanced multislice CT, which have been used to visualise ventricular scar and to 
detect left atrial fibrosis, which seem to have concordance with electroanatomic mapping in 
patients undergoing repeat left atrial ablation.244  
 
 105 
Cardiac MRI has shown promise in the detection of atrial structural remodelling. Studies 
have supported the utility of T1 mapping for the quantification of diffuse atrial scar.245 Late-
gadolinium enhanced cardiac magnetic resonance (LGE-CMRI) imaging appears a useful tool 
of delineating left atrial fibrosis in vivo. Similar to CT, this technique has been extrapolated 
from the imaging of ventricular myocardium, where it has been shown to be an effective 
modality to identify in vivo fibrotic non-viable myocardium in coronary artery disease and 
cardiomyopathies.212,213,225 The late-gadolinium enhancement technique takes advantage of 
the differential uptake and washout kinetics of gadolinium contrast in blood, healthy 
myocardium and myocardial scar. This technique was initially applied to identify ablative scar 
post-pulmonary vein isolation214 and the extent of post-procedural late-gadolinium 
enhancement was reported to correlate with the recurrence of AF.215 With the 
improvement of spatial resolution of MRI and post-processing algorithms, its use has been 
extended to identify non-iatrogenic or intrinsic/native left atrial fibrosis. Whereas ablative 
scar sites are represented by bright scar tissue (healed burn) with LGE-CMRI, native fibrosis 
is subtler. Accepting technical difficulties surrounding spatial resolution of MRI and 
susceptibility to partial volume effects from surrounding tissue, and the challenges of 
quantitative analysis of left atrial and pulmonary venous late-gadolinium enhancements, the 
extent of left atrial fibrosis delineated by LGE-CMRI has been correlated to clinical 
parameters such as left atrial size and the persistence of AF.218 Clinical outcomes post-
ablation are influenced by the degree of structural remodelling (Utah stages I-IV) as 
determined by LGE-CMRI, where patients in Utah stage IV (>30% LA LGE) having the worst 
outcomes.  The same authors have validated their technique with endocardial voltage 
mapping, demonstrating that areas of left atrial late-gadolinium enhancement correlate to 
low-voltage areas in pre-ablation patients.246 Despite these promising data, the use of LGE-
CMRI in clinical practice has only been restricted to a few specialist centres, where the 
majority of the evidence supporting its use has been generated.  
Although there is significant variability in the technique of LGE-CMRI across different 
centres, the MRI late-gadolinium enhanced acquisition sequences are fairly similar and 
standard, with the majority of the difference lying in the detection, and subsequent 
quantification of the left atrial wall intensities/enhancements with varying techniques of atrial 
segmentations, registrations and thresholding. There is yet to be a optimal method.247 
Our group have described a LGE-CMRI technique, with an automated method for operator 
independent quantification of LGE, that correlates with co-located endocardial voltage in a 
cohort of patients with PAF who have undergone an left atrial ablation in the form of 
pulmonary venous isolation.228 In this chapter, we investigated the use on this technique in 
patients with persistent AF undergoing AF ablation in the quantification of native atrial 
fibrosis.  
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3.2 Methods 
3.2.1 Patient selection 
Patients with symptomatic persistent AF (based on the classification of AF by published 
guidelines from the AHA/ACC/HRS/ESC) presenting for their first ablation to Imperial 
College Healthcare NHS Trust were prospectively enrolled. All patients underwent LGE-
CMRI at least 2-4 weeks prior to their scheduled ablation procedure. The study was 
approved by the Local Research and Ethics Committee for Imperial College Healthcare NHS 
Trust and written informed consent were obtained from all patients.  
Clinical demographics and parameters such as duration of persistent AF and left atrial 
dimensions were documented for correlative analysis. Patients in AF at the time of 
enrollment into the study underwent external DCCV to improve the quality of imaging. At 
the time of LGE-CMRI, patients who were in AF, with rapid ventricular rates were excluded 
from the study.  
3.2.2 Late-gadolinium cardiac magnetic resonance imaging (LGE-CMRI) acquisition 
sequence 
All patients underwent left atrial LGE-CMRI using a 1.5 T Philips Achieva MR system, and a 
5- or 32-element phased-array cardiac coil. The acquisition sequences have been previously 
described by the Utah group248, and includes sequences to define the left atrial and 
pulmonary vein anatomy (MR angiography). Initial survey and sensitivity encoding reference 
scans were obtained followed by a 2D multi-cardiac phase cine scan acquired in a four-
chamber orientation where the trigger delay was determined for all subsequent scans in 
order to minimize artefacts from atrial wall motion. The anatomy was obtained by using 
non-ECG gated 3D spoiled gradient-echo contrast enhanced timing robust angiography 
(CENTRA) during the first pass of the gadobenatedime-glumine-enhanced contrast 
(Multihance, Bracco Diagnostic Inc., Princeton, New Jersey), intravenous injection of a dose 
of 0.4ml/kg body weight as a bolus followed by a 15ml 0.9% saline flush). The timing of the 
first pass scan was determined using a MRI fluoroscopic scan. All images were acquired 
during breath-hold in expiration, a transverse (axial) imaging volume with voxel size 1.3 x 1.3 
x 1.3mm. A 3D left ventricular LGE breath-hold sequence, approximately 9-minute post-
contrast, was used to identify optimal nulling time for the left ventricle. 
LGE-CMRI was then used to identify fibrosis within the left atrial wall. This was acquired 12-
20 minute post-contrast injection using a ECG-triggered, free-breathing navigator-gated 
whole heart 3D spoiled gradient echo acquisition sequence, performed in axial orientation 
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to minimize motion artefacts. Respiratory navigation was applied to minimize differences in 
respiratory phase between slices. The resolution was approximately 1.5 x 1.5 x 4mm, 
reconstructed to 1.23 x 1.25 x 2mm. Complete LA coverage was obtained with 40-50 slices. 
Data were acquired within 100-150ms window for each RR interval (defined using cine 
images of the left atrium), with a low-high k-space ordering and spectral pre-saturation with 
inversion recovery for fat-suppression. The echo time of the scans was chosen so that fat 
and water are out of phase and the signal intensity of partial volume fat-tissue voxels was 
reduced to improve definition of the left atrial wall boundary. Inversion recovery delay, 
determined from the Look-locker sequence,249, and was set at an inversion time (TI) to null 
the myocardial and blood signal. Lowering the navigator rescale factor and positioning the 
Navigator away from the right-sided pulmonary veins minimized navigator inflow artifact. 
Typical scan time for the LGE sequence was 10-15minutes depending on the subject 
respiration (aiming for Navigator efficiency of >30%) and heart rate. If the first acquisition 
did not have an optimal T1 or had significant motion artifacts, the scan was repeated.  
All MR images were evaluated by an experienced Cardiac Radiologist to ensure adequate 
quality of scans, and poor quality scans were excluded from the study. MRI digital imaging 
and communications in medicine (DICOM) formatted data sets were exported for 
quantitative analysis and representation of left atrial wall enhanced intensities.   
Interpreting 2D MR slices within a complex structure such as the left atrium and pulmonary 
veins is challenging and therefore most centres describe the generation of 3D atrial 
reconstructions to aid visualisation of atrial enhancement. This is described below. 
3.2.3 Left atrial segmentation 
The high-contrast MR angiogram provides excellent visualisation of the chambers of the 
heart (in particular, the left atrium), and the major blood vessels. Left atrial segmentation 
(3D) was performed on a Philips Healthcare workstation by using the maximum intensity 
projection view to remove structures external to the left atrial blood pool, and delineating 
the pulmonary veins, left atrial appendage and the mitral valve annulus form the MR 
angiography sequences. A volume of interest is created around the left atrium and proximal 
pulmonary veins (Figure 3.1), and structures external to the LA blood pool are then 
removed in a stepwise fashion, as a 3D volume (Figure 3.2). This will in effect, result in 
segmentation of the left atrium along its endocardial border. An endocardial surface model 
was created from the binary volume using the marching cubes algorithm, as implemented in 
the visualization toolkit (VTK) libraries (VTK, Kitware, Inc., NY). Adequate opacification of 
the left atrium during the MR angiogram sequence acquisition is crucial to this process, and 
scans with inadequate opacification are excluded from further analysis. The method of 
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producing the atrial segmentation is not critical to the automated process of atrial scar 
mapping however the quality of the anatomical surface is important for accurately displaying 
regional left atrial enhancements. 
 
Figure 3.1 Setting Volume of Interest from MR angiography 
A region of “volume of interest” is created around the left atrium (LA) and pulmonary veins 
(RUPV: right upper pulmonary vein, RLPV: right lower pulmonary vein, and LLPV: left lower 
pulmonary vein) to exclude the majority of extracardiac structures (such as the pulmonary 
vessels, ascending (Asc Ao) and descending (Dsc Ao) aorta. 
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Figure 3.2 3D segmentation of left atrium from MR angiography 
3D segmentation of the left atrium (LA) from the MR angiography sequences using the 
Philips Healthcare workstation segmentation facility. (A) and (B) demonstrates antero-
posterior (AP) and postero-anterior (PA) projections of MR angiography sequences 
including extracardiac structures. (C) and (D) demonstrating exclusion of extracardiac 
structures from the posterior and anterior LA walls respectively where regions within the 
red contours are excluded and removed. (E) and (F) demonstrates AP and PA projections of 
the segmented LA. The red lines overlying the crosses (+) indicate manually excluded areas.  
 
3.2.4 Registration of atrial segmentation to LGE-CMRI 
To allow for the projection of the left atrial wall intensities onto the 3D shell created, it is 
necessary for this surface to be fused with the LGE sequences (Figure 3.3). The shell 
generated from the left atrial segmentation of the MR angiogram and the LGE sequences are 
registered against each other using an automated software written in C++, where rigid or 
non-rigid registration, depending on the degree of overlap between MR angiogram and LGE 
sequences.250  
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Figure 3.3 Registration of atrial segmentation to LGE-CMRI 
Registration/fusion of the MR angiography derived shell with the late-gadolinium enhanced 
MRI, with both on identical Cartesian points. (RUPV: right upper pulmonary vein, RLPV: 
right lower pulmonary vein, LUPV: left upper pulmonary vein, LIPV: left lower pulmonary 
vein, LAA: left atrial appendage, ascending aorta (Asc Ao) and descending aorta (Dsc Ao). 
  
 
3.2.5 Identifying left atrial wall intensities 
Once the 3D shell and LGE images are fused, vectors at a normal to each vertex on the left 
atrial wall surface were created (as part of an automated process). A maximum intensity 
projection (MIP) of the late-gadolinium was performed at ±3mm at each normal vector, i.e., 
the maximum LA wall intensity (ILA) was determined along the normal to the wall at each 
location, 3 mm inside and outside the LA surface. (Figure 3.4) This was to allow for wall 
thickness and minor registration mismatch. It is assumed that areas of delayed enhancement 
will have higher ILA than areas of healthy myocardium.  
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Figure 3.4 Identification of left atrial wall intensities from LGE-CMRI 
Close up of the registered surface with LGE images, with red line (representing 6mm – not 
to scale) indicating the normal at each point and arrows demonstrating the direction in 
which the maximum intensity projection is taken, in this instance, 3mm in and out of the left 
atrial surface. 
 
 
3.2.6 Thresholding of atrial wall intensities 
Gray scale signal intensity scaling, or more commonly known as thresholding has improved 
reproducibility of evaluation of left ventricular fibrosis with LGE,251 and often uses a semi-
automated approach of defining a region-of-interest, and then via either user-defined cutoffs 
or pixel signal intensity histogram-derived cutoffs, automatically derives the number of pixels 
with a signal intensity above/below the reference value. This limits human subjectivity and is 
inherently more reproducible.  
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The algorithm adopted in our process used the left atrial blood pool as a non-enhancing 
region against which the left atrial wall intensity could be compared and normalized. The 
blood pool was identified in an automated fashion by shrinking the left atrial segmentation 
using mathematical morphology, and the mean blood pool intensity (MBP) and the standard 
deviation (SDBP) of the blood pool intensity were calculated. (Figure 3.5) Left atrial wall 
intensities were expressed as multiples of SDBP above the blood pool mean to provide a 
normalized LA wall intensity (NLA), such that: 
NLA = (ILA − MBP)/SDBP 
NLA was expressed either as a continuous variable or categorically as multiples of SD such 
that: SD 0 is NLA<0.5; SD 1 is NLA= 1 ± 0.5; SD 2 is NLA=2 ± 0.5; etc. 
 
Figure 3.5 Selection of blood pool as baseline 
The left atrial blood pool as a non-enhancing region against which the left atrial wall intensity 
could be compared and normalized. It was identified in an automated fashion by shrinking 
the left atrial segmentation using mathematical morphology, and the mean blood pool 
intensity (MBP) and the standard deviation (SDBP) of the blood pool intensity were calculated. 
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3.2.7 Optimization of post-processing techniques 
Following initial experience in our cohort of patients with persistent AF, we observed 
discrepancies in the registration of the reference anatomy created from segmentation of the 
MR angiography sequences to that of the late-enhancement sequences which resulted in 
misalignment of the surfaces, and hence inaccurate representation and projection of the 
normalized late-gadolinium intensities (Figure 3.6) when we manually verified the registration 
quality prior to analysis of LGE regions.  These errors may have arisen as a result of 
inaccurate left atrial segmentation from the MR angiography sequences as a result of 
inadequate opacification of the left atrium.  
 
Figure 3.6 Misalignment of left atrial surfaces – MR angiography and LGE 
Transverse slices of the left atrium from late-gadolinium enhancement sequences with 
overlying left atrial reference anatomy shells acquired from the MR angiography (yellow 
outline). This illustrates the discrepancies in the registration of the MRA and LE sequences 
which results in inaccurate representation and projection of the normalized late-gadolinium 
intensities onto the reference anatomy. 
 
Segmentation from MR angiography is often challenging at certain regions of the left atrium. 
The anterior wall is intimately associated with the aortic root and proximal segment of the 
ascending aorta, and may either lead to under- or over-sampling during the segmentation 
process. (Figure 3.8) It also has to be noted that the sequences acquired for the MRA and 
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the late-enhancement can be very different, with the former being performed during an 
unknown single breath-hold during the gadolinium contrast bolus, and the latter acquired 
during free-breathing with both ECG and respiratory navigator gated.  
To minimize the errors introduced as a result of (1) inaccurate left atrial segmentation, and 
the (II) subsequent process of registration of the MR angiography-derived left atrial 
reference shell to the LGE images, we adopted an approach of constructing the reference 
left atrial shell from manual 2D slice-by-slice segmentation of the LGE images, which is time-
consuming but offered more accurate representation of the late-gadolinium enhancement 
intensities. (Figure 3.7) This more precise segmentation also offered the advantage of 
accurately delineating the epicardial surface of the left atrium, and excluding late-gadolinium 
enhancing extra-cardiac structures, which are in close proximity and often abuts the left 
atrium such as the oesophagus, ascending and descending aorta and vertebral column. 
Further, this negates the requirement of registration, and the likelihood of introducing 
further errors, as both the derived left atrial shell and LGE images have been obtained on 
identical Cartesian co-ordinates.  
 
Figure 3.7 2D left atrial segmentation from LGE images 
Transverse slices of the left atrium from LGE sequences with overlying left atrial reference 
anatomy shells acquired from slice-by-slice 2D segmentation of the LGE sequences (yellow 
outline). There is hence excellent registration and apposition of the left atrial surfaces. 
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Figure 3.8 Anterior LA wall segmentation: challenges 
(A) illustrates the close association of the aortic root (AoR) and ascending aorta (Asc Ao) to 
the anterior left atrial wall, which can result in difficult and inaccurate segmentation. (B) 
Utilising the LGE images for segmentation allows for clear delineation of the anterior wall 
and aortic root shown with an obvious plane of separation between the 2 structures. 
 
The method of atrial segmentation from MR angiography sequences involved delineating the 
endocardial border of the left atrium. Hence, the detection of left-atrial enhancements 
involved an automated post-processing algorithm whereby the maximum intensity along the 
normal at each location or cell of the surface mesh, to a distance along this chord of 3mm 
inside and outside of the LA surface (to allow for LA wall thickness and minor registration 
mismatch) is identified. In doing so, extra-cardiac enhancements can be falsely “picked-up”. 
This is illustrated in the example in Figure 3.9, where extra-cardiac enhancements from the 
descending aorta results in false characterisation of enhancements on the posterior left atrial 
wall.  
With the improved 2D slice-by-slice segmentation process, the maximum intensity along the 
normal at each location was detected only to a distance along this chord of 3mm inside as 
segmentation delineated the epicardial left atrial surface, excluding the extension of the 
chord to 3mm outside ensuring that enhancement from other extra-cardiac structures (not 
only the descending aorta, but also oesophagus, vertebral column and spinal arteries) are 
not erroneously included. (Figure 3.10) 
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Figure 3.9 Effect of segmentation and direction of maximum intensity 
projection (MIP) on characterisation of posterior wall enhancements 
The close association of the descending aorta in this patient resulted in false characterisation 
of posterior wall enhancements. (Top panel) LGE-CMRI images in axial and sagittal sections 
illustrating the descending aorta (Dsc Ao) almost in contact with the posterior wall, at the 
level of the left inferior pulmonary vein (LIPV). This resulted in enhancements from the wall 
of the descending aorta being projected onto the posterior wall in the atrial scar maps 
(Bottom panel) when the direction of MIP included 3mm in and out using the MR angiogram 
derived atrial segmentation, which improves when MIP direction was restricted to inwards. 
The distribution of scar in the same region of the posterior left atrial wall seem to decrease 
further when LGE derived atrial segmentation was utilized. (LA: left atrium, LAA: left atrial 
appendage, LUPV: left upper pulmonary vein, RUPV: right upper pulmonary vein, LIPV: right 
inferior pulmonary vein, AoR: aortic root). 
 
To summarise, MR angiography and LGE images are acquired at different time-points, 
utilising difference MR sequences (breath hold vs. free-breathing, with and without ECG-
gating), the registration of these left atrial surfaces results in errors which results in 
inaccurate and erroneous representations of left-atrial enhancements. The more deliberate, 
time-consuming manual process of 2D slice-by-slice segmentation overcomes some of these 
limitations.  
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Figure 3.10 Extra-cardiac late-gadolinium enhancing structures 
2D slice-by-slice manual segmentation of the left atrium allows for exclusion of extra-cardiac 
structures (red) which enhance on the late-gadolinium sequences such as the oesophagus, 
wall of the ascending aorta (AscAo) – left panel, and the vertebral column, wall of the 
descending aorta (DesAo) and mitral valve annulus (MVA). RA: right atrium, LA: left atrium, 
LAA: left atrial appendage, LIPV: left inferior pulmonary vein, LV: left ventricle and AoR: 
aortic root.  
 
3.2.8 Evaluation of regional distribution of left atrial enhancements 
The degree of left atrial fibrosis as determined by late-gadolinium enhancement was 
expressed as a percentage of left atrial surface area identified as scar (at each intensity >1SD, 
>2SD and >3SD above the mean blood pool intensity). The constructed atrial scar maps 
were imported into a data visualisation software (Paraview, Kitware, Sandia National 
Laboratories) and the left atrium was manually segmented into the following anatomical 
regions: septum, anterior wall, and posterior wall (Figure 3.11). The posterior was further 
divided in four quadrants: left superior, left inferior, right superior and right inferior). The 
pulmonary veins, left atrial appendage and mitral valve annulus were excluded from analysis. 
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Figure 3.11 Representative segmentation of LA 
The left atrium was segmented into various anatomical sub-regions for the quantification of 
scar based on surface area occupied by enhancements based on NLA. (Green: anterior, blue: 
septum, red: posterior).  
 
3.2.9 Relationship of LGE and clinical characteristics 
The burden of fibrosis as a measure of left atrial structural remodelling is compared to 
accepted clinical markers of structural remodelling such as left atrial size and the patients’ 
CHADS2 score, as a composite measure of patient clinical characteristics. Left atrial surface 
area (%) identified as scar (defined as intensity >2SD above mean blood pool signal intensity) 
was compared in all patients with and without CHADS2 risk factors including hypertension, 
diabetes, previous stroke, age > 65yrs and congestive heart failure, and the duration of AF 
(>1year defined as long-lasting persistent AF).224 
3.2.10 Relationship of regional scar distribution to proximity with late-gadolinium 
enhancing extra-cardiac structures 
To investigate the contributions of the partial volume effect and the proximity of the left 
posterior left atrial wall to late-gadolinium enhancing extra-cardiac structures such as the 
descending aorta and oesophagus, we systematically compared regional scar distributions 
using the different post-processing algorithms discussed above:  
(1) Based on the methodology in which the reference anatomic shell was created (3D 
segmentation of MR angiography [3D MRA] vs. 2D segmentation of LGE images [2D LGE]), 
and  
(2) The direction of the maximum intensity projection (3mm in- and outward projection 
with 3D MRA vs. 3mm inward projection with 2D LGE.   
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3.2.11 Statistical analysis 
All normal variables are expressed as mean and standard deviation (SD). Paired and unpaired 
T-tests were used when appropriate, with Bonferoni correction for multiple tests. One-way 
ANOVA tests with Tukey’s post-hoc test were used for non-parametric analyses of multiple 
groups. A probability of < 0.05 was considered significant. 
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3.3 Results 
3.3.1 Patient demographics 
A total of 60 patients underwent pre-ablation LGE-CMRI. The clinical characteristics were 
typical of a patient population undergoing persistent AF ablation, and a summarized in the 
table below.  
Table 3.1 Clinical demographics in the cohort of patients with persistent 
AF who underwent pre-procedural LGE-CMRI 
Clinical characteristics (n=60)  
Age (years) 66±10 
Male (%) 60%  
Mean LA size on TTE (mm) 46±6 
Mean CHADS2 score 2.3 (0-6) 
Duration of AF (months) 13±8 
 
3.3.2 Burden and distribution of native fibrosis as characterised by LGE 
The mean surface area of the left atrium (excluding pulmonary veins and left atrial 
appendage) was 99.80±19.92cm2. All 60 patients had late-gadolinium enhancements of the 
left atrial wall at least >1SD above mean blood pool intensity, 96% (58/60) had late-
gadolinium enhancements of the left atrium of at least >2SD above mean blood pool 
intensity, and 83% (50/60) had late-gadolinium enhancements of the left atrium of at least 
>3SD above mean blood pool intensity.  
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Figure 3.12 Extent of distribution of atrial enhancements of >1SD, > 2SD 
and > 3SD above mean blood pool (MBP) intensities in all 60 patients. 
The percentage of the total left atrial surface area occupied by scar- scar burden, decreased 
with increasing NLA – each scar category (% total surface area - >1 SD above mean blood 
pool intensity 37.8±11.3%; >2 SD above mean blood pool intensity 14.8±8.4% and >3 SD 
above mean blood pool intensity 5.3±5.1%). One-way ANOVA (non-parametric) with 
Tukey’s post-hoc test showed significant difference in scar burden between all 3 groups.  
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Figure 3.13 Amount of scar (scar burden-%) across scar categories as 
defined by normalized intensities (NLA) of SD above mean blood pool 
intensities  
The percentage of the total left atrial surface area occupied by scar (scar burden) decreased 
with increasing normalised left atrial wall intensity (NLA) with significant differences in scar 
burden’s between all 3 groups. (****- p<0.0001) 
 
Analysis of the mean scar burden across each scar category demonstrated a predilection of 
scar on the posterior wall and the septum. The percentage (%) of surface area with NLA >1 
SD above mean blood pool intensity: posterior wall 41.7±15.5%; septum 40.3±22.2% and 
anterior wall 30.1±15.4%), % surface area with NLA >2 SD above mean blood pool intensity: 
posterior wall 17.4±12.2%; septum 16.0±12.6% and anterior wall 10.0±9.9%, and % surface 
area with NLA >3 SD above mean blood pool intensity: posterior wall 6.4±8.0%; septum 
5.5±6.6% and anterior wall 3.3±5.2% (Figure 3.14).  
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Figure 3.14 Regional distribution of scar across scar categories as defined 
by normalized intensities (NLA) (SD above mean blood pool intensities) 
Predilection of late-gadolinium enhancement across normalized intensities of >1 SD, >2 SD 
and >3 SD above MBP to the septum and posterior wall of the left atrium.  
(* p<0.05, ** p<0.01 and ns = non-significant) 
 
When the scar threshold of NLA >1 SD above mean blood pool intensity was utilized, the 
total left atrial surface area occupied by scar was in excess of 40%, NLA >2 SD the total left 
atrial surface area occupied by scar was approximately 15%, and when NLA >3 SD above 
mean blood pool intensity was utilized, only approximately 5% of the total surface area as 
occupied by scar. Hence, all further analyses were performed using >2 SD above the mean 
blood pool intensity as the threshold for scar as this allowed for meaningful comparative 
analyses to be performed. 
48 out of the 60 patients (80%) had a greater burden of scar (NLA >2 SD above mean blood 
pool intensity) on the posterior wall when compared to the anterior wall. In each of these 
patients, there was an average of 4.7±6.8 times more scar on the posterior wall vs. anterior 
wall. Within the posterior wall, the left inferior quadrant has the highest burden of scar (% 
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inferior 26.5±19.1%, left superior 15.5±16.5%, right inferior 14.4±16.4% and right superior 
13.6±11.3% (Figure 3.15). 
 
Figure 3.15 Scar burden on the posterior left atrial wall (NLA >2 SD above 
mean blood pool intensity (MBP) 
The scar burden on the posterior wall is highly concentrated in the left lower quadrant 
(** p<0.01 and *** p<0.001). 
3.3.3 Distribution of normalized late-gadolinium intensities (NLA) 
There was a wide distribution of normalized (NLA) late-gadolinium intensities within each 
patient, each with a unimodal distribution (Figure 3.16). The mean minimum intensity was   -
6.56±1.77 SD above the mean blood pool intensity, and mean maximum was +6.46±2.20 SD 
above the mean blood pool intensity. The mode of the distribution of late-gadolinium 
intensities in the majority of patients included in the study was between 0-1 SD above the 
mean blood pool intensity.  
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Figure 3.16 Distribution of normalized LGE-intensities across patients 
A unimodal distribution of normalised late-gadolinium intensities (NLA) was observed in all 
patients, with each coloured line representing an individual patient.  The mode NLA for the 
majority of patients fell between 0-1SD above the mean blood pool intensity (unshaded).  
 
3.3.4 Relationship of extent of LGE and left atrial size 
The burden of scar (as defined by the percentage of the left atrial surface area occupied by 
>2SD above the mean blood pool intensity, i.e. extent of LGE) was higher in patients with a 
left atrium that was larger than 45mm on (anterior-posterior dimension on transthoracic 
echocardiography), although this did not reach statistical significance (13.0±7.1% vs. 
19.2±9.9%, p=0.08).  
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Figure 3.17 Extent of LGE and left atrial size 
Patients with a larger left atrium (>45mm) had higher extent of LGE (normalized intensities 
of >2SD above mean blood pool intensity) over the left atrial surface area. 
3.3.4.1 Relationship of LGE and clinical characteristics 
The burden of scar (as defined by the percentage of the left atrial surface area occupied by 
atrial wall enhancements of >2SD above the mean blood pool intensity) was compared to 
clinical characteristics which are conventionally often used as surrogate markers of left atrial 
structural remodelling, and the duration of persistence of AF.  
Figure 3.15 shows that patients with CHADS2 score of 0, 1 and >1 had the percentage of 
total left atrial surface area with NLA of >2 SD above the mean blood pool intensity of 
7.1±7.3%, 14.1±7.6% and 17.1±8.3% respectively. Hence, the extent of late-gadolinium 
enhancement (i.e. left atrial scar burden) was greater in patients with higher CHADS2 scores, 
but this however did not reach statistical significance using one-way ANOVA tests with 
Tukey’s post-hoc test (p=0.08).  
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Figure 3.18 Extent of LGE and CHADS2 score 
The extent of LGE over the left atrial surface area (normalized intensities of >2SD above 
mean blood pool intensity) is higher in patients with higher CHADS2 score (p=0.08).  
 
Patients with persistent AF for more than one-year (termed long-lasting persistent AF) had 
higher extents of scar as defined by LGE-CMRI as a percentage of total left atrial surface 
area (13.6±7.1% vs. 19.2±9.9%; p=0.04).  
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Figure 3.19 Extent of scar and persistence of AF 
There was a higher extent of scar (>2SD above mean blood pool intensity) in patients with 
long lasting persistent AF (>1 year in duration) (* p=0.01). 
  
 
3.3.5 Relationship of regional scar distribution to proximity with late-gadolinium 
enhancing extra-cardiac structures 
As described in 3.3.2, the posterior left atrial wall had a greater extent of late-gadolinium 
enhancement. Anatomically, the posterior wall is often closely associated with late-
gadolinium enhancing structures such as the oesophagus, vertebral column and the 
descending aorta. The posterior wall, adjacent to the left inferior pulmonary vein is often in 
close proximity, if not in contact with the descending aorta as illustrated in Figure 3.10.  
These observations generated the hypothesis that the predilection of posterior wall 
enhancement is as a result of the detection of enhancements from these extra-cardiac 
structures contributed by the partial volume effect, and increasing left atrial size results in 
greater incorporation of extra-cardiac enhancements into the posterior left atrial wall by a 
purely physical/mechanical phenomenon. Comparative analysis was performed between the 
size of the left atrium and the extent of late-gadolinium enhancement on the posterior wall, 
as well the normal distance of the posterior left atrial wall and the descending aorta 
(measured in the axial transverse sections at the level of the left inferior pulmonary vein), to 
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the extent of late-gadolinium enhancement in the left inferior quadrant of the posterior wall 
(Figure 3.17).  
 
Figure 3.20 Measurement of descending aorta to posterior LA wall 
The normal distance (in red) from the posterior left atrial wall, adjacent to the left inferior 
pulmonary vein (LIPV) is measured to the descending aorta (Dsc Ao) from an axial 
(transverse section of LGE-CMRI). (Asc Ao: ascending aorta, LAA: left atrial appendage, 
RIPV: right inferior pulmonary vein, LA: left atrium). 
 
When the effect of left atrial size on the extent of posterior wall late-gadolinium 
enhancement was investigated, using Spearman-rank correlation coefficient analysis, there 
was no relationship between the size of the left atrium to the extent of posterior wall late-
gadolinium enhancement (r=0.3012 p>0.01)(Figure 3.18).  
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Figure 3.21 Effect of LA size on extent of posterior wall late-gadolinium 
enhancement 
There is no relationship between left atrial size, and the extent of posterior wall late-
gadolinium enhancement (>2SD above mean blood pool intensity). 
 
Similarly, when the normal distance of the posterior left atrial wall to the descending aorta 
was correlated to the extent of late-gadolinium enhancement in the left inferior quadrant of 
the posterior left atrial wall, no relationship was evident (Spearman-rank correlation 
coefficient, r=0.07, p>0.01)  (Figure 3.19). 
 
Figure 3.22 Effect of proximity of descending aorta on posterior LA wall 
(left inferior quadrant) enhancements 
There was no relationship between the distance between the descending aorta and the 
inferior quadrant of the posterior left atrial wall, and its extent of enhancements (>2SD). 
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3.4 Discussion 
Although LGE-CMRI is being increasingly used to define the structural substrate of the left 
atrium, there are significant limitations, which have attracted skepticism to the validity of this 
technique in defining left atrial fibrosis. The scar tissue segmentation techniques utilized in 
the derivation of left atrial scar maps (left atrium shells with projected LGE-intensities) are 
varied, and the optimal methodology is yet to be determined,247 with no single algorithm 
deemed clearly superior to the others. In this Chapter, we have improved on a previously 
described technique to ensure a more accurate representation of regional late-gadolinium 
enhancements across the left atrium through addressing some of its limitations, specifically 
optimization of left atrial segmentation and detection of left atrial wall intensities. 
3.4.1 Left atrial segmentation 
Other groups have utilized MR angiography to derive left atrial reference anatomic shells, 
similar to our initial processing algorithm252. However, we have noted that this technique 
lends itself to inaccuracies as a result of poor 3D MR angiogram segmentation, especially 
that of the anterior left atrial wall, and registration errors of 2 different acquisition 
sequences: the MR angiogram being non-ECG gated, and from an unknown breath-hold 
position, and the LGE sequences being ECG, and respiratory gated.  
Non-optimal left atrial segmentation of the MR angiogram is often as a result of poor or 
inadequate opacification of the left atrium, making the delineation of the endocardial borders 
difficult, if not impossible. In addition, even minor errors in segmentation when dealing with 
the left atrial wall, which is only 1-2mm in thickness, can result in significant false detections 
and characterisation of the enhancements. These errors are compounded by the registration 
errors from 2 distinct imaging sequences. To overcome these errors, we adopted an 
approach of segmentation of the left atrium from the LGE imaging sequences. Although 
more laborious and time consuming, this technique allows for more accurate delineation of 
the left atrial wall borders (epicardium), and negates the need for registration, improving 
surface fusion and apposition. This process also ensures exclusion of extra-cardiac 
structures and inclusion of the left atrium in its entirety.  
Similar methodologies have been employed by other groups using LGE sequences, but have 
involved contouring of both the endo- and epicardial borders of the left atrial wall, and antra 
of the pulmonary veins, in each axial LGE-CMRI slice, to segment the left atrial wall itself, 
rather than as a left atrial volume.138 However, it is often difficult to identify the endocardial 
borders, especially when high intensities are encountered in the blood pool, and introduces 
human-subjectivity and inevitable errors into the process. This is evident in their illustrated 
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example (Figure 3.20). Quantification of is then based on the relative intensity of contrast 
enhancement in this segmented left atrial wall within each slice.  
 
Figure 3.23 Examples of endo-epicardium LA segmentation 
As illustrated from (A), although epicardial borders of the left atrial wall can be identified 
with relative ease, identification of endocardial borders is difficult. The yellow arrows in (A) 
represent regions with poor endocardial definition. (B) Despite this lack of clarity, the 
authors have clearly delineated the endo-epicardial borders fairly clearly. Adapted from 
Marrouche.138 
 
In our improved algorithm, we are confident that inaccuracies are kept to a minimum 
through direct manual visual verification, with the coherence of the 2 surfaces. It also 
resulted in alterations of the detection algorithm of left atrial wall intensities, which will be 
discussed below.  
3.4.2 Probing direction in the detection of left atrial intensities and thresholding of 
intensities 
In conjunction with changes with left atrial segmentation, the algorithm for the detection of 
left atrial wall intensities was also altered to ensure exclusion of extra-cardiac enhancements, 
particularly on the posterior left atrial wall. Since left atrial segmentation from the LGE 
images involves contouring of the epicardial surface, the direction of maximum intensity 
projection only included the inward direction, and excluded outward projections to ensure 
that extra-cardiac enhancements were not detected by the automated process (as opposed 
the both in- and out-ward projects when the endocardial border was contoured with 
(A) LGE-CMRI! (B) ENDO-EPI CONTOURS!
 133 
segmentation with the MR angiogram). These changes resulted in a more robust algorithm 
to ensure only true left atrial wall enhancements were detected.  
An intrinsic limitation of LGE, however, is that MRI signal intensity is measured in “arbitrary 
units” with variable magnitude and scale across examinations. Although LA wall image 
intensity on LGE-MRI primarily varies as a function of gadolinium retention in fibrotic 
regions, it is also affected by parameters such as surface coil proximity, contrast dose, delay 
time of image acquisition after contrast injection, patient hematocrit, glomerular filtration 
rate, and body mass index (BMI).253,254 Normalization of the image intensity may decrease 
the variability of measurement with regard to the latter covariates, and various groups have 
adopted different means by which this is can be achieved. A majority of current methods in 
the identification of left atrial scar is dependent on operator judgment to define the level of 
enhancement defined as scar (thresholding). An approach which has been adopted is the 
identification of a bimodal distribution of intensities to define threshold of scar as the 
through between peaks, assisted by the utilization of a volume rendering tool in Corview (an 
in-house visualisation platform).246 However, this was not observed in our cohort of patients. 
Others have also noted this lack of a bimodal distribution which prevents this from being a 
universally applicable technique.  
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Figure 3.24 Bimodal distribution of voxel intensities 
Voxel intensity histogram analysis of left atrial wall identifies delayed enhancement as voxel 
intensities in numbers of SD above the mean in-plane voxel intensity, demonstrating a 
bimodal distribution, which was not observed in our patient cohort. Adapted from Jadidi et 
al.203  
 
 
We adopted the mean blood pool as a non-enhancing reference, and the absolute left atrial 
wall intensity was normalized to the mean blood pool intensity of the entire left atrial blood 
pool using a shrinking model.228 Others have used the mean blood pool intensity of a 2D 
axial slice, to normalize the left atrial intensities of the left atrial wall within the same slice. 
Nazarian et al developed the image intensity ratio (IIR) where the LA myocardium in each 
axial plane was divided into 20 sectors, and the mean pixel intensity of each sector (as 
opposed to each voxel) was then normalized to the mean blood pool pixel intensity of the 
entire LA blood pool.255 In these methods, the intensities expressed as continuous variables. 
Others have used the approach of the definition of scar against healthy tissue as binary 
(categorical variable) but this involves subjective visual operator identification of regions of 
scar and healthy tissue and heavily operator dependent.256  
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3.4.3 Spatial distribution of LGE-enhancement 
Using the technique described, we quantified the spatial/regional distribution of late-
gadolinium enhancements across the entire left atrium in patients with persistent AF. We 
observed that that left atrial delayed-enhancement were more likely to be found on the 
posterior wall than the anterior wall, and in particular, the left inferior quadrant, adjacent to 
the left inferior pulmonary vein. The septum also had a higher extent of delayed-
enhancements. Other groups utilising LGE-CMRI in delineating the structural substrate in AF 
have also noted these observations. Higuchi et al, part of the Utah group, reported the 
highest density area of structural remodelling on the posterior left atrial wall, near the left 
inferior pulmonary vein based on a cohort of 160 patients with both paroxysmal and 
persistent AF.257 The Bordeaux group led by Cochet described a stereotyped distribution of 
atrial delayed enhancements in 190 patients, including patients without a history of atrial 
fibrillation, where atrial delayed enhancements were more likely found on the posterior 
rather than the anterior wall, and particularly, in the area adjacent and below the left inferior 
pulmonary vein ostium, and to a lesser extent, close to the right pulmonary veins. 
Interestingly, this distribution is not related to the underlying clinical condition, and is also 
encountered in patients with no AF and no structural heart disease.258 Most recently, Mont 
et al described the topography of atrial fibrosis in 94 patients with both paroxysmal and 
persistent AF undergoing ablation using LGE-CMRI. Once again, similar to our description, 
fibrosis was more frequently identified in the antral region of the left inferior pulmonary vein, 
and the mitral isthmus region, and fibrotic tissue infiltration based on late-gadolinium 
enhancement was more prevalent on the posterior wall, as opposed to the anterior wall, 
and with higher grades of severity.259 These seemingly constant findings are despite the use 
of significantly different post-processing algorithms in the quantitative analysis of late-
gadolinium enhancement, including that of atrial segmentation techniques and scar 
thresholding as discussed above.  
Our findings of increased late-gadolinium enhancements in the posterior and septal regions 
of the left atrium are consistent with voltage data from electro-anatomic mapping. Regional 
differences in voltage are present in patients with AF, where the posterior and septal walls 
exhibited the lowest voltages using point-by-point mapping with a 8mm ablation catheter in 
sinus rhythm.171 Further, this is also corroborated with histological data where a greater 
amount of interstitial fibrosis is found in the posterior left atrial wall, compared to the left 
atrial appendage in patients with AF undergoing mitral valve surgery. Animal studies have 
also demonstrated that atrial dilatation results in posterior wall fibrosis, concomitant with 
low voltages in a rapid-pacing canine model of AF.260 More recently, left atrial wall thickness 
has been suggested to correlated with atrial scar using multi-detector computed 
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tomography.261 The posterior left atrial wall demonstrated the thinnest wall thickness 
(1.63±0.43mm), and the lowest voltage (0.43±0.82mV) performed during intra-cardiac 
mapping in AF, once again supporting the observations of the predilection of atrial structural 
remodelling in the form of fibrosis to be localised to the posterior left atrial wall.  
The basis for the predilection of the posterior left atrial wall to undergo fibrotic change in 
patients with AF is not clear. Whether this is a consequence of its purported 
arrhythmogenicity or it cause is not clear. Its arrhythmogenicity has been proposed to be 
due to its common embryologic origins to that of the pulmonary veins. It is hence been 
targeted as part of a strategy to improve outcomes of surgical and catheter ablation of AF, 
initially with the Box Lesion set in the Cox-Maze procedure, and more latterly, posterior 
wall isolation.   
Although there are plausible biological and electrophysiological explanations to account for 
the spatial distribution of late-gadolinium enhancement, and its predilection to the posterior 
left atrial wall, the question of whether the phenomenon is in fact an artifact of LGE-CMRI 
or that of the post-processing algorithms (discussed in above in 3.4.6 and 3.4.7) remains. 
The close proximity of the posterior wall to enhancing extra-cardiac structures like the 
oesophagus, vertebral column and descending aorta makes the possibility that the posterior 
wall enhancements are false characterizations representing inappropriate enhancements 
derived from these structures.  
The spatial resolution of current MR imaging is in the realm of 1.25 x 1.25 x 2 mm (voxel 
size), and the walls of the left atrium are within the same dimensions (1-2mm). Hence, MR 
imaging of the left atrial wall is susceptible to the partial volume effect, a phenomenon which 
occurs in biological imaging modalities.262 It is defined as the loss of apparent activity in small 
regions where the size of the structure being imaged is comparable to the spatial resolution 
of the imaging system (i.e. equates to the size of the voxel). This loss of activity in the object 
(voxel) is distributed across adjacent voxels, which as considered outside the object, 
resulting in an increase in activity in these voxels. This increase in activity is referred to as 
spillover, whereas the loss in activity is referred to partial volume loss. Hence, the observed 
activity is the sum of activity due to partial volume loss plus spillover from adjacent regions. 
The issues arising as a result of this phenomenon is well represented in the imaging of the 
posterior left atrial wall, with the surrounding enhancing structures.  
Increasing left atrial size results in a higher degree of compression and indentation of the 
posterior left atrial wall to posterior extracardiac structures, increasing the possibility that 
enhancement from those structures are falsely represented on the posterior left atrial wall. 
We did not demonstrate any relationship between the left atrial dimensions to the extent of 
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enhancements on the posterior wall. With the improved methodology of contouring of the 
epicardial border of the left atrial wall, and adopting an inward only direction of maximum 
intensity projection, the lack of correlation here suggests that the predilection of atrial wall 
enhancement on the posterior left atrium is unlikely to be due to the phenomenon of partial 
volume, nor of inaccurate post-processing algorithms. Similarly, the lack of a relationship 
between the distances of the descending aorta to the extent of enhancements on the left 
inferior quadrant of the posterior wall is in keeping with the above conclusion.  
3.4.4 Correlation of global atrial enhancement to clinical indices 
Current accepted clinical parameters, which reflects the degree of structural atrial 
remodelling in patients with AF includes that of, left atrial size, and the CHADS2 score. We 
observed that patients with left atrial sizes of >45mm had a higher extent of late-gadolinium 
enhancement, which is in keeping with evidence suggesting left atrial size to be a close 
surrogate to structural remodelling.   
Our findings also corroborate to those of Daccarett et al,216 who reported the higher 
amounts of atrial fibrosis based on the extent of late-gadolinium atrial enhancements in 
patients with higher CHADS2 scores. The percentage of atrial enhancements as a 
representation of left atrial structural remodelling as seen in their cohort of patients with 
moderate to high thromboembolic risk was 16-21%, quantitatively similar to that seen in our 
patients 14.1-17.1%, although they had a mixed groups of patients with both paroxysmal and 
persistent AF. This correlation of the CHADS2 score and the extent of left atrial 
enhancements suggest that atrial fibrotic change may represent the final common pathway 
from the structural pathological processes that may occur as a result of age, hypertension 
and diabetes, and this could be independent of the presence of AF. Its use in the clinical 
realm to guide anticoagulation strategies would need further investigation.  
3.4.5 Further limitations  
We have discussed in detail limitations as a result of the current spatial resolution 
specifications of LGE-CMRI, and have introduced techniques as part of quantitative 
evaluation of atrial enhancement, and its visualisation to ensure that the partial volume effect 
phenomena are minimized. In addition, enhancement intensities of the left atrium were 
assigned from that of the highest intensity along the normal from the epicardial contours, 
rather than attempting to distinguish partial and transmural scar, which is utilized in 
ventricular LGE imaging.  
Adjustments for cardiac motion are also crucial with high resolution imaging of small and 
mobile structures. ECG-gating was employed in our study, where imaging was performed 
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during atrial diastole, when atrial motion is at a minimum, reducing cardiac-motion related 
artifact. A proportion of the patients were in AF, and this is more challenging. We excluded 
patients where ECG-gating was poor, but we observed that LGE-CMRI were of sufficient 
quality, and equivalent to that of imaging in sinus rhythm, when patients in AF were 
adequately rate controlled, although the acquisition durations were longer. Respiratory 
motion artifacts were addressed with respiratory gating. Unfortunately, the depending on 
the position of the respiratory navigator, usually in the vicinity of the right diaphragm, this 
can result in artifacts of false high signal intensities in the right inferior pulmonary vein 
(Figure 3.21). In order to minimize this motion artifact, the fold-over direction was chosen 
as the direction least affected by motion (left-right or foot-head) or placing signal saturation 
bands over the chest wall. Interpretation of enhancements in or around the right inferior 
pulmonary veins, especially in patients which have not undergone pulmonary vein isolation, 
has to be performed cautiously. In our analyses, the pulmonary veins are removed to 
exclude inaccuracies of atrial enhancements which might have occurred as a result of this 
phenomenon.  
 
Figure 3.25 Respiratory navigator artifact 
High signal intensities seen in the right inferior pulmonary vein (RIPV) as a result of artifact 
from the respiratory navigator, and enhancements in this region have to be interpreted with 
caution. 
  
 
The question to whether left atrial gadolinium enhancements truly reflect myocardial fibrosis 
is yet to be fully answered. Endocardial voltage mapping has often been used as a surrogate 
marker for tissue fibrosis, and groups have shown correlation of voltage electroanatomical 
maps to that of regions of atrial enhancements246,255, with some attempting to describe LGE 
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as a continuous variable, successfully,228 and unsuccessfully.252 Much of the histological 
evidence of the basis of atrial enhancements have been in animal studies studying chronic 
ablation lesions,263  apart from a single centre study involving 14 biopsy samples from 10 
patients with a history of AF where histological evidence of remodelling based on evaluation 
of collagen content with Masson trichrome staining correlated with structural remodelling 
on LGE-CMRI.218. Details of how co-localisation of minute biopsy specimens with that if 
LGE-CMRI was performed is unclear, and more precise histopathologic correlation needs to 
be pursued. Further, the reproducibility of LGE-CMRI as a technique, both in terms of 
quantitative analysis and acquisition has yet to be addressed in a robust fashion. We have 
begun a systematic evaluation of our technique, in terms of reproducibility, which is beyond 
the scope of this thesis.  
We did not perform LGE-CMRI scans on an assigned group of patients to act as a control as 
our previous experience228 has demonstrated lower burdens of late-gadolinium 
enhancements in a cohort of patients with paroxysmal AF.  
3.5 Conclusion 
Imaging the thin-walled left atrium has its limitations, and further representation of atrial 
late-gadolinium enhancements on a 3D shell is challenging. There is currently no ideal or 
validated methodology. The method used in this thesis has borne similar observations in 
terms of spatial distribution of atrial enhancements to other groups, as well as corroborating 
with biologic and electroanatomic mapping data. Chapter 5 will detail the influence of late-
gadolinium enhancement on the electrophysiologic substrate as a form of validation of this 
technique. 
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4 Electroanatomical mapping in atrial fibrillation: 
endocardial voltage  
 
4.1 Introduction 
Currently, the strategy of catheter ablation for persistent atrial fibrillation is varied but is 
largely empiric and anatomic based. Many involve a step-wise approach with placement of 
linear lesions and some form of electrogram-based ablation after circumferential pulmonary 
vein isolation. The long-term single procedure success rates are disappointingly low, but 
improve with multiple procedures.224 The reasons behind the need for repeat procedures 
are not entirely due to the durability of pulmonary vein isolation from the index procedure, 
but also due to the lack of understanding of the pathophysiology of the mechanisms of the 
maintenance of AF, and its highly remodeled arrhythmic substrate. This is the sum of 
electrophysiological (functional) and structural (anatomic and molecular) changes.  
Clinically, the delineation of the atrial electrophysiological substrate has involved 
electrogram characterisation in both AF and, more recently, sinus rhythm, with the 
“complexity” of the electrograms being used as a surrogate of abnormal electrophysiological 
substrate using time and frequency domain analyses. 264,265 However, fractionated signals may 
not always represent an abnormal substrate, and can be attributed to wavefront collisions223 
which have been demonstrated in healthy atrial tissue.203,266 It has been suggested that 
substrate modification in persistent AF should move towards an individualized patient-
specific approach but the optimal strategy to characterize and target a patient’s arrhythmic 
substrate remains unclear. Several recent studies have suggested potential ablation targets to 
be areas of low-voltage identified from endocardial voltage mapping in sinus rhythm173, or 
areas of fibrosis as determined by left atrial late-gadolinium enhanced cardiac magnetic 
resonance imaging (DECAAF-II).138 More recently, low voltage areas during mapping in AF 
have been targeted for ablation with improved clinical outcomes.134 However, the chaotic 
nature of AF, with spatio-temporal electrogram variation, causes obvious challenges in 
interpretation of voltage mapping, and techniques used, thus far, have not been 
systematically studied due to the lack of available tools.  
More directed panoramic mapping techniques have been recently employed to identify and 
target the underlying mechanisms of the persistence of AF. FIRM-mapping has allowed for 
the detection of stable rotors, which can be ablated and appear to yield improved clinical 
outcomes.18 Body surface mapping using ECGI technology has also demonstrated the 
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presence of rotors, although these were generally short-lived. Nonetheless, these maps of 
rotor locations have been utilized to guide ablation.20 Neither of these newer approaches 
have been corroborated with direct higher-resolution intracardiac recordings, or validated 
independently, nor has there been an explanation for the apparent discrepancies in the 
complexities of AF using each technique. 
We hypothesized that assessment of the spatio-temporal stability of voltage during AF by 
quantifying the time course of mean peak-to-peak AF voltage, and its reproducibility, may 
allow for a meaningful spatial differentiation for the persistent AF substrate. In this chapter, 
we propose to assess the degree of temporal stability of AF voltage for the AF electrogram 
(the relationship of the mean peak to peak AF voltage with time), and demonstrate the 
degree of spatiotemporal stability of low voltage regions during AF (reproducibility of mean 
AF voltage maps). This forms the basis for the subsequent evaluation of the degree of spatial 
correlation of low voltage regions in AF against that of low voltage regions in sinus rhythm, 
as compared to LGE-CMRI. Further interrogation of these distinct sites may yield crucial 
insights into the underlying mechanisms of AF maintenance. Thus, we also evaluated how the 
local AF cycle length is related to AF voltage patterns, which may provide mechanistic 
insights to the AF substrate.  
4.2 Methods 
Patients with symptomatic persistent AF (based on the classification of AF by published 
guidelines from the AHA/ACC/HRS/ESC)6 presenting for their first ablation to Imperial 
College Healthcare NHS Trust were prospectively enrolled. The study was approved by the 
Local Research and Ethics Committee for Imperial College Healthcare NHS Trust and 
written informed consent were obtained from all patients. 
All anti-arrhythmic drugs were discontinued for at least 5 half-lives, and amiodarone was 
discontinued at least 60 days, prior to the ablation procedure. All procedures were 
performed in the post-absorptive state under general anaesthesia. Transoesophageal 
echocardiography was performed in all patients once under general anaesthesia to exclude 
left atrial appendage clot, and to subsequently guide transseptal puncture. A deflectable 
decapolar catheter (Inquiry, St Jude Medical, St. Paul, MN, USA) was positioned in the 
coronary sinus to record electrograms, pace the atrium, and serve as a spatial reference. A 
pentapole with a proximal reference electrode in the inferior vena cava was placed to allow 
for acquisition of unipolar recordings. Single transseptal punctures were performed using a 
Brokenbrough needle through a fixed curve long-sheath (SL0, St Jude Medical, MN, USA). 
Unfractionated heparin was administered to achieve an activated clotting time of 300-350s 
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throughout the procedure. An impedance-based electroanatomical mapping system (NavX 
Ensite Velocity, St Jude Medical, MN, USA) was used. The left atrial geometry and all 
subsequent data were acquired using a 20-pole double-loop catheter (InquiryTM AFocusIITM, 
St Jude Medical, MN, USA) with 4mm electrode spacing. Bipolar electrograms were 
recorded and displayed at filter settings of 30-500Hz, and unipolar electrograms at 0.5-
100Hz during the procedure. Prior to any radiofrequency ablation therapy, map data 
acquisition was performed according to the study protocol.  Subsequent to the study 
protocol, all PV's were isolated, followed by a "stepwise approach" for modification of the 
AF substrate at the operators’ discretion.  
4.2.1 Electroanatomical mapping in AF 
All patients were in AF on the day of the procedure. Baseline AF data was initially acquired 
and displayed in the form of a Complex Fractionated Electrogram (CFE) map. While bipolar 
electrogram data was used during the study, unipolar electrograms were also acquired for 
retrospective analysis.  The technique of acquiring CFE maps (CFEmean) using an automated 
algorithm (NavX EnsiteTM Velocity, St Jude Medical) has been previously described and 
validated. Contact bipolar electrograms were obtained in AF with the AFocusII catheter 
positioned tangentially with the endocardial surface to maximize electrogram fidelity for 8 
seconds at each site, where possible. With the utility of the 20 pole AFocusII, overlapping 
regions of the left atrium were mapped, reducing the probability of the left atrial sites being 
mapped only once, and increasing the likelihood that similar left atrial regions were mapped 
through different catheter positions).  Each acquired point on this CFE map contains an 8 
sec segment of AF that was exported for further analyses as described below. In a subset of 
patients (15), during the generation of the CFE map, AF electrogram data on the posterior 
wall was acquired over a longer duration of recording (up to 30 sec), which allowed for a 
greater number of AF cycle lengths to be analysed retrospectively (Figure 4.1). These 
segments of AF mapping from various left atrial positions are recorded, and are subsequently 
used to generate further CFE maps from the first and last 8 sec from the 30 sec recordings, 
and utilized to evaluate stability of the mean AF voltage over multiple time epochs.  
 
In order to ensure that far-field electrograms are not falsely included as low voltage or 
fractionated, and fidelity of electrograms, in the absence of force sensing functionality of the 
mapping catheter, was optimised using the electrogram projection distance facility on the 
EnsiteTM Velocity 3D mapping system. The accepted electrogram projection distance was 
reduced to 4mm to the left atrial geometry (i.e. electrograms with Cartesian co-ordinates of 
>4mm from the EnsiteTM Velocity-generated geometry were excluded from the map) as a 
surrogate marker of adequate contact on the atrial myocardium.  
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Figure 4.1 Prolonged posterior left atrial wall mapping 
Mapping of the entire posterior left atrial wall with the AFocusII catheter, with electrograms 
recorded up to 30 sec at each site (Left panel – posterior-anterior view, Right panel – right 
lateral view). The high fidelity of electrograms acquired with stable and close approximation 
of the AFocusII catheter to the atrial endocardium as is illustrated above.  
 
In a subset of patients, bipolar sinus rhythm voltage maps were created following external 
DCCV, but prior to any ablation being performed. In a further subset of patients, the CFE 
map was repeated 1-2 mins later, acquiring data which will allow for the assessment of the 
temporal-spatial variability/stability of the AF voltage over distinct epochs of AF.  
4.2.2 Measurement of mean atrial voltage in AF 
The segments of AF recordings were exported into an in-house custom written software for 
electrogram analysis267 (HEART) for measurement of the mean voltage over various 
durations of recordings. Each electrogram from a segment of recording was annotated 
appropriately using the following algorithm: 
1) Identification of the positive and negative peaks through evaluating the maximum (or 
minimum) value within a moving window of size 20 samples (10ms);   
2) These are paired by looking for negative and positive tags within 50 samples (25ms) of 
each other; and 
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3) A refractory window of 100ms is subsequently applied starting at the first deflection, in 
which any other deflections within the window, unless they have larger amplitude than the 
starting deflection are removed. In this case, the larger deflection is taken as the starting 
point for the refractory window (and the initial deflection discarded).  
4) The minimum amplitude was set at 0.04mV to eradicate noise.  
Representative electrograms could be verified and adjusted if necessary to ensure no double 
counting or annotation of far-field signals.  
AF bipolar voltage of each bipole was calculated by evaluating the mean peak-to-peak over 
various lengths of recordings (500ms to 8 sec)/AF cycles to produce a cumulative mean±SD 
voltage (Figure 4.2). In addition, the regional AF bipolar voltage was calculated by evaluating 
the mean peak-to-peak of all the electrograms in the left atrial region subtended by the 
AFocusII catheter (20 bipoles) over a various lengths of recordings (500ms to 8 sec) to 
produce a cumulative mean±SD voltage.  
 
Figure 4.2 Measurement of mean AF voltage 
An exported 8 sec segment of an AF recording with electrograms tagged in accordance to 
criteria described (yellow dots). The mean AF voltage is the mean of the peak-to-peak 
amplitudes of all tagged electrograms. 
 
The mean peak-to-peak AF voltages over multiple sampling windows were then projected 
on the left atrial shell (exported from the 3D mapping system) to display the data as a 
standard electroanatomical map (Figure 4.3).  
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Figure 4.3 Peak-to-peak AF voltage representation over multiple 
sampling windows on HEART 
The 8s segment of electrograms (left panel) exported into custom-written software HEART 
where the mean peak-to-peak AF voltage at each electrode location is analysed over 
multiple sampling windows (1, 2, 4 and 8s illustrated), and data then projected on to an 
anatomical shell (right panel). 
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4.2.3 Measurement of AF cycle length  
Each deflection was appropriately annotated using the algorithm identical to that adopted 
during the evaluation the mean AF voltage (see Section 4.2.2). The time period between 
each deflection is measured, and the mean calculated over 8 sec (Figure 4.4). In addition, 
highly fractionated electrograms were excluded based on a cycle length regularity algorithm 
which was in-built into the EnsiteTM Velocity system – see section 4.2.5).   
 
Figure 4.4 Measurement of AF cycle length 
The duration between each annotated electrogram/deflection was measured (white arrows), 
and the mean over the period of recording was calculated as the mean AF cycle length. 
 
4.2.4 Measurement of fractionation index  
The EnsiteTM NavX CFEmean score was used as the measure of fractionation of a single 
recording from each bipole of the AFocusII catheter was used. We adopted the following 
parameters: the minimum amplitude was set at 0.04mV, with a minimum deflection width of 
10ms and refractory ‘blanking’ period of 40ms. The software then tags deflections meeting 
these criteria and calculates the mean interval between deflections which is then defined as 
the CFEmean score over the entire 8s recording. 
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Figure 4.5 Measurement of fractionation (CFEmean score) 
Pictorial representation of measurement of fractionation within a recording of a segment of 
AF distinguishing between organised and fractionated activity (Left panel). The activation 
detection criteria is illustrated (Right panel) with a peak-to-peak voltage threshold of 
0.04mV, duration threshold (slope) of 10ms to exclude far-filed signals and a refractory 
setting (40ms) to avoid double counting.  
 
4.2.5 Incorporation and evaluation of AF electrogram indices into EnsiteTM Velocity 
3D mapping system 
Following the export and analyses of the AF electrogram indices on our in-house custom 
written software HEART, we subsequently collaborated with the Research and 
Development Division (Cardiac Rhythm Management) of St Jude Medical Inc., and this 
resulted in the incorporation of algorithms within the EnsiteTM Velocity Research module in 
a software update, which subsequently enabled the evaluation of metrics of AF mean peak-
to-peak voltage over multiple sampling windows (of up to 8s) as well as AF cycle lengths 
(including cycle length regularity) and be subsequently projected onto the left atrial shell as 
“standard” electroanatomical maps, which have previously been impossible. The 
incorporated electrogram annotation for the AF mean peak-to-peak algorithms was similar 
to that of our in-house custom written software HEART. In addition, in evaluation of the AF 
cycle length, cycle length regularity functionality was adopted to allow for more 
representative measurements and avoidance of inaccuracies as a result of overly fractionated 
electrograms. Here, the measurement of cycle length is deemed inaccurate and removed 
(voided) when the standard deviation of the cycle lengths over an 8s segment of electrogram 
recording was over 40ms.   
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These features allowed for more streamlined analyses of the acquired electroanatomical 
data. Variables such as electrogram width and refractory periods can be altered as sliding 
criteria as the CFEmean metric. These algorithms are expected to be implemented into the 
clinical EnsiteTM Velocity modules in due course, with the impetus of “live” electroanatomical 
maps being generated to guide ablation as part of a clinical study. This will occur following 
validations of the individual metrics and internal review processes. Figure 4.6 illustrates an 
electroanatomic map of mean peak-to-peak over 8s of AF sampling on the updated software 
on the EnsiteTM Velocity Research module.  
 
Figure 4.6 EnsiteTM Velocity Research Module 
This illustrates the implemented algorithm which enabled the mean AF peak-to-peak voltage 
over a time window of up to 8s (Red boxes: Segment Length 8s and peak-to-peak metric of 
mean AF voltage) to be projected onto the left atrial geometry as a “standard” 
electroanatomical map. Electrogram data can be exported for statistical analyses. 
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4.2.6 Evaluation of effect of late-gadolinium enhancement on voltage 
For each patient, left atrial late-gadolinium enhanced cardiac magnetic resonance (LGE-
CMRI) derived atrial scar maps was then imported into the EnsiteTM Velocity 3D mapping 
system as described in Chapter 3. This allowed for overlap analyses of regions left atrial scar 
defined by late-gadolinium enhancement, and voltage (both in AF and in sinus rhythm). 
Figure 4.7 illustrates voltage electroanatomic scar maps in sinus rhythm and AF, with their 
respective electrograms, and the corresponding LGE-CMRI derived atrial maps on EnsiteTM 
Velocity.  
 
Figure 4.7 Integration of LGE-CMRI scars maps into EnsiteTM Velocity 
Electroanatomical voltage maps, performed in sinus rhythm (left) and AF (middle), with their 
corresponding electrograms. The AF voltage maps were created using 8s segments of 
recordings, and the maps represents the mean peak-to-peak AF voltage. The LGE-CMRI 
derived atrial scar maps (right) are imported, and registered to the left atrial geometries for 
overlap analyses to be performed.  
 
Using variable scar thresholding for late-gadolinium intensities and voltage (for sinus rhythm 
and AF), areas of LGE-CMRI defined scar are outlined on EnsiteTM Velocity using the in-built 
marker facility. Areas of overlap between LGE-defined and voltage (in both sinus rhythm and 
AF) were calculated (Figure 4.8). In addition, voltage data acquired in late-gadolinium and 
non-late-gadolinium enhanced regions of the left atrium were exported for point analysis 
(Figure 4.9).  
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Figure 4.8 Overlap analysis of LGE-CMRI and voltage scar 
The areas of LGE-CMRI defined scar are outlined in white (left). The mean AF voltage scar 
map is then projected onto the left atrial shell, and regions of mean AF voltage scar (0.3mV) 
are outlined in black. The areas of overlap are then quantified for analysis.  
 
 
 
Figure 4.9 Export of data in LGE and non-LGE regions for point analysis 
Voltage data from electrograms acquired in LGE and non-LGE left atrial regions were 
exported for point analysis.  
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4.2.7 Statistical analysis 
All normal variables are expressed as mean and standard deviation (SD) or standard error of 
the mean (SEM). Non-parametric distributions are described as median with the 
interquartile range (IQR). Paired and unpaired T-tests were used when appropriate, with 
Bonferoni correction for multiple tests. Correlation of continuous variables was examined 
with Pearson’s and Spearman’s correlation coefficients for parametric and non-parametric 
data respectively. A probability of < 0.05 was considered significant. For the LGE-CMRI 
analysis, the receiver-operator characteristics (ROC) curve was constructed to assess 
optimal voltage (both AF and sinus rhythm) cutoff values that best sites which distinguished 
left atrial regions overlying LGE-CMRI defined scar compared to regions over areas without 
scar.  
4.3 Results 
AF voltage and activation mapping were performed in 20 patients. Baseline characteristics of 
the study group are presented in Table 6.1. The mean age of the patients was 62±11 years, 
with 55% being male. LA size was 41±6mm. Their AF symptom history was 21.3±10 months 
and mean CHADS score was 2.4 (0-5). The prevalence of structural heart disease was 33%.  
 
Table 4.1 Clinical demographics of patients recruited 
Clinical characteristics (n=20)  
Age (years) 62±11 
Male (%) 55% 
Mean LA size on TTE (mm) 41±6 
Mean CHADS2 score 2.4 (0-5) 
Structural heart disease (%) 33% 
Mean duration of AF (months) 21.3±10 
 
4.3.1 Temporal variability of AF voltage 
160200 AF cycles from 3560 electrode positions from 20 patients were analysed 
(approximately 240 electrode recordings/patient). The mean surface area of the left atrium 
was 100±15cm2, excluding the left atrial appendage and pulmonary veins. The mean number 
of points acquired per CFE map was 360±35, for a mean point density of 3.5±1.1cm2.  
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We systematically characterised voltages in AF over varying time sampling windows to 
quantify the time course of the mean AF peak-to-peak voltage in persistent AF across the 
entire left atrium. The cycle-to-cycle AF voltage (single peak-to-peak measurement) 
variability of a single AF cycle was large, with a coefficient of variation (CoV) of 62%. 
Increasing the number of AF cycles sampled improved the CoV (2 AFCY - 40%, 40 AFCY – 
8%).  
The variability of the mean AF peak-to-peak voltage over time demonstrated 3 distinct 
patterns, illustrated in Figure 4.10. Each line represents the time-course of the mean AF 
peak-to-peak voltage at a distinct electrode location in the left atrium – (Blue) the mean AF 
peak-to-peak voltage is relatively high, and subsequently stabilises to a lower mean AF peak-
to-peak voltage as sampling duration increased; (Gray) the mean AF peak-to-peak voltage is 
relatively stable over increasing sampling durations; and (Red) where the mean AF peak-to-
peak AF voltage is relatively low, and subsequently stabilises to a higher mean AF peak-to-
peak voltage. The final mean AF peak-to-peak voltages fall into distinct categories will enable 
segregation of different regions of the left atrium. 
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Figure 4.10 Time-course of mean AF mean peak-to-peak voltage 
Three distinct patterns of the mean AF mean peak-to-peak AF voltage (AF-V). (Blue) 
Relatively high AF-V which stabilizes to a lower AF-V; (Gray) relatively stable AF-V and 
(Red) relatively low AF-V, which stabilizes to a higher AF-V as sampling duration, increases.  
 
Figure 4.11 shows the crossover of mean AF peak-to-peak voltage between the top and 
bottom quartiles of all electrograms sampled over approximately 8s in a single 
representative patient. Across the 20 patients, this trend was consistent, with clear 
separation of the bottom and top mean AF peak-to-peak voltage quartiles when the sampling 
duration was above 4s (approximately 20 AF cycles), which allows for a meaningful spatial 
differentiation across the entire mapped left atrium (Figure 4.12). In addition, the mean AF 
peak-to-peak voltage tends to “settle” to a stable baseline over a similar sampling window. 
This phenomenon is manifest more clearly when the mean AF peak-to-peak voltage is 
normalised to index mean (mean AF peak-to-peak voltage at 8s), i.e. difference between 
sampled mean AF peak-to-peak voltage and index mean as illustrated in Figure 4.13.  
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Figure 4.11 Mean peak-to-peak AF voltage over increasing sampling 
windows 
Plot of mean peak-to-peak AF voltage (AF-V) measured over increasing number of seconds 
of AF sampled (up to 8s) of all electrograms in a single representative patient. For illustrative 
purposes, electrograms in the bottom and top quartiles of the mean peak-to-peak voltages 
over 8s are in red and blue respectively. AF-V across all electrode measurements tends to 
stabilize when the sampling duration exceeds 4s (dotted line).  
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Figure 4.12 Time-course of mean AF peak-to-peak voltage of all 
electrodes in all patients 
The plots illustrate the time-course of the mean AF peak-to-peak voltage (AF-V) of all data 
acquisition points in all 20 patients recruited in the study. There is some variation in the 
time-course of the AF-V across patients, although there are clear distinct sub-groups of AF-
V which stabilises following 4s of data acquisition (Electrograms in the bottom and top 
quartiles of the mean peak-to-peak voltages over 8s are in red and blue respectively). 
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Figure 4.13 Normalised mean peak-to-peak AF voltage with increasing 
sampling windows in a single patient 
Mean peak-to-peak AF voltage at each sampling window normalised to the index mean peak-
to-peak AF voltage (8s mean) i.e. difference between the sampled mean and the index 8s-
mean voltage over number of seconds of AF sampled demonstrating stabilization of the 
mean AF voltage after about 4s of sampling of AF in a single representative patient. 
 
In addition, the normalised mean peak-to-peak AF voltage of all electrograms in all 20 
patients over increasing sampling windows of AF demonstrates absolute differences of the 
sampled mean and the index 8s mean AF voltage of 0.05mV following a sampling duration of 
4s, approximating to the threshold level of noise (Figure 4.14). 
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Figure 4.14 Absolute difference of sampled and final mean peak-to-peak 
voltage 
A plot of the absolute difference of sampled and the final index mean of the peak-to-peak AF 
voltage over the increasing duration of AF of all electrograms acquired in all patients (black 
lines). The electrograms within the shaded confines represent electrograms in the upper 
95% confidence interval for all the data acquired. The red line represents the normalised 
mean peak-to-peak AF voltage over number of seconds of AF sampled of all electrograms, 
and demonstrates a decrease to a level which approximates to that of noise (0.05mV) at 4s 
of AF sampled.   
 
The percentage of subsampled electrograms where the mean AF peak-to-peak voltage 
deviated from the 8s index mean AF voltage by >10% is shown in Figure. 4.15 where 
progressively more points demonstrate >10% difference from the 8s-index value as the 
sampling duration shortens. By 4s of AF sampling, the percentage of “erroneous” readings 
falls under 10%. Intra-class correlation coefficients (ICC) of subsampled electrogram mean 
AF voltage as compared to the 8s-index mean AF voltage quantifies this weakening 
relationship as sampling durations become shorter (1s: ICC 0.88, 2s: ICC 0.94, 3s: ICC 0.96, 
4s: ICC 0.98, 5-6s: 0.99 and 7s: ICC 1.00)  (Figure 4.16).  
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Figure 4.15 Percentage of electrograms deviating from 8s-index mean 
over various AF sampling windows 
Percentage of electrograms deviating by >10% from 8s-index mean AF peak-to-peak voltage 
which show a greater proportion of inaccuracies as duration of AF sampling shortens.     
 
 
Figure 4.16 Intra-class correlation coefficient plots 
Scatter plots of 8s-index mean AF-V (y-axes) vs. the values for the same point derived from 
the 7-, 6-, 5-, 4-, 3-, 2-, and 1-s subsamples (x-axes). Note the decreasing ICCs with shorter 
sampling duration. A value of 1 indicates prefect agreement, and 0 indicates no agreement. 
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4.3.2 Spatial variability of AF voltage 
The spatial distribution of the mean peak-to-peak AF voltage (across the left atrium) varies 
over varying sampling windows. Although of the extent of change of the mean AF voltage 
maps does vary to some extent across the 20 patients, they tend to remain stable after 4s of 
sampling of AF. Hence, low and high mean AF voltage regions seem to remain unchanged 
when the mean AF voltage map is generated with a minimum sampling duration of 4s, but 
demonstrates significant variability when sampling durations are less than 4s. This is 
illustrated in Figure 4.17, where electroanatomical maps created on HEART of mean AF 
peak-to-peak voltage over multiple AF sampling windows (0.2s, 0.4s, 2s, 4s, 6s and 8s) in a 
single representative patient. The maps remain unchanged after 4s of AF sampling.  Visually, 
the spatial variability of the mean peak-to-peak voltage stabilizes after approximately 4s of 
AF sampling, and this corroborates with the per electrogram analyses illustrated in Figures 
4.11 and 4.13.  
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Figure 4.17 Spatial variability of mean AF voltage across the left atrium 
Left atrial electroanatomical voltage maps generated on HEART demonstrating the spatial-temporal stability/variability of mean AF peak-to-peak voltages 
with increasing AF sampling windows (0.2s, 0.4s, 2s, 4s, 6s and 8s) with scar at voltage<0.1mV in a single representative patient. In this patient, the maps 
remain unchanged after 4s of AF sampling. (Top panel: antero-posterior views, Bottom panel: postero-anterior views).  
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4.3.3 Reproducibility of mean AF voltage left atrial maps 
Mean peak-to-peak AF voltage maps were then created from data acquired over 2 distinct epochs of 
AF, from the first and last 8 sec segments from the 30 sec length recordings. This demonstrated 
increasing similarity of the left atrial electroanatomical AF voltage maps as the duration of AF 
sampling increases (Figure 4.18).  
 
Figure 4.18 Electroanatomic mean AF voltage maps over 2 distinct epochs 
of AF 
Electroanatomic voltage maps created on HEART using increasing sampling durations of AF 
(1 AF cycle length, 4s and 8s) over 2 separate time epochs of AF illustrating stability of low 
voltage areas (<0.3-0.40mV) with a minimum of 4s of sampling windows in a single 
representative patient.  
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The electroanatomical mean AF peak-to-peak voltage over 8s maps over the 2 epochs of AF were 
subsequently more expeditiously constructed on the EnsiteTM Velocity 3D mapping system when the 
algorithms were implemented into a software upgrade (Figure 4.19).  
 
Figure 4.19 Reproducibility of 8s mean AF peak-to-peak voltage map 
Examples of mean AF peak-to-peak voltage electroanatomical maps generated from 8s 
segments of AF demonstrating similarities in regions of low voltage (posterior left atrial 
wall).  
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These observations were corroborated using statistical analyses of the individually exported 
electrogram data acquired from each of the distinct time epochs of AF mapped in all the patients. In 
total, 3441 acquired electrogram data points were exported. Figure 4.20 illustrates improving intra-
class correlation coefficients with increasing samplings windows in each time epochs of AF (1 AF 
cycle length: ICC 0.83, 4s: ICC 0.923 and 8s: ICC 0.945) but more importantly demonstrates a high 
degree of congruency of mean peak-to-peak AF voltage of the individual acquired data points mapped 
during distinct AF time epochs.  
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Figure 4.20 Intra-class correlation coefficient of AF voltage over 2 AF 
epochs 
Scatter plots of sampled mean peak-to-peak AF voltage obtained from AF epoch 1 (y-axes) 
against the values for the same point derived from AF epoch 2 (x-axes) over 1 AF cycle 
(left), 4s (middle) and 8s (right). Note the increasing intra-class correlation coefficients 
(ICCs) with longer sampling durations. A value of 1 indicates perfect agreement, and 0 
indicates no agreement.  
 
4.3.4 Correlation of voltage and late-gadolinium enhancement 
10 patients also underwent LGE-CMRI pre-procedurally, and had atrial scar maps generated using 
our in-house custom written software, which were subsequently imported into the EnsiteTM Velocity 
3D mapping system to allow correlation of electrophysiological data to late-gadolinium enhancement 
following registration. Regions of the left atrium with normalized intensities of >2SD above the mean 
blood pool intensities were considered as scar.  
4.3.4.1 Surface overlap analysis 
The mean total surface left atrial area was 154.9±24.8cm2. The mean late-gadolinium enhanced left 
atrial surface area was 35.5±10.5cm2, accounting for 23.7±9.0% of the total left atrial surface area. 
Subsequent analysis was only performed only on the posterior wall of the left atrium due to the high 
fidelity of electrograms obtained on the posterior wall, and the fact that late-gadolinium 
enhancements largely affected the posterior wall (as described in Chapter 3).  
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The mean surface area of the left atrial posterior wall was 53.2±20.4cm2. The mean late-gadolinium 
enhanced surface area of the posterior left atrial wall was 20.3±6.7cm2, accounting for 38.6±15.9% of 
the total posterior left atrial surface area.  
Cumulatively, when atrial scar thresholds for the mean AF peak-to-peak voltage were set at various 
levels (0.45mV to 0.1mV), the total posterior wall surface areas in all 10 patients with corresponding 
left atrial scar based on the respective voltages were as follows: AF scar <0.1mV: 35.4cm2 (6.6%), 
<0.2mV: 151cm2 (28.3%), <0.25mV: 198.2cm2 (37.2%), 0.3mV: 263.5cm2 (49.4%), <0.35mV: 304.2cm2 
(57.1%), <0.4mV: 343cm2 (64.3%) and <0.5mV: 403cm2 (75.6%). The surface areas of overlap of 
regions of late-gadolinium and low voltage regions based on their respective voltages (and their 
percentage of overlap) were as follows: <0.1mV: 20.3cm2 (11.1%), <0.2mV: 79.6cm2 (43.5%), 
<0.25mV: 100.4cm2 (54.8%), <0.3mV: 121.7cm2 (66.5%), <0.35mV: 137.2cm2 (74.9%), <0.4mV: 
159.1cm2 (81.4%) and <0.5mV: 161.8cm2 (88.4%). Figure 4.21 includes AF voltage maps and atrial scar 
maps derived from late-gadolinium enhanced cardiac magnetic resonance imaging (LGE-CMRI) from 
each patient included in the analyses, where voltage scar threshold was set at <0.4mV.  
Similar overlap analyses were performed for sinus rhythm voltage, with scar thresholds set at various 
levels (3.0mV to 0.5mV). The total posterior wall surface areas in all patients with the corresponding 
left atrial scar based on the respective voltages were as follows (and as a percentage of the total 
posterior wall surface area): SR scar <0.5mV: 46.1cm2 (11.7%), <1.0mV: 109.4cm2 (27.8%), <1.5mV: 
168.5cm2 (42.8%), <2.0mV: 224.2cm2 (56.9%), <2.5mV: 269.9cm2 (68.5%) and <3.0mV: 298.1cm2 
(75.6%). The surface areas of overlap of regions of late-gadolinium and low voltage regions in sinus 
rhythm based on their respective voltages (and their percentage of overlap) were as follows: SR scar 
<0.5mV:  23.9cm2 (18.4%), <1.0mV: 48.1cm2 (37.1%), <1.5mV: 69.7cm2 (53.8%), <2.0mV: 87.7cm2 
(67.7%), <2.5mV: 99.3cm2 (76.6%) and <3.0mV: 106.5cm2 (82.2%). Figure 4.22 includes sinus rhythm 
voltage maps, and LGE-CMRI left atrial scar maps in the subgroup of patients who underwent sinus 
rhythm voltage mapping following external DCCV, with a variable voltage scar threshold to aid 
visualisation and appreciation of the surface overlaps.  
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Figure 4.21 Surface correlation of AF voltage maps and LGE-CMRI derived scar maps 
Voltage scar maps using mean AF peak-to-peak voltage over 8s (voltage scale shown) and the corresponding left atrial posterior wall scar maps derived late-
gadolinium enhanced cardiac MRI (purple – healthy myocardium; red >4SD, yellow >3SD and grey >2SD above mean blood pool intensity) demonstrating 
correlation of scar as determined by AF voltage mapping over 8s, and LGE-CMRI in 9 patients.  
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Figure 4.22 Surface correlation of SR voltage maps and LGE-CMRI derived scar maps 
Sinus rhythm voltage scar maps (with respective variable voltage scale) and the corresponding left atrial posterior wall scar maps derived late-gadolinium 
enhanced cardiac MRI (purple – healthy myocardium; red >4SD, yellow >3SD and grey >2SD above mean blood pool intensity) demonstrating correlation 
of scar as determined by AF voltage mapping over 8s, and LGE-CMRI. 
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Figure 4.23 Comparative assessment of SR and AF voltage maps, with LGE-CMRI derived atrial scar maps 
The comparative assessments (in 2 patients) of voltage maps in both sinus rhythm and AF, with their respective left atrial scar maps derived from the LGE-
CMRI demonstrating closer surface overlaps of voltage maps performed in AF, as opposed to that in SR to the LGE-CMRI scar maps. The regions marked in 
red illustrate the discrepancies in the AF and SR voltage maps.  
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These values were then utilized to generate the following ROC curves to derive specificities 
and sensitivities for voltage, both in AF and in SR, in detecting late-gadolinium enhancements. 
In AF, the bipolar cut-off for the mean peak-to-peak AF voltage over 8s was 0.3mV appeared 
to offer the best sensitivity and specificity (66.5% and 59.5% respectively). In SR, the bipolar 
voltage cut-off was 1.5mV, and offered poor sensitivity and specificity (53.8% and 62.6%) 
respectively (Figure 4.24).  
Due to the limitations of the methodology of overlap analysis which are susceptible to 
inaccuracies as a result of interpolation of point regions on the EnsiteTM Velocity system 
(although this was controlled by reducing the interpolation distance to 5mm), and that some 
measured surface area regions were small and were within the margins of error, we 
performed similar analysis using data from the point distribution, described in 4.3.4.2, and 
illustrated in Figure 4.29.  
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Figure 4.24 Receiver Operator Characteristics (ROC) curve – surface 
overlap analysis 
ROC analysis to determine optimal voltage cut-off values (both in AF and sinus rhythm) for 
discriminating the left atrial scar as defined by LGE-CMRI from healthy myocardium using 
surface overlap analysis. In AF and SR, a bipolar cut-off of 0.3mV and 1.5mV respectively 
appeared to offer the best sensitivities and specificities.  
 
4.3.4.2 Point analysis 
The median AF voltage over the posterior left atrial wall (mean peak-to-peak over 8s) was 
0.305mV (IQR: 0.168-0.5288). In regions of LGE, the median AF voltage was 0.1933 (IQR: 
0.1285-0.31) and in regions of non-LGE, the median AF voltage as 0.4564mV (IQR: 0.301 – 
0.6471), p<0.0001 (Figure 4.25).  The median global SR voltage was 1.49mV (IQR: 0.7763-
2.546). The median SR voltages in regions with and without late-gadolinium enhancement 
were 1.205mV (IQR: 0.6065-2.145) and 1.804mV (IQR: 1.049-2.9613), p<0.0001 (Figure 
4.26).  
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Figure 4.25 Distribution of mean AF voltage in regions of LGE and non-
LGE 
The distributions of mean AF peak-to-peak voltages in regions of the posterior left atrial wall 
with (AF LGE) and without late-gadolinium enhancement (AF non-LGE), p<0.0001. 
  
 
Figure 4.26 Distribution of sinus rhythm voltage in regions of LGE and 
non-LGE 
The distribution of sinus rhythm voltages in regions of the posterior left atrial wall with (SR 
LGE) and without late-gadolinium enhancement (SR non-LGE), p<0.0001. 
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Box-Whisker plots of the distribution of voltages in AF (peak-to-peak mean over 8s) and 
sinus rhythm are represented in Figure 4.27 and 4.28 respectively.  
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Figure 4.27 Distribution of mean AF voltage in LGE and non-LGE regions 
Box-Whisker plots of the distribution of mean AF voltage in regions of the left atrium with 
and without late-gadolinium enhancements, demonstrating negligible overlap in mean AF 
voltage measurements with an approximate cut-off value of 0.30mV - red-dotted line.  
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Figure 4.28 Distribution of sinus rhythm voltage in LGE and non-LGE 
regions 
Box-Whisker plots of the distribution of voltages in sinus rhythm in regions of the left 
atrium with and without late-gadolinium enhancements, demonstrating a significant overlap 
in SR voltage measurements (1.1-2.2mV) – between red-dotted lines.   
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In addition, using the point voltage (on both AF and sinus rhythm) values in regions of the 
left atrium with and without late-gadolinium enhancements, receiver operator characteristics 
(ROC) curves were generated. The mean AF voltage map detected for the presence of left 
atrial late-gadolinium enhancement with a sensitivity of 79% and a specificity of 75% at a 
threshold of 0.35mV with an area under the curve of 0.84. Sinus rhythm voltage was less 
good in predicting regions of late-gadolinium enhancements, with a sensitivity of 64% and 
specificity of 60% at a voltage threshold of 1.8mV, and area under the curve of 0.66 (Figure 
4.29).  
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Figure 4.29 Receiver Operator Characteristics (ROC) curve – point 
analysis 
According to the ROC curves, the AF-V map detected for the presence of LGE with a 
sensitivity of 79% and a specificity of 75% at a threshold of 0.35mV (with an area under the 
curve [AUC] of 0.84).  Less favourably, the SR-V map had a sensitivity of 64% and specificity 
of 60% at a threshold of 1.8 mV (with an AUC of 0.66). 
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4.3.5 AF voltage and cycle length 
In the comparative assessment of global mean AF peak-to-peak voltage over 8s and mean AF 
cycle lengths over the same period of sampling, over 2200 data points from 15 patients were 
exported. The median AF mean voltage sampled over 8s was 0.49mV (IQR: 0.07-3.89), and 
the median AF cycle length 161ms (IQR: 118-238). There was no demonstrable correlation 
of AF mean voltage and AF cycle length over 8s (Figure 4.30).  
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Figure 4.30 AF mean voltage and AF cycle length 
There was no demonstrable correlation of AF mean voltage and AF cycle length over 8s 
 
Using an AF mean voltage threshold of 0.35mV as a representation of “scar” (as per the 
ROC curve analysis above) in binarisation of the data, there was no difference in the 
distributions in AF cycle lengths in regions with AF mean voltages of <0.35mV and >0.35mV 
(Figure 4.31).   
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Figure 4.31 AF mean voltage and AF cycle length - binarised 
Using an AF mean voltage threshold of 0.35mV as representative of scar, there was no 
statistical difference in the distribution of AF cycle lengths in regions with AF mean voltage 
of >0.35mV and <0.35mV.  
 
Although there was no clear relationship of AF mean voltage and AF cycle length on a global 
basis, we subsequently reviewed spatial patterns (absolute and relative) of both voltage and 
cycle length on a per patient basis and allowed for the appreciation of the following 
interesting observations in specific patient subset groups.  
1. Regions with “patchy” heterogeneous low-voltage zones (LVZ), when low voltage zones 
were defined as regions <0.35mV were co-localised with the shortest AF cycle lengths. This 
phenomenon was however not mutually exclusive, and is illustrated in Figure 4.32.  
2. The border zones of low and high voltage zones exhibited significant changes of the local 
AF cycle length, i.e. demonstrating an AF cycle length gradient (Figure 4.33). Regions of high 
voltage zones do no exhibit AF cycle length gradients.  
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Figure 4.32 Spatial overlap of AF mean voltage and cycle lengths 
AF cycle length and mean voltage maps in 3 representative patients demonstrating regions of 
shortest AF cycle lengths co-localising with regions “patchy” heterogeneous low-voltage 
zones (LVZ), when low voltage zones were defined as regions <0.35mV (white rings). (Black 
outline – regions of low-voltage <0.35mV and red outline – regions of shortest AF cycle 
lengths <130ms).  
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Figure 4.33 Spatial overlap of AF mean voltage and cycle lengths 
AF cycle length and mean voltage maps in 3 representative patients demonstrating AF cycle 
length gradients in AF mean voltage border zone regions (white rings). (Black outline – 
regions of low-voltage <0.35mV and red outline – regions of shortest AF cycle lengths 
<130ms). 
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4.3.6 AF voltage and fractionation 
A quantitative analysis of the AF mean voltage and CFEmean score over 8s was performed in 
all patients. This demonstrated an inverse relationship, i.e., sites with higher degree of 
fractionation showed higher AF mean bipolar voltages (Pearson correlation co-efficient r=-
0.7673, p<0.0001) illustrated in Figure 4.34. AF mean voltage at left atrial regions with 
continuous atrial electrogram fractionation (CFAE) (CFEmean<80ms) were significantly 
higher that at in non-CFAE regions (CFEmean >120ms) [CFAE: median 0.6537mV (IQR: 
0.4541-0.9155) vs. non-CFAE: median 0.2328mV (IQR: 0.1735-0.4115), p<0.0001] (Figure 
4.35).  
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Figure 4.34 AF mean voltage and CFEmean interval 
Inverse relationship of AF mean voltage and CFEmean intervals (R=-0.7673, p<0.0001).  
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Figure 4.35 AF mean voltage in regions with continuous fractionation 
(CFEmean score <80ms) and non-CFAE site (CFEmean score >120ms) 
Regions with continuous fractionated atrial electrograms (CFAE) (CFEmean score <80ms) 
had significantly higher AF mean voltages than in non-CFAE sites (CFEmean scores >120ms), 
p<0.0001).  
 
 
Figure 4.36 Inverse relationship of mean AF voltage and fractionation 
Electroanatomic maps demonstrating low voltage regions using mean AF voltage over 8s (A) 
demonstrating a consistent relationship with LGE-CMRI defined scar (B), and inverse 
relationship with regions with highly fractionated electrograms (CFEmean score <80ms). 
Low AF mean voltage and low fractionation (D), and high AF mean voltage and highly 
fractionated electrograms (E) demonstrated in representative panels.   
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4.4 Discussion 
With the characterisation of voltages in AF over various sampling windows and 
quantification of the time course of the mean peak-to-peak voltage in patients with 
persistent AF, we have demonstrated that increasing the duration of sampling windows up 
to, and beyond 4 sec, results in temporal stabilization, and allows for meaningful spatial 
differentiation across the entire left atrium. There is also high degree of spatiotemporal 
stability of low voltage regions during AF with progressively longer duration of sampling 
windows over distinct epochs of AF.  
Regions of low voltage in AF seem to correlate better with left atrial late-gadolinium 
enhancement, than that of low voltage regions in sinus rhythm. A mean AF voltage of 
0.35mV had a sensitivity and specificity of almost 80% and 75% respectively in detecting late-
gadolinium enhancements of >2SD above the mean blood pool intensity.  
Although there was no discernable global relationship between AF mean voltage and AF 
cycle length, it was observed in this study population that electrograms with shortest AF 
cycle lengths occurred in “patchy” heterogeneous low-voltage zones, and low-voltage zones 
in AF co-localised with regions with AF cycle length gradients. Counter-intuitively, there was 
an inverse relationship of AF mean voltage and electrogram fractionation which is also 
reported and discussed in Chapter 6.  
4.4.1 Spatio-temporal stability of mean AF voltage  
Although there are clinical studies which use AF voltage as an index to target catheter 
ablation, all have utilized AF voltage measurements of only over 1-2 AF cycle lengths which 
might lead to erroneous results. This chapter aims to evaluate the time course of AF 
voltages in a systematic fashion. All, bar one, of the previous studies which have utilized AF 
voltage have made efforts in evaluating the spatio-temporal variability of voltage. Chen et al, 
in assessing the disparities of electrogram measurements during AF and sinus rhythm with 
non-contact mapping, demonstrated consistency of consecutive measurement of derived 
unipolar AF electrograms over 7 and 9 sec, with intra-class correlation coefficient (ICC) of 
greater than 0.75 and accepted this as a validation for their subsequent analysis.179 In this 
Chapter, we have demonstrated ICCs of greater than 0.98 when AF is sampled for at least 4 
sec. In a recent publication where regions of AF low-voltage regions of <0.5mV with 
rotational or rapid activity were abolished with catheter ablation, Jadidi et al performed 
voltage mapping in AF determined by the maximum bipolar voltage of 2 consecutive AF 
beats with exclusion of QRS complexes from the window of interest.134 This is likely to have 
been restricted by the algorithms of current commercially available 3D mapping systems. 
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We have demonstrated that the cycle-to-cycle AF voltage (single peak-to-peak 
measurement) is highly variable, but increasing its sampling window improves with increasing 
the number of AF cycle lengths (sampling duration) improves the coefficient of variation, 
with the mean AF voltage approximating to the 8 sec index mean AF voltage after about 4 
sec. This allows for a meaningful spatial differentiation of the left atrium on the basis of this 
metric.  
More importantly, we also demonstrate high degrees of spatio-temporal stability of low 
voltage regions (AF mean voltage <0.35mV) over distinct epochs of AF suggesting an 
underlying electroarchitectural basis of AF voltage, when adequately sampled, may be an 
undeclared manifestation of the dynamic functional and fixed underlying structural substrate. 
This has not been previously reported.   
4.4.2 Correlation of sinus rhythm/AF voltage and LGE-CMRI 
Previous studies have suggested that sinus rhythm bipolar voltages of between 0.5-1.0mV 
may represent various degrees of “diseased” low voltage regions, and correlated to regions 
of enhancement on LGE-CMRI228,268 in patients who have not undergone previous left atrial 
ablation, in patient cohorts with both paroxysmal and persistent AF. In our series of patients, 
visual surface analysis of voltage scar (in sinus rhythm) of <0.5-1.0mV did not demonstrate 
any correlation with regions of late-gadolinium enhancements, and higher voltage thresholds 
(1.5-2.0mV) were required to visualise correlative surface overlap, and only in a sub-group 
of patients, and represented an area under the curve of only 0.66 using ROC curve analysis. 
Bipolar sinus rhythm voltage of 1.8mV had a sensitivity and specificity of only 64% and 60% in 
detecting late-gadolinium enhancements of >2SD above the mean blood pool intensity. On 
the contrary, the mean AF voltage was observed to offer a better correlate to left atrial late-
gadolinium enhancement, with a mean AF voltage of 0.35mV had a sensitivity and specificity 
of almost 80% and 75% respectively in detecting late-gadolinium enhancements of >2SD 
above the mean blood pool intensity. 
This discrepancy may be due to the underlying electrophysiologic basis of electrogram 
amplitude in the spatio-temporally variable rhythm of AF, representing multiple wavefront 
interactions at rapid rates of atrial activation (cycle lengths of 150-200ms) as opposed to 
single (mostly) wavefront propagations at a much longer cycle lengths (500-600ms) during 
pacing and sinus rhythm, and their interactions with the underlying atrial myocardium. This 
multiplicity in wavefront activation and interactions may lead to a reduction of common far-
field voltage and may overcome, in part, the limitation of the field of view of the 4 mm 
spaced bipoles associated with the AFocusII catheter. The relatively widely spaced bipoles 
on the AFocusII catheter may account for the less good correlation of sinus rhythm voltage 
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and late-gadolinium atrial enhancements due to the increased field of view with the 4 mm 
spaced bipoles, and incorporation of a larger far-field component of peak-to-peak voltage. 
This may also explain the larger sinus rhythm voltages which we observed which co-localised 
with late-gadolinium enhanced defined atrial scar compared to that of other studies which 
have predominantly utilized point-by-point mapping  (as apposed to multipolar mapping) with 
a 3.5 to 4 mm tip electrode and a 1 to 2 mm ring electrode separated by 2 mm inter-
electrode spacing which results in a reduction of the far-field contributions, and lower 
voltages observed.228,268 Tung et al studied the influence of inter-electrode distances and the 
3D spatial effects of scar in an ex vivo porcine infarct model and MRI-defined scar image 
integration, and demonstrated that using a fixed statistically-derived normal threshold was 
not fully sensitive in detecting non-transmural scar during bipolar voltage mapping. Utilising 
catheters having different bipolar inter-electrode spacings (2, 5 and 8 mm), they described a 
positive linear relationship between voltage amplitude and bipolar inter-electrode distance, 
with 95% cut-off values being higher with wider inter-electrode spacings.269 Hence, a fixed 
statistically derived bipolar threshold is less sensitive in detecting scar when mapping with 
catheters with inter-electrode distances of greater than 2 mm, consistent with our 
observations during sinus rhythm voltage mapping as compared to previous studies using 2 
mm spaced electrode mapping catheters.  
In conjunction with the functional rate-dependency of voltage with the rapid atrial 
activations in AF (which will be examined and discussed in Chapter 6), these may party 
explain the basis of voltage mapping in AF (with adequate sampling duration) providing a 
more accurate representation of underlying remodelled structural substrate. 
4.4.3 Identification of fibrosis as the arrhythmia substrate of persistent AF 
Endocardial voltage is often used as a surrogate marker for myocardial fibrosis, largely from 
data extrapolated from mapping in the ventricles, and in identifying diseased myocardium as 
part of a substrate based approach in catheter ablation of ventricular tachycardia.211 By 
virtue of this, atrial voltage mapping may represent an electrophysiologic function of the 
underlying atrial substrate in AF. There is evidence to support that the underlying atrial 
substrate in the form of low voltage areas can predict the outcomes of catheter ablation of 
AF.168 Slow conduction in diseased myocardium may be necessary for sustaining rotor 
activity, and localised rotational activity observed with multipolar endocardial mapping tends 
to co-localise with regions with very low voltages in AF (<0.1mV).133 Electrogram amplitudes 
(unipolar) have been noted to be reduced at rotor sites critical to the maintenance of 
persistent AF, as determined by FIRM-mapping,135 although the same authors have previously 
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reported mixed bipolar electrogram amplitudes at source regions,201 which has subsequently 
corroborated by others.270  
Late-gadolinium cardiac magnetic resonance imaging (LGE-CMRI) has now been used to 
detect atrial fibrosis. The burden of atrial fibrosis as determined by LGE-CMRI positively 
correlates with clinical indices of atrial structural re-modelling and outcomes of catheter 
ablation138, and with the number of sites exhibiting high rotor activity using non-invasive 
mapping, and rotor trajectories showed a clustering around borders of fibrotic areas136. 
Authors from the DECAAF study have coined the concept of “residual fibrosis” where the 
overlap of ablation-induced scar with underlying atrial fibrosis predicts response to catheter 
ablation in atrial fibrillation, i.e., patients with less “residual fibrosis” had better clinical 
outcomes, and the extent of residual fibrosis not targeted during substrate modification 
ablation is a predictor of atrial arrhythmia recurrence.227   This has formed the basis of the 
DECAAF-2 where atrial scar as determined by LGE-CMRI will be targeted during catheter 
ablation for AF.  
In this chapter, the close correlation of mean AF voltages of <0.35mV and late-gadolinium 
atrial wall enhancements suggests that AF voltage, when adequately sampled, may provide a 
novel marker of the arrhythmic substrate and represent a functional marker of atrial fibrosis. 
This may well negate the need for the use of LGE-CMRI in identifying fibrotic regions which 
can be targeted for catheter ablation, utilising techniques which are more available and 
transferable across various centres and institutions.  
4.4.4 Cycle length gradients and regions of low mean AF voltage 
Contrary to the phenomenon of rate dependency of voltage, we did not detect a 
relationship between AF cycle length and mean AF voltage over 8 sec, i.e. lower AF voltage 
with shortening of AF cycle lengths. This observation might suggest that regions with low 
mean AF may be both as a result of increased fibrosis in the underlying atrial myocardium, 
or functional tissue refractoriness which would normally display normal voltage during slow 
regular rhythms (either sinus or paced).  
However, we observed that regions of heterogeneous low mean AF voltages exhibited the 
shortest AF cycle lengths. Heterogeneous “patchy” low voltage regions may provide the 
underlying substrate and tissue anisotropy for re-entry to occur, and may result in rapid and 
rotational local activation patterns. Jadidi et al targeted regions of low voltage in AF 
(<0.5mV) or at the border zones with catheter ablation, achieving high rates of termination 
of AF to sinus rhythm (13%) or an atrial tachycardia (65%).134 The sites of termination were 
located within low voltage areas in 80% and within border zones in 20%, displaying 
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prolonged regional electric activity spanning >70% of the AF cycle length suggesting 
repetitive rotational activity, and discrete rapid activity, consistent with our observations.  
The repetitive rotational activity may represent a localised re-entry source perpetuating AF, 
propagated by a slowly conducting isthmus manifesting the low voltage regions. Anisotropic 
conduction as a result of local myocardial architecture, both in terms of fibrotic change 
and/or fibre orientations may encourage pivoting of AF wavefronts, which may lead to 
repetitive chimeric pivoting (alternating in one or another direction).  
Further, we detected cycle length gradients in regions of the left atrium displaying 
homogenous low mean AF voltages, which suggest that the low voltage regions represent 
structural fibrotic change which results in conduction slowing as wavefronts traverse the 
regions. These 2 distinct electrophysiologic changes, which occur in the regions of low mean 
AF voltages, may allow stratification and differentiation of this metric as a potential target for 
catheter ablation.  
 
4.4.5 Mean AF voltage and fractionation 
There was an inverse relationship between mean AF voltage and electrogram fractionation. 
This has been previously described by the Bordeaux group,271 which supports the suggestion 
that electrogram fractionation, in the context of AF, may well have a predominant functional 
rather than a structural element. Although electrogram-based substrate modification 
techniques have previously encouraged targeting fractionated electrograms, more 
contemporaneous randomised clinical trials196,197 (STAR-AF II, BOCA) have not 
demonstrated any beneficial effect of this strategy. Narayan et al have reported that most 
CFAE sites are localised remote from AF sources defined by FIRM-mapping and are not 
suitable targets for catheter ablation of AF.201 These further support our observations.  
The specificity of fractionation algorithms and the difficulties in the distinction of different 
CFAE types may account for some of the discrepancy in clinical outcomes in the literature.  
4.4.6 Clinical outcomes of scar ablation strategies 
Left atrial fibrosis has been reported to correlate with endocardial voltage and the extent of 
left atrial late-gadolinium enhancements, and these influence the clinical outcomes of 
catheter ablation of persistent AF. 168,217 This, in conjunction with the concept of “scar 
homogenization” from substrate based ablation in ventricular tachycardia, has led to the 
targeting of low voltage regions, in both sinus rhythm,173 and AF,134 as an ablation strategy in 
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persistent AF patients with improved clinical success rates, and high incidence of acute AF 
termination.  
4.5 Limitations 
High-density electroanatomic data was utilized in our study, as opposed to point-by-point 
mapping performed in previous studies, which improves the robustness of our data and their 
subsequent analysis. However, the size and electrode spacing of the mapping catheters can 
affect the acquired electrical data. We utilized the AFocusII catheter, which is a double spiral 
circular mapping catheter with 1 mm electrodes with 4 mm bipole spacing, which may result 
in an excessive detection of far-field components of the electrogram, especially when 
mapping was performed in sinus rhythm. There are now more advanced mapping catheters 
with smaller and more closely spaced electrodes, which will allow for increased resolution, 
especially within areas of low voltage. Josephson et al compared bipolar voltage amplitudes 
acquired with a 3.5- and 1 mm (Pentaray, Biosense Webster; Diamond Bar; inter-electrode 
spacing 2-6-2 mm) electrode catheters and reported higher mean bipolar voltage amplitudes 
in areas of low voltage with the 1 mm electrode catheters, and electrograms were more 
distinct (rather than fractionated) and allowed for more precise determination of local 
activation times in scar tissue.272 The Rhythmia mapping system incorporates the use of its 
Orion mini-basket catheter (Boston Scientific Inc., Cambridge, MA) which consists of 8 
splines, each containing 8 electrodes (surface area of each electrode is 0.4mm2 with an inter-
electrode spacing of 2.5mm), and this has the potential of further improving resolution and 
delineation of isthmi in scarred myocardium. It is crucial to note that scar thresholding will 
have to be performed against each of these mapping catheters, as a function of electrode 
size and separation, and values cannot be extrapolated across mapping catheters.  
Although the AFocusII catheter was held in position in a stable manner before acquisition of 
data, the variability of electrogram morphology due to cardiac and respiratory motion is a 
limitation in this study in the absence of contact sensing multipolar mapping catheters. This 
was overcome, in part, in particular during voltage mapping in AF, but the fact that up to 8 
sec of data was acquired and the mean AF voltage was evaluated, hence, reducing any 
substantial errors. As a surrogate marker of contact, the internal projections distance was 
controlled and restricted to 5mm from the surface of the left atrial geometry.  
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4.6 Conclusion 
Regions of conduction slowing as a result of fibrotic change increases the susceptibility to 
atrial arrhythmias, but it is crucial to note that these regions are not entirely fibrotic/scarred, 
and are certainly not electrically silent.   Thresholds for defining pro-arrhythmogenic atrial 
fibrosis and healthy myocardium using voltage have yet to be defined. We have attempted to 
achieve this in this chapter with the utility of non-invasive scar mapping with LGE-CMRI and 
high-density electroanatomic mapping in both AF, having systematically characterised its 
spatio-temporal variability, and in sinus rhythm.  
AF voltage, when adequately sampled and appropriately evaluated, may provide a novel 
marker of the arrhythmic substrate and represent a functional marker of atrial fibrosis, 
recognizing and building upon the interaction between structure and electrical remodelling. 
The clinical utility of targeting these low voltage regions in AF will have to be prospectively 
investigated. 
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5 The influence of late-gadolinium enhancement on the 
electrophysiologic substrate of the left atrium 
 
5.1 Introduction 
Late-gadolinium enhanced cardiac magnetic resonance imaging (LGE-CMRI) appears a 
promising tool for delineating left atrial fibrosis in vivo, both iatrogenic ablative, and intrinsic 
native scar types.216,218 Its use in clinical practice has only been restricted to a few specialist 
centres, where the majority of the evidence supporting its use has been generated.214,248,273 
There is still much debate with regards to the sensitivity and specificity of this technique, 
with each centre adopting unique imaging sequences, and complex post-processing steps for 
quantification of atrial enhancements to eventually derive an “atrial scar map” to aid direct 
visualisation of areas of fibrosis,274 and this has been discussed earlier in Chapter 3.   
Endocardial voltage is often used as a surrogate marker for scar, and this has been 
extrapolated largely from electroanatomic mapping of ventricular tachycardia, with specific 
focus on scar mapping to elucidate the underlying fibrotic substrate.275,276 Hence, much of 
the validation of late-gadolinium enhancement of the atrium has been performed utilising 
endocardial voltage mapping, and this had largely, if not exclusively involved ablative scar 
rather than native intrinsic scar. Conflicting results have been reported by various groups, 
some of whom have described a useful correlation of bipolar endocardial voltages to various 
thresholds of gadolinium enhanced atrial wall intensities, whilst others have not been able to 
demonstrate this relationship.228,252,255 These may be due to the heterogeneity of 
methodologies of LGE-CMRI scar mapping utilized by different centres, as well as the 
challenges of point-by-point comparison of left atrial intensities with co-located data 
acquired during electroanatomic mapping, and the need for registration of anatomical shells 
which introduces error which may exceed the resolution of the original raw data sets and 
MR imaging. There has only been a single small study to-date validating late-gadolinium 
enhancement of the left atrium to histology in humans, and this certainly exemplifies the 
skepticism of this technology when applied to the thin-walled atria.218 
Fractionated electrograms have long been associated with non-uniform propagation in the 
atria as a result of a heterogeneous substrate marked by fibrosis, but have also been 
attributed to wavefront interactions and conduction abnormalities (conduction 
slowing/block, pivot points, asynchronous activation and wave collision).93,191 Others have 
observed that fractionated atrial electrograms in AF are typically located in areas 
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surrounding the autonomic ganglionated plexi.277,278 Areas harbouring fractionated atrial 
electrograms have been, and continue to be targeted, during catheter ablation of persistent 
AF with variable clinical outcomes. Jadidi et al have previously described the counter-intuitive 
inverse relationship between areas harbouring fractionated atrial electrograms, and that of 
fibrosis as determined by their in-house late-gadolinium enhancement CMRI technique.203  
Conduction velocity (CV) is an important electrophysiologic index, with reduced myocardial 
conduction velocity increasing the risk of re-entrant arrhythmias.  Ion channels, and the 
physical properties of cardiac myocytes and their interconnections determine conduction 
velocity. Structural remodelling in conjunction with electrical remodelling, synergistically 
contributes to the arrhythmic substrate in AF. Increased fibroblast proliferation, and 
extracellular matrix deposition through mechanisms discussed in Chapter 1 results in altered 
tissue architecture that reduces myocyte-myocyte coupling and increases fibroblast-myocyte 
coupling, which alters axial resistance, and capacitance, causing conduction slowing.279 The 
effect of atrial late-gadolinium enhancement on tissue conduction velocity in patients with 
persistent AF has not been studied in a systematic fashion.   
Endocardial voltage measurements have been studied as part of validation of the technique 
of LGE-CMRI, but other parameters that define the electrophysiologic substrate have not 
been fully elucidated. This will be helpful to define the underlying mechanisms of the 
persistence of AF, and to potentially guide computer modelling of AF. Our group has 
developed an in-house LGE-CMRI algorithm to clearly demonstrate correlation between 
late-gadolinium enhancement left atrial intensities and endocardial voltages in patients who 
have undergone left atrial ablation as part of pulmonary venous isolation.228 Utilising this 
technique, with optimization of the post-processing algorithms as described in Chapter 3, 
we studied how left atrial late-gadolinium enhancement influences the underlying 
electrophysiologic substrate in the virgin (unablated) left atrium, assessing parameters of 
endocardial voltage (in AF and organised rhythm – sinus rhythm/paced), electrogram 
fractionation and tissue conduction velocities.  
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5.2 Methods 
5.2.1 Patient selection 
Patients with symptomatic persistent AF (based on the classification of AF by published 
guidelines from the AHA/ACC/HRS/ESC) presenting for their first ablation to Imperial 
College Healthcare NHS Trust were prospectively enrolled. Patients with contraindications 
to cardiac magnetic resonance imaging were excluded from the study.  All patients 
underwent LGE-CMRI at least 2-4 weeks prior to their scheduled ablation procedure. The 
study was approved by the Local Research and Ethics Committee for Imperial College 
Healthcare NHS Trust and written informed consent was obtained from all patients. Patients 
in AF at the time of enrollment into the study underwent external DCCV to improve the 
quality of imaging. At the time of LGE-CMRI, patients who were in AF, with rapid ventricular 
rates were excluded from the study to ensure optimal quality of the images. Data from 4 
patients in this study protocol was also used for analysis in Chapter 6.  
5.2.2 Late-gadolinium cardiac magnetic resonance imaging (LGE-CMRI) 
All patients underwent left atrial LGE-CMRI using a 1.5 T Philips Achieva MR system. The 
technique used for LGE imaging has been described in 2.2.1. All images acquired were then 
processed in a manner described in 2.2.5 to construct left atrial scar maps, which are then 
integrated in the 3D mapping system where the density of scar was measured.  
5.2.3 Degree of left-gadolinium enhancement 
The degree of left-gadolinium enhancement overlying each mapped area of the left atrium 
using the roving AFocusII catheter was categorised into healthy, patchy and dense “scar”, 
with “scarred” regions defined as areas of the left atrium with normalized atrial intensities 
(NLA) of greater than 2 SD above the mean blood pool intensity (MBPI). The percentage of 
the total surface area of the left atrium subtended by the roving AFocusII catheter (Kernel) 
occupied by NLA >2 SD above the MBPI was quantified for each of the electroanatomically 
mapped left atrial sites. An example is illustrated in Figure 5.1. Healthy left atrial sites were 
defined as Kernels with <20% of the left atrial surface area occupied by normalized atrial 
enhancements of > 2 SD above MBPI; patchy scarred regions – 20-80%, and densely scarred 
regions >80% of the total area subtended by the roving AFocusII catheter (Kernel) (Figure 
5.2). 
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Figure 5.1 Evaluation of extent of LGE across each Kernel 
The atrial scar maps are integrated into the 3D mapping system, and following creation of 
left atrial geometry, the shells are registered to allow for localization and quantification of 
scar. The region of the left atrium mapped or subtended by the roving AFocusII catheter 
(1cm in radius) is defined as a Kernel (bottom left). The area within each Kernel occupied by 
atrial enhancements of >2SD above MBPI is outlined in red (bottom right), and the extent of 
scar is then calculated as above. 
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Figure 5.2 Degree of left-gadolinium enhancement overlying each Kernel 
Representative examples of regions of healthy, patchy and dense scar during 
electroanatomical mapping with the roving AFocusII catheter. Each kernel is defined as the 
area subtended by the roving AFocusII catheter (Red areas - healthy tissue; purple and blue 
areas – scar, as defined by LGE-CMRI with NLA >2SD above the mean blood pool intensity). 
 
 
5.2.4 Electroanatomic mapping 
Following left atrial access (as described in 2.3), electroanatomic data was obtained prior to 
any ablation being performed. Subsequent to data acquisition in accordance to the study 
protocol, all pulmonary veins were isolated, followed by a "stepwise approach" for 
modification of the AF substrate (at the discretion of the operator).  
The majority of patients were in AF on the day of the procedure. Baseline AF data was 
initially acquired and displayed in the form of a Complex Fractionated Electrogram (CFE) 
map. If they were in sinus rhythm, AF was induced with burst atrial pacing with a quadripolar 
catheter in the high right atrium or coronary sinus (CS). Patients in whom AF could not be 
sustained were excluded from the study. Following electroanatomical mapping in AF, all 
patients underwent external electrical cardioversion to sinus rhythm before localised 
electroanatomical maps (unipolar voltage and activation) were created during left atrial 
pacing over highly-focused areas over the left atrium which had been categorised based on 
the “scar” density as defined but atrial intensities derived from the LGE-CMRI described in 
5.2.3. Pacing was performed from 2 separate left atrial sites (usually from the low posterior 
wall with pacing from the CS catheter and from the left atrial roof with the ablation 
catheter). This was performed to ensure planar wavefront activations occurred across each 
mapped left atrial site (Kernel) to avoid any wavefront interactions (e.g. collisions). 
Electrogram data acquisition was repeated at multiple cycle-lengths (CL) of 600ms, 400ms, 
350ms, 300ms and 250ms. While bipolar electrogram data was used during the study, 
unipolar electrograms were also acquired for retrospective analysis. Unipolar signals were 
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used for measurements of voltage to remove any discrepancies due to variation in bipole 
orientation on the AFocusII catheter. 
5.2.5 Electrogram fractionation in AF 
Each bipolar atrial electrogram simultaneously acquired from the AFocusII catheter, 
encompassing a Kernel, during fractionation mapping in AF was assigned an individual score, 
the NavX CFEmean score as described in 2.3.5. The electrograms were defined as 
fractionated if their CFEmean scores where <80ms.203 The cumulative extent of electrogram 
fractionation in AF over each Kernel was expressed as a percentage of fractionated atrial 
electrograms. The Kernels were subsequently binarised into “CFAE” sites if the percentage 
fractionation was >50% or non-CFAE sites if the percentage fractionation was < 50%. Figure 
5.3 illustrates this.  
 
Figure 5.3 Electrogram fractionation in AF on a per Kernel basis 
(Top panel) Each bipolar atrial electrogram acquired from is assigned an index of 
fractionation based on the NavX CFEmean score: fractionated electrograms have a 
CFEmean score of <80ms. (Bottom panel) The Kernels are then binarised into “CFAE” and 
“non-CFAE” sites based on the percentage of fractionated atrial electrograms. 
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5.2.6 Voltage and conduction velocity during pacing 
Measurements of peak-to-peak voltage and conduction velocities were derived from 
unipolar electrograms as described in 2.3.2 and 2.3.4 respectively, and summarised in Figure 
5.4. Planarity of the wavefront activation was assessed using an algorithm which generates a 
residual which indicates planarity of the wave230 prior to conduction velocity being evaluated 
using methods described by Bayly et al, but adapted to data acquired using the AFocusII 
mapping catheter.280 
 
Figure 5.4 Summary of data acquisition during the paced-rhythm 
(Left panel) Localised electroanatomical mapping was performed during left atrial pacing (in 
this instance, during CS56 pacing) on the left atrial posterior wall. (Middle panel) Unipolar 
electrograms acquired are used to create voltage and activation maps. (Right panel) From 
the voltage maps, the peak-to-peak voltage on each electrode of the AFocusII catheter is 
exported to derive the mean peak-to-peak voltage across the Kernel. Location and local 
activation times (LAT) from the activation maps were exported into Matlab to generate an 
average conduction velocity across the Kernel (This technique is described in detail in 
section 2.3.4). 
 
 
5.2.7 Comparative data statistical analysis 
All the comparative data analysis was performed using a Kernel as a unit of measurement as 
described in 2.3.1. All normal variables are expressed as mean and standard error of the 
mean (SEM). Paired and unpaired T-tests were used when appropriate. A probability of < 
0.05 was considered significant.  
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5.3 Results  
5.3.1 Clinical demographics 
A total of 35 left atrial sites (Kernels) were analysed from 15 patients. The clinical 
demographics are summarised in the table below (Table 5.1).  
 
Table 5.1 Clinical demographics 
Clinical characteristics (n=15)  
Age (years) 68±8 
Male (%) 50% 
Mean LA size on TTE (mm) 49±6 
Mean CHADS2 score 2.4 (0-5) 
Structural heart disease (%) 33% 
Total number of Kernels 35 
 
5.3.2 Paced-rhythm mean unipolar voltage and density of late-gadolinium 
enhancement (scar density) 
There was an inverse relationship between mean voltages and scar density across all pacing 
cycle lengths (CL 600ms- healthy 2.43±0.29mV, patchy scar 1.65±0.13mV, dense scar 
1.49±0.09mV; CL 300ms- healthy 2.15±0.27mV, patchy scar 1.57±0.12mV, dense scar 
1.31±0.09mV) (healthy vs. patchy and healthy vs. dense at both 300ms and 600ms, p<0.05). 
Hence, on a per Kernel basis, higher mean peak-to-peak unipolar voltages were observed in 
healthy regions, as compared to patchy and densely scarred regions. 
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Figure 5.5 LGE-CMRI defined scar density and paced-voltages 
The effect of LGE-CMRI defined scar on mean unipolar voltage during left atrial pacing at 
cycle lengths of 600ms (top) and 300ms (bottom).  Mean unipolar voltages were higher in 
healthy areas compared to patchy and densely scarred areas at both cycle lengths (* p<0.05). 
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5.3.3 Mean AF voltage and density of late-gadolinium enhancement (scar density) 
An inverse relationship between mean AF voltage and scar density was also observed. On a 
per Kernel basis, the mean AF voltages in healthy regions were significantly higher than in 
patchy and densely scarred regions (healthy: 0.746±0.12mV; patchy scar 0.428±0.01mV and 
dense scar 0.307±0.02mV) (healthy vs. patchy and healthy vs. dense, p<0.05) (Figure 5.6).  
 
Figure 5.6 LGE-CMRI defined scar density and mean AF voltage 
The effect of LGE-CMRI defined scar on mean AF voltage. Mean AF voltages were lower in 
healthy areas compared to patchy and densely scarred areas at both cycle lengths (* p<0.05). 
 
5.3.4 Relationship of pacing cycle length and mean unipolar voltage 
In the subset of 10 left atrial sites, shorter pacing cycle-lengths resulted in a reduction in 
mean voltage (1.80±0.1mV at 600ms vs. 1.59±0.09mV at 300ms, p<0.05) (Figure 5.6) 
Analysis of the relationship between all pacing cycle lengths (300ms, 350ms, 400ms and 
600ms) and mean voltage revealed a consistent drop in mean voltage with shorter pacing 
CLs                   (-0.1mV/100ms, p<0.001) (Figure 5.7). The scar densities did not influence 
this relationship between mean voltage and pacing rates.  
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Figure 5.7 Mean unipolar voltage and pacing cycle length 
Mean unipolar voltages were lower at high rate pacing (cycle length 300ms) compared to 
low rate pacing (cycle length 600ms)(* p<0.05). 
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Figure 5.8 Voltage and pacing cycle lengths 
This graph shows data acquired from a single representative patient, demonstrating a drop in 
mean unipolar voltages with higher pacing rates (from 600ms to 300ms). Each point series 
represents data acquired from 4 different left atrial sites (Kernels). The gradient of each line 
of best fit was used to quantitatively describe the relationship between mean endocardial 
unipolar voltage and varying pacing cycle lengths. 
 
5.3.5 Relationship of pacing direction and voltage  
In the same subset of 10 left atrial sites, there was a significant difference in mean voltage 
(1.57±0.09mV vs. 2.08±0.12mV, p<0.05) when activation wavefronts were from opposite 
directions, during differential pacing from CS (bottom to top) and left atrial roof (top to 
bottom) across all pacing cycle lengths (Figure 5.8). The extent of late-gadolinium 
enhancements (scar densities) did not influence this relationship.  
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Figure 5.9 Effect of wavefront activation on voltage 
Alteration of the wavefront activation achieved by pacing from CS as apposed to left atrial 
roof resulted in significantly change in the mean unipolar voltage (* p<0.05). 
 
 
5.3.6 Electrogram fractionation and density of late-gadolinium enhancement 
There was a higher percentage of fractionated atrial electrograms (AEGM) in regions of 
healthy, when compared to patchy and densely scarred regions as determined by LGE-CMRI 
(65.9±7.0% vs. 42.3±4% and 65.9±7.0% vs. 41.3±8.0% respectively, p<0.05) (Figure 5.9). 
There was no significant difference in the extent of fractionated AEGMs in patchy and 
densely scarred regions (42.3±4% vs. 41.3±8.0% p=0.9). Pooled data from patchy and 
densely scarred regions maintained the relationship of higher extent of fractionated AEGMs 
in healthy regions, when compared to scarred regions (65.9±7.0% vs. 42.0±3.8%, p<0.05) 
(Figure 5.10).  
1.4 
1.6 
1.8 
2 
2.2 
2.4 
M
ea
n 
vo
lta
ge
 (
m
V
) 
Opposite pacing direction 
* 
0 1 
 199 
 
Figure 5.10 Degree of late-gadolinium enhancement and extent of 
fractionation 
There was a higher percentage of fractionation atrial electrograms (AEGM) in regions of 
healthy, when compared to patchy and densely scarred regions as determined by LGE-CMRI 
(*P<0.05).   
  
 
When the Kernels were binarised into CFAE (>50% fractionated AEGMs) and non-CFAE 
(<50% fractionated AEGMs) sites, mean unipolar paced tissues voltages (600ms) were 
significantly higher in CFAE compared to non-CFAE sites (2.07±0.21mV vs. 1.14±0.08mV, 
p<0.05) (Figure 5.11). This relationship was maintained for mean unipolar voltages during 
pacing at 300ms (1.88±0.19mV vs. 1.14±0.11mV, p<0.05).   
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Figure 5.11 Extent of fractionation in healthy and scar regions 
There was significantly higher percentage of fractionated AEGMs in healthy regions, when 
compared to scarred regions (* P<0.05). 
  
 
 
Figure 5.12 Voltages in non-CFAE and CFAE sites 
Higher mean unipolar endocardial voltages during pacing at 600ms were observed in CFAE 
sites (>50% fractionated AEGMs) (* p<0.05). 
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5.3.7 Tissue conduction velocity and density of late-gadolinium enhancement  
The mean tissue conduction velocities across all left atrial sites (kernels) was 0.94±0.03m/s 
and 1.06±0.03m/s at pacing cycle lengths of 300ms and 600ms respectively. There was a 
downward trend (i.e. decreasing conduction velocities) with increasing extent of late-
gadolinium enhancements at both pacing cycle lengths of 600ms and 300ms. However, these 
did not reach statistical significance (Pacing CL 600ms: Healthy 1.17±0.09m/s, Patchy scar 
1.07±0.08m/s, Dense scar 0.98±0.07m/s) (Figure 5.12). However, we noted a significant 
difference in conduction velocities between patchy and densely scarred regions at pacing 
cycle length of 300ms (Healthy 1.09±0.16m/s; Patchy 1.04±0.04m/s; Dense scar 
0.86±0.06m/s, P<0.05) (Figure 5.13).  
 
Figure 5.13 Extent of late-gadolinium enhancement and conduction 
velocity during pacing at cycle length of 600ms 
There was a downward trend of conduction velocities during pacing at cycle length of 600ms 
with increasing extent of scar determined by LGE-CMRI but these did not reach statistical 
significance. 
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Figure 5.14 Extent of late-gadolinium enhancement and conduction 
velocity during pacing at cycle length of 300ms 
There was a similar downward trend of conduction velocities during pacing at cycle length of 
300ms with increasing extent of scar as determined by LGE-CMRI, with statistically 
significant drop in conduction velocity in patchy compared to densely scarred regions 
(*p<0.05). 
 
Healthy and patchy scarred regions had similar mean conduction velocities at both low and 
high rate pacing, and pooled data analysis of healthy and patchy scarred regions, against 
densely scarred regions demonstrated a significant difference in conduction velocities at 
pacing cycle length of 300ms but not at 600ms (Healthy/Patchy scar 1.05±0.05 vs. Dense 
scar 0.86±0.06m/s, p<0.05 at 300 ms; Healthy/Patchy scar 1.10±0.03 vs. Dense scar 
0.98±0.05m/s, p=0.07 at 600 ms) (Figure 5.14). 
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Figure 5.15 Extent of late-gadolinium enhancement (pooled) and 
conduction velocity during low and high rate pacing 
Conduction velocity was lower in densely scarred regions compared to Healthy/Patchy 
scarred regions, but only reached statistical significance at high rate pacing (cycle length 
300ms) (* p<0.05). 
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5.4 Discussion 
The presumptive underlying mechanism of atrial late-gadolinium enhancement is that of 
increased extracellular matrix deposition in fibrotic regions of the left atrium, leading to 
slower washout kinetics and prolonged contrast retention.281,282 The global extent of left 
atrial late-gadolinium enhancement have been proposed to be a useful non-invasive method 
of assessment of atrial structural remodelling, and been purported to be associated with AF 
persistence and predict clinical outcomes following catheter ablation for AF.138 However, the 
underlying electrophysiologic changes, which occur at left atrial sites reflected by regional 
late-gadolinium enhancement, has not been fully studied in a systematic fashion. To-date, the 
majority of studies have been conducted in post-ablation patients, describing iatrogenic scar 
and its use in predicting “scar-gaps” and sites of pulmonary vein re-connections. 283,284 
Although there have been attempts to develop voltage criteria to allow discrimination of 
iatrogenic non- or slowly-conducting myocardial scar tissue regions,285 no work has been 
performed to delineate the electrophysiology of de novo native left atrial scar.  
We have adopted a unique and novel approach which utilizes the Kernel, defined as the area 
subtended by the high-density multipolar mapping catheter (AFocusII) as a unit of measure. 
This allows for systematic and objective comparisons to be performed on both structural 
(late-gadolinium enhancement intensity) and electrophysiologic indices which reflect atrial 
re-modelling - voltage and tissue conduction velocity. Quantification of conduction velocity 
was evaluated over a larger area of atrial tissue (the kernel) resulting in a lower resolution 
but is less susceptible to inaccurate annotations of local activation times, which presents a 
challenge with point-by-point data acquisitions. This methodology overcomes several 
limitations with the use of a point-by-point co-localised comparison between the acquired 
3D anatomic geometry and LGE-CMRI shell by landmark and iterative closest point 
registration. The Kernel approach allows for us to ensure the fidelity and robustness of the 
acquired electrogram data in the absence of multipolar mapping catheters with contact 
sensing capabilities. This approach also prevents erroneous extrapolation of electrical data 
(acquired during 3D mapping), to the anatomical shell (acquired from the segmented LGE-
CMRI images), ensuring the best-possible fit of electrical and anatomical data for correlative 
analysis.  
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The major findings were as follows:  
(1) Lower mean unipolar voltages were observed in regions with higher extent of late-
gadolinium enhancements.  
(II) Increasing pacing rates (i.e. shorter cycle lengths) resulted in a drop in measured 
mean unipolar voltages. 
(III) Change in direction of wavefront activation results in significant changes in measured 
mean unipolar voltages. 
(IV) Sites of fractionated atrial electrograms during AF occur in healthy, rather than LGE-
CMRI defined scar regions.  
(V) Lower tissue conduction velocities were observed in regions with higher extent of 
late-gadolinium enhancements.  
5.4.1 Endocardial voltage and late-gadolinium enhancement 
In terms of fundamental physics, the contact electrogram is derived from the superposition 
or summation of the electric fields of ions in the vicinity of the recording electrode. Ion 
fluxes across cell membranes, which produce the action potential, and the propagation of 
the action potential, can lead to variations in the electric field strength surrounding the 
electrode and the subsequent recorded electrogram morphology.219 Low amplitude 
electrograms are commonly associated with areas of fibrosis, which produce a reduced 
electric field and consequently a lower potential difference between the measuring electrode 
and the reference point. Further, cellular electrophysiological studies have demonstrated 
diseased atrial tissue being relatively unexcitable, with a lower resting membrane potential.286 
The decrease in the recorded unipolar voltage in diseased myocardium may be a 
manifestation of less depolarized myocytes and more interstitial fibrosis.287 Hence, structural 
properties of tissue can be estimated from the spatial distribution of the electrogram 
amplitude – peak-to-peak voltage. The use of local tissue endocardial voltage as a 
determinant of myocardial health has been largely described in ventricular electroanatomic 
mapping, with specific bipolar and unipolar voltage cut-off values shown to accurately identify 
scar/fibrosis. 211,276  
We have demonstrated that mean unipolar voltages were significantly lower in regions of 
the left atrium with higher extents of late-gadolinium enhancement. Unipolar peak-to-peak 
voltage was utilized to overcome the limitations of bipolar electrograms in relation to 
wavefront activations and bipole orientations, despite its increased “field-of-view” which is 
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offset with the use of the Kernel as a unit of measure. Utilisation of the kernel as a unit of 
measure reduces errors introduced from co-localisation of anatomic data from LGE-CMRI 
and electrophysiologic data from electroanatomic mapping. This provides validation of our 
technique of left atrial LGE-CMRI to detect native de novo myocardial fibrosis, utilising 
endocardial voltage as a surrogate marker of myocardial scar/fibrosis, in the absence of 
histomorphometric indices. Our group has previously demonstrated correlation of atrial 
enhancements with co-localised endocardial bipolar and unipolar voltages in patients 
following left atrial ablation, where late-gadolinium enhancements of 3, 4 and 5 SD above the 
mean blood pool intensity were associated with progressively lower bipolar voltages 
compared to the preceding enhancements (0.85±0.33, 0.50±0.22 and 0.38±0.28mV; p=0.002, 
p<0.001 and p=0.048 respectively).228  
The Utah group from the CARMA centre, which has the most extensive experience with 
LGE-CMRI, has similarly demonstrated the correlation of endocardial voltage and the 
intensities of late-gadolinium enhancement of left atrial tissue.246 In their study, 81 patients 
with persistent AF underwent LGE-CMRI, and intra-procedural bipolar voltage mapping 
(59% in sinus rhythm, 33% in AF and 8% in atrial flutter) with >100 points spread evenly 
throughout the atrium. A regional correlation of the voltage and extent of delayed 
enhancement was performed where the left atrium on the electroanatomic maps and LGE-
CMRI derived scar maps were sub-divided into 18 specific regions, with scores for extent of 
enhancements (0: no enhancement, 1: mild enhancement, 2: moderate enhancement and 3: 
extensive enhancement) and voltage (0: healthy tissue >1mV, 1: mild illness >0.1 to <0.5mV, 
2: moderate illness >0.1to <0.5mV and fibrotic scar <0.1mV, and 3: disease tissue with 
significant scarring <0.1mV). The overall score was the average sum of each of the 
respective 18 regions, and quantitative analysis of regions of enhancement on LGE-CMRI and 
low voltage regions on electroanatomic maps demonstrated a positive correlation of R2 
=0.61. This cohort of patients represented those undergoing first time left atrial ablations, 
and hence describes de novo native scar. It was interesting that a standardized voltage 
threshold was set in all patients although there was heterogeneity in the mapped rhythm 
(sinus rhythm, AF and atrial flutter). There was no methodological description of how 
voltage mapping was performed in the disorganized rhythm of AF where there is 
spatiotemporal variability of electrogram amplitudes. There was no attempt to characterise 
absolute endocardial bipolar voltages to specified intensities of late-gadolinium 
enhancements, and correlate the enhancements to currently accepted voltage thresholds of 
<0.5mV288 and <0.1mV289 to identify “atrial fibrosis” and dense scar respectively, although 
the former represents de novo native atrial scar, and the latter ablative iatrogenic scar. Using 
similar a methodology of LGE-CMRI sequencing and post-processing, Jadidi et al also 
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reported lower mean bipolar voltages in AF (assessed using an 8 sec period of recording 
although the precise methodology is not fully described) in regions with dense delayed 
enhancement compared to electrograms in regions of patchy delayed enhancement and 
unenhanced regions (dense: 0.63±0.8mV; patchy: 0.86±1.09mV and no delayed 
enhancement: 0.86±0.89mV; p<0.001). There was no significant difference in bipolar voltage 
at patchy and unenhanced regions.203 
Nazarian et al utilized a normalized measure, the image intensity ratio (IIR) for the 
assessment of left atrial scar on LGE-CMRI, where the local IIR was defined as the left atrial 
myocardial signal intensity for each of the subdivided 20 sectors on contiguous axial images 
planes divided by the mean left atrial blood pool image intensity. This was then correlated to 
intracardiac point-by-point sampled electroanatomic map points (performed in sinus rhythm) 
which had been co-registered with the corresponding image sectors255 in 75 patients, of 
which approximately half of them had previous left atrial ablations, hence a heterogeneous 
population of both de novo native and iatrogenic scar. They demonstrated that the IIR was 
strongly associated with the bipolar electrogram voltage, and also determined IIR thresholds 
corresponding to accepted bipolar voltage thresholds. These left atrial intensity thresholds 
corresponding to typical voltage thresholds in distinguishing abnormal and scar tissue were 
stable across patients, where local IIR thresholds of >0.97 and >1.61 corresponded to a 
bipolar voltage of <0.5mV and <0.1mV respectively. They concluded that IIR might be useful 
for inter-patient and longitudinal intra-patient comparisons of left atrial scar burden. 
However, they highlighted the likelihood of inaccurate registration, a limitation present due 
to point-by-point comparisons. They also accepted that alterations in electrogram amplitude 
and voltage may be as a result of variability of contact force and the orientation of the 
mapping catheter, leading to bias.  
Similar findings have been observed by Williams et al where 12 patients undergoing first time 
pulmonary vein isolation underwent both LGE-CMRI and high-density bipolar voltage 
mapping during pacing from two atrial sites.290 Late-gadolinium enhanced signal intensity was 
described as the image intensity ratio (IIR), and electrogram voltage was significant reduced 
at areas of high late-gadolinium enhancements (IIR >0.97 – 0.9mV vs. 1.3mV, p=0.049). This 
atrial “scar” threshold differed from Nazarian et al, where IIR >0.97 corresponded to 
voltages of <0.5mV, and may be attributed to the different methodology of characterizing 
the left atrial signal intensities.  
However, there has not been uniform acceptance of atrial late-gadolinium enhancement 
being representative of fibrotic change. Sramko et al failed to demonstrate a correlation 
between the extent of left atrial late-gadolinium enhancement (using similar techniques 
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utilized by the Utah group) and global bipolar voltage (left atrium mapped in spontaneous or 
induced AF) in a cohort of 73 patients undergoing catheter ablation for AF.291 The 
methodology of bipolar voltage mapping was not elaborated on. There was poor spatial 
correlation of late-gadolinium enhancement and low voltage areas. In addition, they did not 
report a correlation of the extent of pre-ablation late-gadolinium enhancement to clinical 
outcomes (AF recurrence), although other markers of such as type of AF, increased left 
atrial volumes and lower global AF bipolar voltages were significantly associated with poorer 
clinical outcomes. They authors questioned the validity of LGE-CMRI due to the lack of 
correlation of the extent of late-gadolinium enhancements and traditional makers of left 
atrial structurally remodelling.   
5.4.2 Histopathological basis of atrial wall late-gadolinium enhancement 
As opposed to ventricular late-gadolinium enhancement where pathological validation of 
delayed enhanced ventricular myocardium has been comprehensively demonstrated in 
canine myocardial infarction models,292 and electroanatomic ventricular scar has then been 
shown to correlate with delayed enhancement abnormalities on CMRI,212 the histological 
changes associated with atrial late-gadolinium enhancements has been poorly studied. 
Harrison et al reported the first histopathological validation of atrial delayed gadolinium 
enhancement CMRI and endocardial voltage mapping in a porcine model, to define acute and 
chronic ablation tissue injury, 263 demonstrating a linear drop in bipolar voltages with 
increasing atrial intensities. Surprisingly, the histological changes underpinning left atrial late-
gadolinium enhancements in humans was only investigated fairly recently. In a small cohort 
of 10 patients undergoing cardiac surgery, Marrouche et al reported atrial tissue fibrosis 
matched with regions of left atrial enhancement on CMRI (no electroanatomic mapping was 
performed) and concluded that tissue enhancements on the left atrium reflected structural 
remodelling changes.218 This is the only study thus far which provides the histological basis of 
late-gadolinium enhancement on the virgin left atrium, and the description of de novo atrial 
fibrosis.  
Studies involving ablative atrial scar represents a pathophysiologically distinct substrate to 
that of de novo atrial fibrosis. Further, the different characterisation of fibrosis may have 
distinct affects on tissue electrophysiology. Interstitial fibrosis separate muscle bundles, and 
does not affect tissue conduction and hence, is not pro-arrhythmogenic, in both the atria 
and ventricles. In contrast, myocardial necrosis results in reparative fibrosis which results in 
electrical discontinuities impairing tissue conduction, and this may results in non-uniform 
anisotropic conduction which promotes arrhythmogenesis. Fibrosis occurring as a result of 
catheter ablation may have different imaging patterns of appearances, which will need to be 
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investigated to allow for more meaningful interpretations. Nazarian et al have reported 
greater contrast uptake and denser fibrosis in ablation-induced late-gadolinium enhanced 
tissue than de novo atrial enhancements, with the former regions having thinner left atrial 
myocardium.293 Hence, studies on post-ablation scar cannot be extrapolated to de novo 
fibrosis.  
5.4.3 Is endocardial voltage a useful surrogate of the structural fibrotic substrate? 
Endocardial voltage is often used as to quantify myocardial tissue fibrosis, and has been 
shown to correlate with late-gadolinium enhanced myocardial imaging. The terms “low-
voltage” and “scar/fibrosis” are used fairly interchangeably. However, there is a fundamental 
difference between these 2 terms. It has long been known that bipolar voltage amplitude, in 
both atrial and ventricular tissue, is influenced by various factors and can be highly variable, 
that can reach a difference of 300%, even when sampled at identical locations.187. The 
relationship between the propagating wavefront and the recording bipoles, bipole 
orientation to the tissue, electrode size and spacing, tissue proximity and contact and 
filtering can all alter the amplitude of the bipolar electrogram. In 3D electroanatomical 
mapping, the mapping density and resolution can also affect the voltage maps due to 
interpolation.  
In this study, we utilized unipolar electrograms for the purposes of obtaining more precise 
local activation timings (-dV/dt), which can be problematic with bipolar electrograms, in 
investigating how the direction of wavefront propagation affects the electrogram amplitude, 
and its dependence of its underlying structural substrate. Unipolar electrograms, by its 
nature, incorporates more remote events (far-field) and is more noise sensitive. However, it 
has been reported to be a useful tool in identifying irreversible myocardial fibrosis in 
mapping the ventricular substrate,294 and more recently, transmurality of ablated lesions 
during pulmonary vein isolation.295 In AF, unipolar electrograms with monophasic action 
potential based filtering (as apposed to physiological “filtering” based on simple 
repolarisation criteria) have been suggested to allow for more accurate activation mapping 
to reveal rotors,296 as opposed to bipolar electrograms which may contain and show far-field 
signals within atrial tissue refractoriness, explaining, in part, the discrepancies with optical 
mapping.  
In this chapter, albeit the use of unipolar electrograms to exclude the influence of bipolar 
orientation and activations vectors, we have demonstrated that unipolar voltages decrease in 
amplitude with higher rates of pacing, and alterations of the direction of wavefront 
propagation results in significant changes in the unipolar voltage amplitudes. The extent of 
late-gadolinium enhancements (scar densities) did not influence the relationships between 
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mean voltage and wavefront activations (both pacing cycle lengths and direction of 
wavefront activation). 
This is consistent with the phenomenon of tissue voltage discordance, which has been 
discussed in Chapter 1.180 More recently, our group has also reported progressive 
reductions in bipolar electrogram amplitudes during epicardial mapping of the lateral right 
atrium during cardiac surgery using a high density array during rapid atrial pacing compared 
to sinus rhythm (SR 1.38±0.70mV; 500ms 1.11±0.57mV; and 200ms 0.91±0.61mV). This was 
associated with prolongation of the electrogram.297  
Our findings suggest that voltage mapping should be qualified by alterations in cycle lengths 
and direction of wavefront propagations. Regions of functional “scar” as a result of 
wavefront interactions (e.g. collisions) may further compound the challenges involved in 
utilising endocardial voltage as a reliable surrogate marker of myocardial fibrosis, and its use 
in the validation of new and novel cardiac tissue imaging techniques need to be interpreted 
with caution. This may account to some of the incongruence in the literature in using LGE-
CMRI in identifying gaps lesions sets following catheter ablation for AF.274 
5.4.4 Local conduction velocity and atrial late-gadolinium enhancement 
Conduction velocity is a crucial quantitative electrophysiologic index and the local 
conduction velocity describes the propagation of the action potential wavefront though 
myocardial tissue and is defined empirically as the distance travelled by a propagating 
wavefront in a unit of time. This is broadly determined by the ion channel expression and 
the physical properties of the myocytes and their interconnections. Myocardial conduction 
velocity is closely associated to the maximum rate of action potential depolarisation, 
(dV/dt)max, as determined by the fast Na+ current; the axial resistance to local circuit current 
flow between interconnecting myocytes; their membrane capacitances, and the tissue 
architecture defining the geometrical relationship between successive myocytes. Hence, 
fibrosis and ionic channel or gap junction remodeling can lead to reduced macroscopic 
conduction velocity, and mapping regions of reduced local conduction velocity can identify 
regions of scar or of adversely remodelled myocardium, a fundamental determinant of AF.   
Atrial myocardial fibrosis in animal models of AF has been associated with changes in tissue 
conduction velocity.298,299 Myocardial fibrosis in turns causes conduction delay and block, 
which promotes functional re-entry. In addition to the “increased path length” (zig-zag 
conduction) of travel in fibrotic regions which results in conduction slowing, there is 
heterogeneous cell-coupling between myocytes and fibroblasts resulting in conduction 
slowing, and excitation failure observed in monolayer models and computer 
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simulations.300,301 Myocardial fibrosis is also associated with gap-junction and Na+ channel 
abnormalities which leads to conduction delay and block.279   
We have demonstrated lower local conduction velocities in left atrial regions with higher 
extent of gadolinium enhancements, i.e., Kernels with dense LGE-CMRI defined “scar” had 
lower measured conduction velocities compared to those with underlying patchy 
scar/healthy tissue. This slowing in conduction was exaggerated during high rate pacing at 
cycle length of 300ms, compared to that during low rate pacing at cycle length of 600ms. 
These observations corroborate with previous studies which have reported that excised 
diseased atrial tissue from atria of patients with atrial arrhythmias demonstrated slow 
response action potential during shorter atrial pacing cycle lengths. 287,302. This exaggerated 
drop in conduction velocity with high rate of pacing is the result of reduced excitability due 
to the reduced availability of Na+ channels leading to a reduction of INa (conduction velocity 
restitution). 
Fukumoto et al from the Hopkins group, which had previously described a relationship 
between endocardial bipolar electrograms and left atrial gadolinium enhancements,255 
reported similarly that left atrial myocardium regions with increased gadolinium uptake had 
lower conduction velocity, with a 0.20m/s decrease in conduction velocity per increase in 
unit image intensity in 22 patients undergoing first time catheter ablation for AF (a mixture 
of paroxysmal and persistent AF). The results were adjusted for both left atrial wall 
thickness as well as myocardial fibre orientation. Voltage mapping was performed with a 
3.5mm tip mapping catheter (Navistar Thermocool, Biosense Webster) in sinus rhythm and 
patients in AF were excluded. It was noted that there was no statistically significant 
association between atrial wall gadolinium enhancements and conduction velocity in the 
subgroup of patients with PAF. The mean conduction velocity in our cohort of persistent AF 
patients was similar to that in this study (1.06m/s vs. 0.98m/s). In this study, the factors such 
as direction of wavefront activation, wavefront curvature and wavefront collision were not 
controlled for which was accounted for in our study with pacing either from the roof or the 
low posterior was (decapolar in coronary sinus) to ensure planar wavefront activation in the 
regions of the left atrium interrogated with the AFocusII catheter.  Controlling for direction 
of wavefront activation during sinus rhythm or right atrial pacing during voltage mapping of 
the left atrium can be challenging due to variability of right atrium to left atrium electrical 
connections (septum, Bachmann’s bundle, coronary sinus) resulting in inconsistent left atrial 
activations (and potential wavefront collisions), which was overcome with direct left atrial 
pacing in our study.   
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In a smaller study by Williams et al, conduction delay and block was assessed in relation to 
atrial late-gadolinium signal intensities with high density mapping using a multipolar electrode 
(Pentaray, Biosense Webster) during a pacing protocol with a single extra stimulus following 
a 2-beat drive train. There was no relationship between gadolinium enhanced signal 
intensities to conduction delay or conduction block, with left atrial extra stimulus 
conduction curves demonstrating significant variation between patients with apparently 
similar structural remodelling as defined by LGE-CMRI findings.   
5.4.5 Measuring conduction velocity: its challenges 
A number of approaches have been developed to determine localised myocardial conduction 
velocity, each with their strengths and weaknesses.230 Triangulation provides planar 
conduction velocity estimates from triads of recording points through a trigonometric 
relation between inter-electrode distances and activation times and with a sufficient number 
of electrograms it can produce moderately high-density velocity maps,303 but are susceptible 
to erroneous readings due to inaccuracies in assigning local activations times (which is 
problematic with bipolar electrograms) and measurements over small distances. Large 
distances between the vertices may lead to errors if the wavefront is not truly planar, while 
if the points are in very close proximity, the relative error in the estimation increases. 
Cosine-fit techniques essentially extend triangulation to fit a planar or circular wavefront to 
a larger number of points. The gradient of the activation surface may then be computed to 
calculate conduction velocity. Fukumoto et al adopted a previously described technique 
where the local conduction velocity of each electroanatomic point was the mean conduction 
velocity between 5 adjacent points along the activation wavefront, where the conduction 
velocity was defined as the linear distance between the points divided by the difference in 
activation times, susceptible to small errors in measurements.304 To ensure the exclusion 
conduction velocity measurements in a different direction (as wavefront direction was not 
controlled for as mapping was performed in sinus rhythm), points with a difference in local 
activation times of <5ms from the reference point were removed.  
There are a number of other approaches to conduction velocity estimation including finite 
difference techniques305 and computing isopotential lines306 however, many of these have 
requirements not typically available in data acquired in the clinical electrophysiology 
laboratory and are limited to experimental cardiac electrophysiology. We adopted a 
polynomial surface fitting technique which is more robust to noise, but is less localised in 
nature.307 
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5.4.6 Fractionated atrial electrograms and atrial late-gadolinium enhancement 
We demonstrated an inverse relationship between electrogram fractionation in AF, and the 
extent of atrial late-gadolinium enhancement, i.e., sites of fractionated atrial electrograms 
during AF occur in healthy, rather than LGE-CMRI defined scar regions. This observation is 
counterintuitive as fractionated electrograms have previously been associated with slow or 
anisotropic local tissue conduction which occur in regions of fibrosis,223 and have 
implications on electrogram based approaches to substrate modification during catheter 
ablation in AF targeting fractionation. 
However, this observation is supported by Jadidi et al.203 Using high density mapping during 
AF using the AFocusII catheter, and high-resolution LGE-CMRI for imaging of atrial fibrosis, 
they similarly found that the majority of continuous fractionated atrial electrograms in AF 
(NavX CFEmean score of <80ms) occurred in regions of the left atrium where there was no 
late-gadolinium enhancements. Only 19% of fractionated electrograms were observed to be 
co-localised to within or around dense regions of late-gadolinium enhancement. Although 
electroanatomical mapping was performed in a similar fashion, the methodology of 
generating left atrial scar maps was different from that which was used in our study, 
specifically in the thresholding of atrial signal intensities (which was performed with a slice-
by-slice histogram analysis as described in Chapter 3).   
These findings suggest that the genesis of fractionation of electrograms in AF may have a 
more dominant functional, rather than a structural basis and corroborates our observations. 
Hence, when fibrillation waves encounter partially or totally refractory tissue, local tissue 
conduction slowing or alterations in wavefront propagation can lead to electrogram 
fractionation.188 Rostock et al has previously reported that bipolar electrogram fractionation 
is dependent on the activation rate through observations that shortening of the regional AF 
cycle length precedes the development of electrogram fractionation.191 This is corroborated 
by others who have demonstrated electrogram fragmentation in areas of slow intra-atrial 
conduction in patients with AF, 154 and prolongation of fractionated atrial electrograms in 
patients with AF and atrial flutter with premature extrastimuli.308 With the use of 
monophasic action potentials, Narayan et al described that the majority of complex 
fractionated atrial electrograms represent far-field signals, AF acceleration or 
disorganization.309 More recently, by comparing electrogram fractionation in sinus rhythm, 
coronary sinus pacing and AF, Jadidi et al observed that the distribution of fractionated 
electrograms is highly dependent on the rhythm, with little overlap between them suggesting 
a functional basis of fractionation. Fractionation observed in sinus rhythm or during pacing 
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reflected wavefront collisions, and fractionated electrograms in AF corresponded to atrial 
myocardial with normal voltages (>1.0mV) and electrogram morphology in sinus rhythm.310 
5.4.7 AF sources and atrial late-gadolinium enhancement  
The precise mechanistic links between structural remodelling with fibrotic change and AF 
sources (including re-entrant drivers and rotors) in persistent AF remains unknown. With 
the increasing use of LGE-CMRI to delineate the structural substrate, and the use of global, 
simultaneous AF mapping to detect AF sources, there is interest in understanding how and if 
atrial fibrosis influences these AF sources. There is evidence based on computational 
experimental models that suggest that areas of fibrosis, through the provision of an 
anisotropic substrate, may anchor fibrillatory rotors and that stable AF rotor locations 
typically lie at the borders zones of fibrotic and healthy tissue, with increased heterogeneity. 
311,312 
The Bordeaux group, through the use of global bi-atrial mapping (body surface mapping with 
a 256-electrode vest enabling real-time panoramic mapping of atrial electrical activation) and 
LGE-CMRI reported an association between the extent of fibrosis and the number of 
regions driving AF (sites exhibiting high rotor activity) in 41 patients with persistent AF.136 
These regions driving AF were targeted by catheter ablation, with acute endpoint of AF 
termination. The burden of late-gadolinium enhancement and the number of AF driving 
regions were both inversely correlated with acute AF termination. In a subset of 12 patients, 
the body-surface mapping and the LGE-CMRI data were co-registered, and visual analysis of 
the trajectories of the rotors observed showed a clustering along the borders of fibrotic 
regions. This predilection of “rotors” at the border zones of healthy and fibrotic tissue in 
the atrium has recently been challenged. Schotten et al have suggested that rotational activity 
observed with phase singularity detection may be a result of artefact at regions of lines of 
block at such border zones.63  
However, the Hopkins’s group, using FIRM-mapping to identify rotor incidence with global 
and regional late-gadolinium enhancement (using distinct post-processing algorithms to the 
Bordeaux group), failed to demonstrate an association between the rotor sites and fibrosis 
as determined by LGE-CMRI.137 This discrepancy in findings may be attributable to the 
different methodologies used in both mapping rotors, and that of LGE-CMRI. Maps derived 
from body surface mapping demonstrate varying spatiotemporal behavior of driver activities, 
with non-sustained re-entrant circuits which meandered significantly and recurred 
repetitively in the same region19 whereas rotors or focal sources observed with FIRM 
mapping are stable over prolonged periods of time, precessing or “wobbling” within narrow 
confines of the left atrium for thousands of cycles.313   
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5.4.8 Limitations 
One of the major limitations of this study arose from the use of LGE-CMRI as a modality to 
visualise atrial fibrosis, and the restrictions imposed by the current resolution of this imaging 
modality. This has been discussed in Chapter 3.  
Although we were meticulous during the acquisition of electrical data, contact sensing 
multipolar catheters were not available during the time of the study. We ensured that 
electrogram quality was optimised prior to data acquisition, with the AFocusII catheter being 
placed tangential to the left atrial surface in a stable fashion but changes of electrogram 
morphology due to cardiac motion and respiration cannot be completely eliminated. The 
internal projection on the EnsiteTM Velocity system as set at a stringent 5mm as an exclusion 
criteria for insufficient electrode tissue contact. Data was only accepted when at least 18/20 
electrodes on the AFocusII catheter were discernable, and we found data acquired from the 
posterior left atrial wall offered best quality data. The use of contact sensing multipolar 
catheters based on impedance change, which are now available, may further improve the 
robustness of the quality of electrograms and reduce the propensity for bias. 
The registration of the left atrial “scar map” derived from LGE-CMRI and the 
electroanatomic points may be limited by the possibility of positional errors, and some 
unmeasured confounding likely exists. The registration was performed with the validated and 
widely accepted EnsiteTM FusionTM Registration module (St Jude Medical), and has been 
shown to be highly accurate.231 We avoided “tenting” of the left atrium during 
electroanatomic mapping, and rigorous “shaving” and re-assignments of the left atrial 
geometry acquired during mapping was performed prior to registration with the atrial shell 
derived from LGE-CMRI.  
We utilized unipolar electrograms to account for the known affects of rate and wavefront 
activations on bipolar electrograms, and far-field components in measurements of voltage 
may confound our results. The facility to derive bipolar electrograms from the acquired 
unipolar data was unfortunately not possible due to technicalities in the manner in which the 
electrical data was acquired. Nevertheless, we found significant correlations with atrial 
enhancements and conduction velocity, as well as a reproducible relationship with 
fractionated electrograms in AF, as others have described.  
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5.4.9 Conclusion 
The investigations studying the tissue electrophysiologic characteristics in regions of atrial 
late-gadolinium enhancement ultimately aims to validate LGE-CMRI as a non-invasive tool 
for the assessment of structural remodelling in the form of fibrotic change. Through robust 
methodology, our findings here are consistent with the much observed and accepted role of 
fibrosis in AF, and the quantitative relationships linking the development of the arrhythmic 
substrate via the effects on conduction velocity.  
It is important to note that whilst atrial late-gadolinium enhancement has been associated 
with a remodelled atrial substrate based on voltage and conduction velocity, it has not been 
systematically compared to histology. Hence, patient-tailored ablation strategies through the 
increasing use of computer simulations and modelling with the integration of electrical and 
structural data needs to be interpreted with caution.   
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6 Comparative assessment of electrophysiologic 
parameters of atrial fibrillation and the paced-rhythm 
in the persistent atrial fibrillation substrate 
 
6.1 Introduction 
Catheter ablation is now an established and effective therapeutic option in the treatment of 
AF.6 This has focused on electrical isolation of the pulmonary venous (PV) triggers of AF,314 
but when AF has become persistent, atrial myocardial remodelling producing the substrate 
for perpetuation of the AF has evolved.8 Pulmonary vein isolation alone in persistent AF has 
a very high AF recurrence rate, and ablative treatment of persistent AF therefore requires 
modification of the highly remodelled substrate (both structural and electrical).9 Current 
approaches to modifying the atrial myocardial substrate responsible for the maintenance and 
perpetuation of AF are heterogeneous across centres and operators, and lack a mechanistic 
basis.6 Some involve the ablation of complex fractionated atrial electrograms (CFAE) without 
clear and consistent definitions, or much understanding of the genesis of such electrograms, 
with varying reported results, while others involve the use of wide area circumferential 
ablation with the partial goal of disrupting the AF substrate. 196,264 More recently, low voltage 
areas in sinus rhythm have been targeted as part of a substrate based approach to catheter 
ablation in patients with persistent AF, but voltage mapping techniques have been 
heterogeneous (both in AF and sinus rhythm) with variable thresholds of “scar” utilised.134,173 
Part of the reason for the incomplete understanding of the persistence of AF is the difficulty 
in identifying the structural (architectural) or functional (electrophysiological) myocardial 
determinants (electroarchitecture) of the arrhythmic substrate, because of the complexities 
of mapping the spatiotemporally varying electrical activity and myocardial architecture in AF 
in the human heart.  
 
Endocardial voltage has been used as a surrogate for myocardial fibrosis, and this is largely 
based on studies on ventricular scar mapping, although more recently, been investigated in 
the atrium as discussed in Chapter 5. Atrial fibrosis has been described to influence 
electrogram fractionation, and wavefront propagation in AF.271,310 Conduction velocity is 
another important parameter that can influence atrial arrhythmias with slow conduction 
promoting re-entrant circuits, and may reflect the underlying atrial structural substrate 
(architecture).279 Electrogram fractionation indices, in spite of a lack of specificity have also 
been widely studied in the context of the wavefront mechanism.124 
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This study sought to simplify the problem of understanding the electrical properties of AF. 
We hypothesized that the comparative assessment of the electrophysiologic properties of 
the superficially organized and native disorganized rhythm of AF will provide us with a better 
understanding of the underlying arrhythmic substrate. On a regional basis, we assessed 
voltage, fractionation indices and conduction velocity during atrial fibrillation in comparison 
with the same electrophysiological parameters during paced-rhythms in patients with 
persistent AF undergoing catheter ablation.  
 
6.2 Methods 
Patients with symptomatic persistent AF (based on the classification of AF by published 
guidelines from the AHA/ACC/HRS/ESC6) presenting for their first ablation to Imperial 
College Healthcare NHS Trust were prospectively enrolled. The study was approved by the 
Local Research and Ethics Committee for Imperial College Healthcare NHS Trust and 
written informed consent were obtained from all patients. Data from 4 patients in the study 
protocol described in Chapter 5 was incorporated in this chapter. 
All anti-arrhythmic drugs were discontinued for at least 5 half-lives, and amiodarone was 
discontinued at least 60 days, prior to the ablation procedure. All procedures were 
performed in the post-absorptive state under general anaesthesia. Transoesophageal 
echocardiography was performed in all patients once under general anaesthesia to exclude 
left atrial appendage clot, and to subsequently guide transseptal puncture. A deflectable 
decapolar catheter (Inquiry, St Jude Medical, St. Paul, MN, USA) was positioned in the 
coronary sinus to record electrograms, pace the atrium, and serve as a spatial reference. A 
pentapole with a proximal reference electrode in the inferior vena cava was placed to allow 
for acquisition of unipolar recordings. Single transseptal punctures were performed using a 
Brokenbrough needle through a fixed curve long-sheath (SL0, St Jude Medical, MN, USA). 
Unfractionated heparin was administered to achieve an activated clotting time of 300-350s 
throughout the procedure. An impedance-based electroanatomical mapping system (NavX 
Ensite Velocity, St Jude Medical, MN, USA) was used. The left atrial geometry and all 
subsequent data were acquired using a 20-pole double-loop catheter (InquiryTM AFocusII, St 
Jude Medical, MN, USA) with1 mm electrodes and 4mm spacing. Bipolar electrograms were 
recorded and displayed at filter settings of 30-500Hz, and unipolar electrograms at 0.5-
100Hz during the procedure. Prior to any radiofrequency therapy, map data acquisition was 
performed according to the study protocol.  Subsequent to the study protocol, all PV's were 
isolated, followed by a "stepwise approach" for modification of the AF substrate.  
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6.2.1 Electroanatomical mapping in AF 
All patients were in AF on the day of the procedure. Baseline AF data was initially acquired 
and displayed in the form of a Complex Fractionated Electrogram (CFE) map. While bipolar 
electrogram data was used during the study, unipolar electrograms were also acquired for 
retrospective analysis.  The technique of acquiring CFE maps using an automated algorithm 
(NavX Ensite, St Jude Medical) has been previously described and validated. Atrial bipolar 
electrograms acquired using a multipolar catheter were analysed to compute the mean 
interval between the multiple deflections over an 8 second period of time (CFEmean). The 
CFEmean is then represented on the geometric shell as a colour-coded display (Figure 6.1). 
Based on previous studies, CFE areas were defined as sites having a CFEmean of <80 ms. 
We used the following CFEmean tool parameters: CL 80-120ms; EGM width <10 ms (to 
avoid detecting far-field signals); EGM refractory period 40 ms; peak-to-peak sensitivity 0.04 
mV (to avoid sensing noise); Interpolation was set to 10 mm, and interior projection 5 mm 
(as an exclusion criteria for insufficient contact). Contact bipolar electrograms were 
obtained in AF with the AFocusII catheter positioned tangentially with the endocardial 
surface to maximize electrogram fidelity for 8 seconds at each site. This data was then 
acquired, stored and displayed as part of the global CFE map. The mean surface area of the 
left atrium was 100±15cm2, excluding the left atrial appendage and pulmonary veins. The 
mean number of points acquired per CFE map was 360±35, for a mean point density of 
3.5±1.1cm2. 
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Figure 6.1 Complex Fractionated Electrogram (CFE) mapping in AF 
A representative CFE map created during AF prior to any left atrial ablation. Areas in white 
(CFE sites) harbour highly fractionated atrial electrograms with CFEmean scores of <80ms 
(yellow box), and areas in purple harbour organised atrial electrograms with CFEmean 
scores of >120ms (red box).  
 
6.2.2 Electroanatomical mapping during left atrial pacing 
All patients then underwent external electrical cardioversion to sinus rhythm. Mapping was 
only performed after a 15 min interval to avoid any acute post-cardioversion phenomenon. 
Localised electroanatomical maps (unipolar voltage and activation) were created during left 
atrial pacing. Unipolar signals were used for measurements of voltage to remove any 
discrepancies due to variation in bipole orientation on the AFocusII catheter, and its 
interaction with variable wavefront activations. Pacing was performed from 2 separate left 
atrial sites (usually from the low posterior wall with pacing with the CS decapolar and from 
the left atrial roof with the ablation catheter), at cycle-lengths of 600ms, 400ms, 350ms, 
300ms and 250ms. The AFocusII catheter was held stable, tangential to the LA surface, for 
up to 3 seconds during appropriately captured pacing before electroanatomical data was 
acquired (Figure 6.2). Upon acquisition, unipolar voltages (peak-peak) and activation timings 
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(peak -dV/dt) were catalogued (Figure 2.8).  As a further safeguard against insufficient contact, 
the interior projection distance was set to 5 mm.  During pacing at each independent site 
and rate, a mean number of 53±10 points were collected consisting of 2.6±0.5 acquisitions 
or simultaneously acquired "Kernels" evenly distributed across the posterior left atrial wall. 
Due to the “flat” nature of the posterior wall, mapping of the posterior left atrial wall allows 
for the acquisition of a good complement of high quality electrograms due to optimised 
tissue contact of the majority of the 20 electrodes of the AFocusII catheter as apposed to 
mapping of other left atrial sites.  
 
Figure 6.2 Electroanatomical mapping on the posterior left atrial wall 
Illustrative example of electroanatomical mapping on the NavX Ensite Velocity 3D mapping 
system of the posterior left atrial wall with a spiral high-density mapping catheter (AFocusII) 
during left atrial wall during pacing from electrodes 7,8 of the decapolar catheter placed in 
the coronary sinus at cycle lengths of 600ms (left) and 300ms (right).  
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Figure 6.3 Acquisition of unipolar paced electrograms 
Illustrative example of unipolar electrogram recordings from the mid-posterior left atrial 
wall during pacing from electrodes 5,6 of the decapolar catheter placed in the coronary 
sinus (Left panel). The corresponding acquired electrograms are shown (Right panel).  
 
 
Figure 6.4 Measurement of voltage and activation time for paced 
electrograms 
2 illustrative examples of the measurement of the peak-to-peak voltage and local activation 
time referenced to a fixed electrode (in this instance a CS electrode) from the annotated 
unipolar electrograms (peak negative dV/dt). 
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6.2.3 The Kernel as a Regional Unit for Comparative Measurements 
The challenge of making regional comparisons of various electrophysiologic metrics such as 
conduction velocity, voltage and fractionation was resolved by establishing the "Kernel" as 
the spatial element of measure.  As acquired from the AFocusII catheter, any given Kernel 
consists of a set of 20 simultaneously acquired electrograms (both unipolar and bipolar).  As 
dictated by the dimensions of the electrode configuration on the catheter (and accounting 
for 5 mm extrapolation beyond the boundary electrodes) the Kernel takes the shape of a 
circle, 3 cm in diameter, resulting in an extrapolated surface area of ~10.6 cm2.  20 unipolar 
recordings evenly spread across this surface yield a Kernel point density of 1.89pts/cm2.  
Thus at any given Kernel location, the AF characteristics could then be compared directly 
with the paced results. 
6.2.4 Measurement of endocardial atrial voltage in AF and pacing 
AF bipolar voltage was calculated by evaluating the mean peak-to-peak of all the 
electrograms in the left atrial region subtended by the AFocusII catheter over a 8 second 
recording to produce a cumulative mean±SD voltage using a Matlab code. Appropriate 
annotation of an electrogram is first achieved by identifying the positive and negative peaks 
through evaluating the maximum (or minimum) value within a moving window of size 20 
samples (10ms). These are paired by looking for negative and positive tags within 50 samples 
(25ms) of each other. A refractory window of 60ms is subsequently applied starting at the 
first deflection, in which any other deflections within the window, unless they have larger 
amplitude than the starting deflection are removed. In this case, the larger deflection is taken 
as the starting point for the refractory window (and the initial deflection discarded). 
Representative peak-to-peak voltages could be verified and adjusted if necessary to ensure 
no double counting or annotation of far-field signals (Figure 6.5). During left atrial pacing, the 
unipolar peak-to-peak voltage over each Kernel encompassed by the AFocusII catheter was 
calculated when exported into Matlab with a code to produce the cumulative mean±SD 
voltage across each Kernel.  
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Figure 6.5 Measurement of mean peak-to-peak AF bipolar voltage over 8 
sec 
An 8 second segment of bipolar AF recording at a single left atrial site is exported. Each 
electrogram within an AF cycle is detected (indicated with a yellow marker) using a sliding 
algorithm to ensure no inappropriate annotation due to electrogram fractionation or far-
field ventricular signals. The mean peak-to-peak voltage is then calculated from all annotated 
electrograms within the 8 sec segment of recording. 
 
6.2.5 Measurement of conduction velocity during pacing 
The location (x,y,z co-ordinates) and local activation times (-dV/dt)max from each of the 20 
electrodes of the AFocusII catheter were exported from EnsiteTM  Velocity into Matlab, with 
a code written to calculate conduction velocity over the area encompassed by the Kernel. 
3D electrogram positions were first projected onto the 2D plane of best fit. The 2D 
positions along with their activation times, (Xi, Yi, Ti), were then fit to a planar model using 
ordinary linear least squares. The mean conduction velocity (represented by the slope of the 
plane) was then calculated using the gradient of the fitted activation time (Figure 2.9). This 
process was repeated twice at each kernel location and averaged for comparison. In addition 
to mean conduction velocity, the degree of planarity of conduction r2 (i.e. coefficient of 
determination) was also computed. 
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Figure 6.6 Measurement of conduction velocity across a Kernel 
(Left panel)  An illustrative example of an isochronal map during left atrial pacing from 
electrodes CS56 with the AFocusII catheter placed on the mid-posterior left atrial wall. 
(Right panel) Schematic representation of the calculation of conduction velocity across the 
area subtended by the AFocusII catheter with each coloured dot representing an electrode 
on the 20 pole AFocusII catheter with local activation times (LATs) and 3D co-ordinates 
exported into Matlab.  
6.2.6 Scoring of electrogram fractionation  
Within the kernel, each bipolar atrial electrogram acquired during CFE mapping was 
assigned an individual CFEmean score (described above). These were defined as fractionated 
electrograms if their CFEmean scores were <80ms. The cumulative extent of electrogram 
fractionation for each Kernel was expressed in two ways:  
1) The percentage of fractionated atrial electrograms within each kernel (i.e. number of 
fractionated atrial electrograms/ total number of atrial electrograms*100); and  
2) In a binarised version as follows was calculated. In our study, kernels with percentage of 
fractionated atrial electrograms of <50% and >50% were defined as “non-CFAE” and “CFAE” 
sites respectively. Kernels containing less than 10 bipolar atrial electrograms acquired during 
CFAE mapping were discarded from any analysis.  
 
6.2.7 Statistical analysis 
All normal variables are expressed as mean and standard error of the mean (SEM). Paired 
and unpaired T-tests were used when appropriate, with Bonferoni correction for multiple 
tests. Correlation of continuous variables was examined with Pearson’s and Spearman’s 
correlation coefficients for parametric and non-parametric data respectively. A probability of 
<0.05 was considered significant. 
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6.3 Results 
A total of 40 left atrial sites/Kernels were analysed from 15 patients (2.7±0.5 
Kernels/patient). Baseline characteristics of the study group are presented in Table 6.1. The 
mean age of the patients was 65±9 years, with 50% being male. LA size was 41±7mm. Their 
AF symptom history was 21.3±10 months and mean CHADS2VASC2 score was 2.8 (0-6). 
The prevalence of structural heart disease was 50%.  
 
Table 6.1 Clinical demographics of patients recruited  
Clinical characteristics (n=15)  
Age (years) 65.3±11 
Male (%) 50% 
Mean duration of AF (months) 21.3±10  
Mean LA size on TTE (mm) 41±7 
Mean CHADS2VASC2 score 2.8 (0-6) 
Structural heart disease (%) 50% 
Number of Kernels 40 
 
6.3.1 Pacing and AF metrics 
During high and low rate pacing at cycle lengths of 300ms and 600ms respectively, the basic 
metrics of mean unipolar voltage (Vp) and conduction velocity (CVp) were assessed on a per 
Kernel basis. The mean unipolar voltage as a function of pacing cycle length and wavefront 
direction, and the conduction velocity were assessed.  
During AF, the degree of fractionation using the mean NavX CFEmean score (CFEAF) and 
mean bipolar peak-to-peak voltage over 8 secs (VAF) across each Kernel was assessed. 
Taking into account fractionation from 30Hz high pass bipolar recordings, the mean CFEAF  
was 170±89ms. The overall percentage of fractionated electrograms (<80ms CFEmean) per 
Kernel was 47.7±89%. 15/40 (37.5%) of the Kernels which has >50% fractionated atrial 
electrogram were defined as “CFAE” sites. The mean VAF across all Kernels was 
0.47±0.04mV.  
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6.3.2 Voltage and pacing rate 
The mean paced unipolar voltages across all Kernels from pacing at 600ms and 300ms were 
1.80±0.09 mV and 1.59±0.10 mV respectively. This demonstrated a significant drop in those 
unipolar voltages with shorter pacing cycle lengths, i.e.  (p<0.05)(Figure 6.7). Analysis of the 
relationship between all pacing cycle lengths (300ms, 350ms, 400ms and 600ms) and mean 
voltage revealed a consistent drop in mean voltage with shorter pacing CLs (-0.1mV/100ms, 
p<0.001). (Figure 6.8)  
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Figure 6.7 Mean unipolar voltages across all LA sites 
Pacing at shorter cycle lengths (300ms vs. 600ms) results in a significant drop in unipolar 
paced voltages, *p<0.05. 
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Figure 6.8 Voltage and cycle lengths 
This graph shows data acquired from a single representative patient, demonstrating a drop in 
mean unipolar voltages with higher pacing rates (from 600ms to 300ms). Each point series 
represents data acquired from 4 different left atrial sites (Kernels). The gradient of each line 
of best fit was used to quantitatively describe the relationship between mean endocardial 
unipolar voltage and varying pacing cycle lengths. 
 
This change in unipolar voltage as a function of pacing cycle lengths is further illustrated in a 
single case example with mapping of the posterior wall of the left atrium over 3 sites 
(Kernels) in the voltage maps created during electroanatomic mapping with the EnsiteTM 
Velocity 3D system (Figure 6.9). 
 229 
A
B B
A
C C
CS78%pacing%600ms% CS78%pacing%300ms%
AUni5600* AUni5300*
3.48mV* 2.96mV*
BUni20600* *BUni20300*
2.01mV* 1.35mV*
CUni14600* CUni14300*
4.17mV* 3.05mV*
0mV%
5mV%
 
Figure 6.9 Voltage maps during differential cycle length pacing from CS 
(Top) An illustrative example electroanatomical maps from the EnsiteTM Velocity 3D 
mapping system during voltage mapping of posterior left atrial wall demonstrating changes in 
unipolar voltage maps with a change in pacing cycle length with left atrial pacing from CS78 
at 600ms and 300ms. (Bottom) Representative unipolar electrograms from selected 
electrodes on the AFocusII catheter in each Kernel mapped showing a reduction in peak-to-
peak amplitudes with pacing from 600ms to 300ms. 
 
6.3.3 Voltage and direction of wavefront propagation 
In a subset of 10 kernels from 5 patients, where electroanatomic mapping was performed on 
the posterior wall during roof and coronary sinus pacing, there was a significant differential 
in absolute mean unipolar paced voltages (1.57±0.08mV vs. 2.08±0.12mV, p<0.05) where the 
wavefront activations were in opposite directions during pacing from 2 distinct left atrial 
sites across all pacing cycle lengths (Figure 6.8). Figure 6.10 demonstrates the significant 
change in the mean unipolar paced voltage in the 10 kernels during pacing at cycle lengths of 
300ms and 600ms as a function of direction of wavefront propagation (CL300ms: 
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1.40±0.17mV vs. 2.05±0.25mV; p<0.05 and CL600ms: 1.77±0.19mV vs. 2.455±0.26mV; 
p<0.05).   
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Figure 6.10 Combined paced voltage and direction of wavefront 
propagation 
Change in direction of wavefront propagation (opposite) when pacing from 2 different left 
atrial sites resulted in a significant change in the absolute mean paced unipolar voltages 
(*p<0.05).   
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Figure 6.11 Paced voltage and direction of wavefront propagation 
Alteration of the direction of wavefront propagation (opposite) during roof and coronary 
sinus pacing resulted in an absolute change in paced mean unipolar voltages at cycle lengths 
of 300ms (red) and 600ms (blue) (CL300ms: 1.40±0.17mV vs. 2.05±0.25mV; p<0.05 and 
CL600ms: 1.77±0.19mV vs. 2.455±0.26mV; p<0.05). 
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This is further illustrated in a single case example with mapping of the posterior wall of the 
left atrium over 3 sites (Kernels) in the voltage maps created during electroanatomic 
mapping with the EnsiteTM Velocity 3D system where the wavefront propagations were in 
opposite directions as a result of pacing from the left atrial roof, and CS78 (left atrial floor) 
(Figure 6.11).  
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Figure 6.12 Voltage maps during differential cycle length pacing from 2 
leaf atrial sites  
An illustrative example electroanatomical maps from the EnsiteTM Velocity 3D mapping 
system during voltage mapping of posterior left atrial wall demonstrating changes in unipolar 
voltage maps with a change in pacing direction (and hence wavefront propagation) with left 
atrial pacing from CS78 and roof at cycle length of 600ms (Left panel) and 300ms. (Right 
panel)  
 
6.3.4 Paced/AF voltage and cycle length 
 There was a good correlation of paced unipolar voltages during left atrial pacing at cycle 
lengths of 300ms and 600ms (R2= 0.659 p<0.0001) (Figure 6.8), with mean unipolar voltages 
lower during pacing at 600ms (1.80±0.09 mV vs. 1.59±0.10 mV; p<0.05)(Figure 6.7).  
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Figure 6.13 Relationship between paced voltages at cycle lengths of 300ms 
and 600ms 
Paced unipolar voltages at cycle lengths of 300ms and 600ms showed a good correlation 
(R2= 0.659 p<0.0001).  
 
The mean peak-to-peak AF voltage over 8 sec across all Kernels was 0.405±0.103mV. At 
each mapped LA site, the mean peak-to-peak voltage over 8s in AF correlated with the 
mean paced voltages at both 300ms (R2=0.4742 p<0.0001) (Figure 6.9) and 600ms 
(R2=0.4742 p<0.0001) (Figure 6.10).  
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Figure 6.14 Relationship of AF voltage and mean paced voltage at 300ms 
There is a correlation of mean peak-to-peak AF voltages over 8sec with that of mean paced 
voltages (during pacing at 600ms) across all Kernels (R2= 0.5114 p<0.0001). 
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Figure 6.15 Relationship of mean AF voltage and mean paced voltage at 
600ms 
There is a correlation of mean peak-to-peak AF voltages over 8sec with that of mean 
paced voltages (during pacing at 600ms) across all Kernels (R2= 0.5114 p<0.0001). 
 
The mean unipolar voltages during pacing were significantly lower in regions with low peak-
to-peak AF voltages over 8 sec of <0.3mV at both pacing cycle lengths of 300ms (VP300 
0.841±0.104mV vs. 1.602±0.284mV, p<0.01) and 600ms VP600 0.789±0.101 vs. 
1.785±0.302mV, p<0.001) (Figures 6.16 and 6.17 respectively). 
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Figure 6.16 Comparison of mean AF voltage and mean paced voltage at 
300ms 
Regions of low mean peak-to-peak AF voltage over 8 sec had significantly lower mean 
voltages during pacing at cycle length of 600ms (**p<0.01).  
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Figure 6.17 Comparison of mean AF voltage and mean paced voltage at 
600ms 
Regions of low mean peak-to-peak AF voltage over 8 sec had significantly lower mean 
voltages during pacing at cycle length of 600ms (***p<0.001).  
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6.3.5 Electrogram fractionation and voltage 
Across all Kernels, the mean percentage of fractionated atrial electrograms was 50.1±19.0%. 
There was a positive correlation between the percentage of fractionated atrial electrograms 
to the mean peak-to-peak voltage in AF over 8 secs (R2= 0.4310 p<0.001) (Figure 6.11), as 
well as mean paced voltages at both 300ms (R2= 0.4310 p<0.001) (Figure 6.12) and 600ms 
(R2= 0.498; p<0.001) (Figure 6.13) pacing cycle lengths.  
R²#=#0.43097#
0#
0.2#
0.4#
0.6#
0.8#
1#
1.2#
10# 20# 30# 40# 50# 60# 70# 80# 90# 100#
M
ea
n%
vo
lta
ge
%+%
AF
%(m
V)
%%
Percentage%of%frac6onated%electrograms%(%)%
p<0.0001%
 
Figure 6.18 Correlation of AF voltage and percentage of fractionated 
electrograms 
There was a positive correlation between the mean peak-to-peak voltage in AF and the 
percentage of fractionated electrograms across each Kernel (R2= 0.4310 p<0.0001).  
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Figure 6.19 Correlation between mean paced voltage at 300ms and 
percentage of fractionated electrograms in AF 
There was a positive correlation between the mean peak-to-peak voltage in AF and the 
percentage of fractionated electrograms across each Kernel (R2= 0.49789 p<0.0001).  
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Figure 6.20 Correlation between mean paced voltage at 600ms and 
percentage of fractionated electrograms in AF 
There was a positive correlation between the mean peak-to-peak voltage in AF and the 
percentage of fractionated electrograms across each Kernel (R2= 0.4443 p<0.0001). 
 
Kernels with >50% fractionated atrial electrograms (“CFAE sites”) had significantly higher 
mean paced voltages at both 300ms and 600ms cycle lengths than Kernels with <50% 
fractionated atrial electrograms (“Non-CFAE” sites) (Pacing CL 300ms: 1.88±0.19mV vs. 
1.14±0.11mV, p<0.05 (Figure 6.14) and Pacing CL 600ms: 2.07±0.21mV vs. 1.14±0.08 mV, 
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p<0.05) (Figure 6.15). Although there was a trend to lower mean peak-to-peak AF voltages 
over 8 sec in Kernels in “non-CFAE” sites compared to those within “CFAE” sites, this did 
not reach statistical significance (0.483±0.17mV vs. 0.386±0.12mV, p=0.06) (Figure 6.16).  
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Figure 6.21 Mean paced unipolar voltages at 300ms in “non-CFAE” and 
“CFAE” sites 
There were significantly higher mean paced voltages of Kernels in “CFAE” sites, as apposed 
to those in “non-CFAE” sites during pacing at 300ms cycle length (p<0.05). 
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Figure 6.22 Mean paced unipolar voltages at 600ms in “non-CFAE” and 
“CFAE” sites 
There were significantly higher mean paced voltages of Kernels in “CFAE” sites, as opposed 
to those in “non-CFAE” sites during pacing at 600ms cycle length (p<0.001). 
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Figure 6.23 Mean AF voltage in “non-CFAE” and “CFAE” sites. 
Lower mean voltages in AF over 8 secs in “non-CFAE” compared to “CFAE” sites but did 
not reach statistical significance (p=0.06).  
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6.3.6 Voltage and conduction velocity 
The mean conduction velocity over all 40 Kernels during left atrial pacing at cycle length of 
300ms and 600ms were 0.97±0.29ms-1 and 1.11±0.29ms-1 respectively. There was no 
consistent relationship between voltage in AF and conduction velocities during left atrial 
pacing at 300ms and 600ms (R2=0.0845 p=0.10 and R2=0.0027 p= 0.769 respectively) ( 
Figure 6.24 and Figure 6.25 respectively). Similarly, there was no correlation between 
voltages during left atrial pacing at both pacing cycle lengths of 300ms (R2=0.015 p=0.457) 
and 600ms (R2= 0.051 p= 0.685) to conduction velocities across each Kernel (Figures 6.18 
and 6.19 respectively).  
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Figure 6.24 Conduction velocity and mean unipolar voltage during pacing 
at 300ms. 
There was lack of a consistent relationship between conduction velocity and mean voltage 
during left atrial pacing at a cycle length of 300ms across all Kernels.  
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Figure 6.25 Conduction velocity and mean unipolar voltage during pacing 
at 600ms. 
There was lack of a consistent relationship between conduction velocity and mean voltage 
during left atrial pacing at a cycle length of 600ms across all Kernels. 
 
There was also no relationship between the mean peak-to-peak AF bipolar voltage with 
conduction velocity across all Kernels studied at pacing cycle lengths of 300ms and 600ms 
(R2=0.00023 and R2=0.00091 respectively) (Figure 6.19).  
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Figure 6.26 Conduction velocity and mean voltage in AF 
There was no discernable relationship between conduction velocity and the mean peak-to-
peak AF bipolar voltage over 8 secs across all Kernels during left atrial pacing at 300ms (top) 
and 600ms (bottom).   
  
6.3.7 Conduction velocity and fractionation 
There was no consistent relationship between the percentage of fractionated electrograms 
of atrial electrograms in each Kernel to their conduction velocities, at both pacing cycle 
lengths of 300ms and 600ms (R2=0.037 and 0.015 respectively)(Figure 6.20). 
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Figure 6.27 Conduction velocity and percentage of fractionated atrial 
electrograms per Kernel 
There was no relationship between the percentage of fractionated electrograms of atrial 
electrograms in each Kernel to their conduction velocities, at either pacing cycle lengths of 
300ms and 600ms (R2=0.037 and 0.015 respectively) 
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There was no significant difference in the conduction velocities in Kernels with >50% 
fractionated atrial electrograms (CFAE) and those with <50% fractionated atrial 
electrograms (non-CFAE) at both pacing cycle lengths of 600ms and 300ms (CL 600ms: 
1.08+/-0.19ms-1 vs. 1.10+/-0.36ms-1, p=0.85; CL 300ms: 1.03+/0.16ms-1 vs. 0.96+/-0.241ms-1, 
p=0.38) (Figure 6.21).  
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Figure 6.28 Conduction velocity in “CFAE” and “Non-CFAE” sites 
There was no difference in conduction velocity during pacing at 300ms and 600ms in 
“CFAE” and “non-CFAE” kernels (p=0.38 and 0.85 respectively).   
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6.4 Discussion 
The aim of this study was to investigate the relationship of electrophysiological indices in the 
spatiotemporal variable rhythm of AF, and the regular paced-rhythm. Once again, as in 
Chapter 5, we used the Kernel as a unit of measure. The main findings are as follows: 
1) Unipolar atrial voltages are dependent on both rate and the direction of wavefront 
propagation; 
II) There is a linear relationship between the paced unipolar voltage, to the mean peak-to-
peak AF bipolar voltage over 8 secs; 
III) There is an inverse relationship between areas of CFAE and unipolar voltage; and 
IV) There is no relationship between conduction velocity and CFAE or unipolar voltage. 
6.4.1 Voltage and atrial activation rate 
In this chapter, we have demonstrated that unipolar voltages decrease in amplitude at higher 
atrial rates of activation accomplished through higher rates of pacing, with a predictable drop 
in tissue voltages with shortening of pacing cycle lengths (600ms: to 300ms). These 
observations corroborate with that of Chen et al utilising simultaneous high-density virtual 
unipolar electrograms from non-contact mapping where the mean global voltage of the right 
atrium was evaluated in different rhythms (sinus rhythm, atrial pacing at 300 and 500ms, 
supraventricular tachycardia and AF). The mean global right atrial unipolar voltage decreased 
during atrial pacing with shorter pacing cycle lengths, observed in patients with atrial flutter 
and AF.182  
More recently, our group has also reported progressive reductions in bipolar electrogram 
amplitudes during epicardial mapping of the lateral right atrium during cardiac surgery using a 
high density array during rapid atrial pacing compared to sinus rhythm (SR 1.38±0.70mV; 
500ms 1.11±0.57mV; and 200ms 0.91±0.61mV).297 Electrograms in AF demonstrated the 
lowest amplitudes (0.85±0.51mV, p<0.001 vs. sinus rhythm). This was associated with 
prolongation of the electrogram, and activation time during rapid pacing which suggests 
conduction slowing. Ndrepepa et al have also previously observed similar findings, where 
bipolar electrogram voltage was inversely related to fibrillatory cycle length. 315 In a control 
group of patients in a study examining the distribution of bipolar atrial electrograms voltages 
in patients with congenital heart disease, bipolar voltages in during atrio-ventricular 
reciprocating tachycardia were significantly higher than during sinus rhythm (1.45±1.66mV vs. 
1.90±1.45; p<0.0001).316  
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As demonstrated in Chapter 5, conduction slowing is seen during high rate pacing on 300ms, 
and the conduction slowing is more exaggerated in regions of fibrosis as determined by 
LGE-CMRI. Higher pacing rates resulting in more rapid atrial activation could result in 
wavefront propagation through partially repolarized tissue (i.e. during their relative 
refractory period), which has been shown to generate signals of reduced amplitude and 
voltage.317 In addition, conduction slowing as a result of asynchronous atrial myofibre 
activation and functional wavefront interactions, may account for the lower unipolar voltages 
seen here. 
Our findings are contradictory to the reported findings of Shivkumar et al where the overall 
bipolar voltage was surprisingly higher in typical atrial flutter where there was a shorter 
cycle length, compared to voltages in sinus rhythm.180 
6.4.2 Voltage and wavefront propagation 
We observed significant changes in the mean unipolar voltage with the alteration of the 
direction of wavefront propagation achieved through controlled left atrial pacing from the 
roof and low posterior wall (endocardial mid-coronary sinus) pacing to ensure opposing 
planar wavefront activations and avoid wavefront interactions. Others have reported 
discrepant voltage maps during differing atrial rhythms (sinus rhythm vs. flutter/paced) but 
have largely utilized bipolar electrograms, which inherently change with varying activation 
vectors which occur with changes in rhythms.180,182,316 
This discordance may be due to effects of the local tissue (fibrosis and regions of functional 
block/delay as a result of change in fiber orientations) and their interactions with the 
propagating wavefront. There is also suggestion that atrial endocardial activation is not 
homogenous, and has focal inputs. In a study identifying “low-voltage bridges” in the left 
atrium during voltage mapping in AF and sinus rhythm, these “bridges” were observed to 
activate the atrial endocardium selectively such that eradication of these “bridges” results in 
a regional loss of voltage within the atrium.177 The local ablation of these focal inputs results 
in remote changes on tissue voltages emphasizing the present voltage maps in the context of 
wavefront activations/atrial rhythms.  
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Figure 6.29 Local ablation results in remote voltage change 
The ablation of low-voltage bridges (LVBs) results in dramatic changes in endocardial 
voltage. As seen in the figure, LVBs are observed along the anterior septum. Ablation 
targeted to these few LVBs resulted in a significant collapse of voltage on the anterior atrial 
wall. Adapted from Bailin et al.177  
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Although specialized conduction tissue does exist in the atria (in the form of well-defined 
un-insulated bundles in the atrial muscle within which current flow is fast) in the Bachmann’s 
bundle, crista terminalis and pectinate muscles,318 conduction across the left atrium 
endocardium (intra-atrium) does not seem to involves these structures. Hence, regions of 
fibrosis and/or changes of fibre orientation can affect tissue conduction and ultimately affect 
voltage measurements.  
6.4.3 Voltage discordance 
All the abovementioned-referenced studies have demonstrated disparities in tissue voltages 
(both unipolar and bipolar) in various rhythms predominantly during mapping of the right 
atrium. Our study is the first to objectively examine the effect on the atrial cycle length and 
the direction of wavefront propagation on tissue voltages in the left atrium. There may well 
be significant functional dynamic substrates, above that of fixed structural substrates which 
influence local tissue voltages. These observations put into question the validity of tissues 
endocardial voltage as a surrogate marker of fibrosis, and whether these measurements can 
represent consistently the atrial substrate energy, and its utility in understanding the 
substrate of complex atrial arrhythmias including AF. 
6.4.4 Voltage mapping in AF and paced-rhythm 
The mean bipolar peak-to-peak voltage over 8 secs correlates to paced unipolar voltages at 
both high and low rate pacing, although the absolute voltages are significantly lower in AF 
compared to the paced rhythms (accepting the different modality of the recordings made 
during the paced rhythm and in AF) (VAF 0.47±0.04mV vs. VP600 1.80±0.09 mV vs. 
VP3001.59±0.10 mV). The methodology of AF voltage measurements in the literature is 
unclear, and inconsistent,178,271 and we have described in Chapter 4, a novel method of 
evaluation of AF voltage by means of averaging the mean peak-to-peak voltages over a 
sampling period of 8 sec, which correlates well with scar as determined by LGE-CMRI.  
The lower voltages observed in AF compared to sinus rhythm has been described in patients 
with devices where intra-cardiac electrograms seen on the atrial lead during sinus rhythm 
are typically larger than in atrial flutter, or AF (SR: 1.59±1.36mV vs. AF 0.77±0.58mV; 
p<0.0001 and SR: 1.81±2.07mV vs. 1.5±1.81mV; p<0.0001). Similar to our observations, 
there was a significant correlation between the mean electrogram amplitudes in AF with 
amplitudes in sinus rhythm (R=0.79 p<0.0001). They also noted that very low amplitude 
electrograms in AF (<0.3mV) were associated with low mean sinus rhythm electrogram 
amplitudes.181 This is consistent with our observations where the mean paced voltages were 
significantly lower in regions where the mean peak-to-peak AF voltage over 8 sec were 
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<0.3mV, suggesting that the underlying structural substrate can be interrogated during 
mapping in AF, and paced voltages can predict regions of low voltages in AF. Bailin et al, 
when performing bipolar voltage gradient mapping in sinus rhythm and AF (methodology of 
AF voltage mapping undisclosed), observed remarkable similarities in the 2 maps in terms of 
identifying low voltage bridges (similar locations regardless of underlying rhythm).177  
Ndrepepa et al have also previously demonstrated significantly reduced bipolar voltages 
during AF compared to sinus rhythm with biatrial mapping using a multi-electrode basket 
catheter.315 However, although the reduction in bipolar voltage was seen across all the 
biatrial endocardial recordings, the degree of voltage reduction showed significant regional 
disparity. Similarly, Chen et al, using derived unipolar electrograms from non-contact 
mapping of the left atrium observed discordant voltages in AF (mapped over 7 secs in 
duration) and sinus rhythm concluding that the peak electrogram unipolar voltage during AF 
did not represent the voltage during sinus rhythm, 179 and low voltage regions in sinus 
rhythm could not predict corresponding regions in AF at the majority of sites mapped, but 
there was improved correlation when the root-mean-square measure of amplitude 
(temporal integral that represents the steady state value) to be more predictive. 
The lower voltages seen in AF (regional voltage decrease during AF ranged from 33% to 
80%179,182,319) reflects the rate dependency of voltage, as we have discussed in 6.4.1 explained 
by the shorter cycle lengths in AF resulting in wavefront propagations through incompletely 
excitable tissue which has been shown to result in reduced amplitudes. High-resolution 
mapping during AF have demonstrated spatial and temporal dissociated conduction,93,317 
resulting in asynchronous local activations with multiple wavefront interactions and smaller 
voltage amplitudes.  
6.4.5 Electrogram fractionation and atrial voltage 
Substrate modification strategies targeting potential AF drivers in regions of complex 
fractionated atrial electrograms was previously utilized to improve clinical outcomes, and 
these regions were initially shown to correlate well with areas of low voltage in AF.320 Our 
results demonstrate left atrial regions, which harbour fractionated electrograms in AF, 
appear to correlate to regions with higher paced unipolar tissue voltages as well as to mean 
peak-to-peak bipolar electrograms in AF. This finding corroborates with the inverse 
relationship between fractionated atrial electrograms (defined as the NavX CFEmean score 
of <80ms) and atrial fibrosis as determined by late-gadolinium enhanced cardiac magnetic 
resonance imaging and bipolar voltage mapping in AF in patients with persistent AF271. 
Ghoraani et al also showed similar findings, with CFAE areas (defined as those with a 
fractionation index of greater than 7) had a linear inverse relationship with areas with low 
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bipolar voltages in AF defined as <0.1mV (local bipolar AF voltage in this study was 
determined as the maximum peak-to-peak voltage within a 2.5 sec window).133 Only a single 
study compared the relationship of fractionation of atrial electrograms with bipolar voltage 
in sinus rhythm, but this was only performed after pulmonary vein isolation, and the voltage 
measurements may have been compromised as a result of ablation lesions.202 Contrary to 
the above studies, Park et al reported left atrial CFAE areas to be co-localised with regions 
of low bipolar voltage acquired during right atrial pacing, and to be surrounded by high-
voltage areas.321  
In our study, we opted to utilize unipolar voltage recordings during atrial pacing, and 
selecting left atrial regions where there was a single planar wavefront activation to exclude 
wavefront collisions which would influence voltage recordings,322 as well as to remove the 
aspect of wavefront directionality on bipole electrode orientation in the measurement of 
tissue endocardial voltages as previously discussed. In the former 2 studies, bipolar voltages 
were recorded in AF, 124,271 and the inverse relationship with fractionation indices could have 
been attributed to the mis-representation of low voltage electrograms as non-fractionated 
due to pre-settings involved in the measurements of the fractionation indices, which would 
have excluded low amplitude electrograms of <0.05mV. Voltage mapping during atrial pacing, 
which was adopted in our study, overcomes this significant limitation.  Despite the 
limitations of the other studies, our investigations have yielded similar findings.  
The genesis of these fractionated atrial electrograms during AF is not entirely clear. They 
may represent areas of slow conduction, pivot points for re-entrant circuits or localised re-
entrant circuits (rotors) which may potentiate and maintain AF,84,188 or they can be 
attributed to by-stander phenomenon of passive depolarization, wavefront collisions, and 
even double counting of far-field electrograms especially in the septum and coronary 
sinus.309 Jadidi et al observed that the distribution of fractionated electrograms is highly 
rhythm-dependent and are non-overlapping, suggesting the functional nature of there 
electrograms, with most of the CFAE areas targeted during catheter ablation of persistent 
AF representing areas of atrial myocardium with normal voltages (bipolar >1.0mV)310.  
These observations are contrary to the belief that these fractionated atrial electrograms 
indicate changes in cardiac tissue structure representing regions of abnormal atrial substrate, 
and indirectly represent increased fibrosis, occurring in regions of low atrial voltage and with 
age. 223,321,323 However, this does not preclude the possibility that regions harbouring 
fractionated atrial electrograms in AF may co-localise with AF drivers in a region of normal 
atrial myocardium.  
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6.4.6 Conduction velocity and atrial voltage/fractionation 
Slowed myocardial conduction velocity is associated with increased risk of re-entrant 
excitation, predisposing to arrhythmias. Global conduction velocity slowing have been 
reported in patients who had a lower left atrial mean voltage.324,325 Regional conduction 
velocity has been reported to be significantly lower in low voltage regions in AF (bipolar 
voltages varying between <2.0 and <0.5mV), and was frequently associated with fractionated 
electrograms in patients with AF (both persistent and paroxysmal).321,323,326 The fractionated 
electrograms may hence presented delayed conduction, and rotation about a pivot point 
with local conduction block. Contradictory findings were reported by d’Avila et al where 
areas of CFAEs corresponded to areas of normal atrial voltage and normal conduction 
velocity during sinus rhythm.202 The Kalman group reported similar observations in a cohort 
of 12 patients with persistent AF undergoing catheter ablation,178 where no evidence of 
conduction slowing was observed in regions of complex fractionated electrograms, with 
normal voltage during left atrial pacing.  
This study has not demonstrated a relationship between conduction velocities, and paced 
unipolar tissue voltages and the degree fractionation of atrial electrograms. The 
discrepancies in these findings may be attributable to the measurement of conduction 
velocity in various different rhythms, and well as using different techniques in the 
measurement of conduction velocity. In addition, the Kernel as a unit of measure may 
encompass too large an area of the left atrium, and result in “normalization” of these indices 
when averaged over the 20 poles of the AFocusII catheter.  
6.4.7 Limitations 
The direct comparison of any contact electrograms, and hence voltages, at the same location 
between the different pacing rates and direction, as well as rhythms is difficult due to the 
systemic error in the labelled 3D Cartesian co-ordinates of a particular location, and the 
true location of the electrode.327 In addition, the difference in the degree of tissue contact 
during the manipulation of the multipolar mapping catheter may influence the electrograms 
and voltage amplitude.328  
The modality of voltage mapping (i.e. unipolar vs., bipolar) is a point of contention, each with 
its own limitations. The fundamental advantages of utilising unipolar electrograms were two-
fold: Firstly, the delineation of local activation timings is more precise, and the maximum 
downslope of the unipolar electrogram is now accepted to be the most accurate marker of 
local tissue activation.329 In contrast to unipolar electrograms, the choice of marker of local 
tissue activation time when utilising bipolar electrograms varies (maximum absolute voltage, 
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maximum absolute slope IdV/dtI and minimum voltage), and these may be challenging when 
dealing with fractionated signals. This allowed for more precise measurements of timings for 
the calculated conduction velocity readings. Secondly, the voltages of unipolar recordings are 
not susceptible to variation as a result of alterations in electrode orientations relative to the 
endocardial surface and direction of wavefront propagation. In contrast, bipolar 
electrograms by definition, represents the difference in electric potentials between distal and 
proximal electrodes, and hence is dependent on the direction of the electrode axis, and will 
alter voltage measurements in different rhythms.330 However, peak-to-peak voltages of the 
unipolar electrogram may represent distant excitation waves (far-field potential) especially in 
low voltage regions,331 but as we adopted the Kernel as a unit of measurement (area of atrial 
tissue encompassed by the AFocusII mapping catheter approximates to 3.14cm2), this is not 
likely to result in incorrect representations of the underlying substrate which may pose a 
problem when point-by-point comparisons are made.  
6.4.8 Conclusion 
We have systematically demonstrated the voltage discordance phenomenon in patients with 
persistent AF,  which re-emphasises the need to qualify any voltage measurement by rhythm, 
rate and direction of activation, raising the question of the robustness of endocardial voltage 
as a surrogate marker of fibrosis. In corroboration with other studies and our findings in 
Chapter 5, we have demonstrated an inverse relationship between atrial electrogram 
fractionation and voltage which draws into question the strategies involved in current AF 
ablation and suggests that fractionation in AF may have more of a functional rather than a 
structural basis. The electrophysiologic substrate of AF can be interrogated during pacing, 
and this could provide interesting insights into the underlying mechanisms of AF. 
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7 Ex-vivo reverse translation experiments: structural and 
functional determinants of electrogram morphology, 
and their relationship to fibrillatory conduction 
 
7.1 Introduction 
The contact electrogram, routinely recorded clinically form 2-4mm electrodes in contact 
with the myocardium is the signature of electrical activation and architecture of the 
underlying local myocardium. The extracellular electrogram is derived from the propagation 
patterns and morphology of composite action potentials. “Simple electrograms” arise from 
healthy myocardium. However, pathological changes can alter the electrogram morphology, 
which can render them more “complex” – these can be due to either abnormalities of 
transmembrane ion channels, changes in cell-to-cell coupling in the presence of abnormal or 
non-conductive myocardium. It has been suggested that arrhythmogenesis may involve an 
interdependence of these mechanisms. 
In the clinical arena, morphological characteristics of the contact electrogram have been 
used to guide substrate modification as part of catheter ablation of persistent AF. Regions of 
the left atrial harbouring complex fractionated atrial electrograms (CFAE) have been thought 
to represent continuous re-entry of fibrillation waves into the same area, perpetuating AF. 
These areas have been targeted as part of substrate modification, and although this strategy 
was initially widely adopted following promising clinical outcomes,11 it has recently fallen out 
of vogue due to poor reproducibility of clinical outcomes across other groups.196,332 The lack 
of understanding of the underlying pathophysiological mechanism of atrial electrogram 
fractionation in AF may in part contribute to the divergent and limited success rates of 
catheter ablation strategies targeting CFAE. 
Similarly, low voltage regions are now targeted as part of a substrate modification approach, 
with reported improved clinical success.173,333 Endocardial voltage is often used a surrogate 
marker of scar. Structural remodelling that occurs in AF is manifest as atrial fibrosis, creating 
an anatomical substrate favourable for re-entry. Slow conduction in scarred myocardium 
may be necessary for sustaining rotor activity, and localised rotational activity observed with 
multipolar endocardial mapping tends to co-localise with regions with low voltages.133  
Although attempts have been made to correlate structure with function, the direct 
relationship between characteristics of the extracellular electrogram and myocardial 
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structure and electrophysiology remain very unclear. However, what little has been inferred 
from mechanistic research provides a variety of putative structural and electrophysiological 
explanations for fractionation,223 but with many unanswered questions and apparent 
inconsistencies. An example is the general assumption that fractionation relates to fibrotic 
change and, therefore, translates to reduced electrogram voltage. However, there is a 
consistently reported inverse, and counterintuitive, relationship between voltage and 
fractionation in atria of patients with AF, consistent with our findings presented in Chapter 
4.203,334 Emerging clinical evidence for focal ablation to treat persistent AF has not yet shown 
any specific electro-architectural features to denote these sites.  
 
Electrical remodelling can occur as a result of electrical uncoupling resulting in conduction 
slowing.335,336 Gap-junctions are responsible for the electrical coupling of adjacent 
cardiomyocytes and allow for the continuous spread of electrical activity. Each gap junction 
consists of hemi-channels called connexins, with each connexin consisting of 6 connexin 
proteins.336 Alterations to gap-junction localisation and expression are well documented in 
human and animal models of cardiac arrhythmia,337 and can lead to discontinuous conduction 
and electrogram fractionation. 
Computer simulations have demonstrated that homogenous or uniform conduction via 
sodium channel blockade or cellular uncoupling reduces electrogram amplitude and prolongs 
electrogram duration but has no effect on electrogram fractionation. Conversely 
heterogeneous conduction slowing such as seen with micro-fibrosis, may cause fractionation, 
which is more synonymous with disease.338  
The underlying mechanisms for fractionation remain largely not well understood. Human 
and animal models have their limits in the degree of manipulation that can be applied. The 
justification of using in vitro methods firstly lies with the degree of manipulation which is 
possible, and secondly with the reduction in complexity such that changes can be more 
directly correlated with a single phenomenon. Cell monolayer models utilising neonatal rat 
ventricular myocytes are well established and characterised, and our laboratory has 
particular expertise in them. Although we have been able to isolated neonatal rat atrial 
myocytes, the practicalities of this process from the small atria results in small numbers of 
atrial myocytes being harvested. Conduction velocities in ex-vivo neonatal atrial and 
ventricular rat myocytes are similar, and are representative of in vivo findings. Further, 
although in vivo differences in cell shape and fiber orientation exists in atrial and ventricular 
myocytes, isolated myocytes used in monolayer preparations adopt similar rounded 
characteristics.  
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We therefore sought to investigate cellular abnormalities underlying electrogram 
fractionation and hypothesised that increased fibroblast burden and/or conduction slowing 
would result in greater fractionation and arrhythmia susceptibility in a cellular model of scar. 
We investigated the hypothesis that fibrosis induces propagation discontinuities and results 
in fractionation of the electrogram. These preparations were treated with the gap-junction 
uncoupler carbenoxolone to investigate the hypothesis that conduction slowing via gap-
junction uncoupling leads to discontinuous conduction and fractionation. Incremental pacing 
of the co-cultures was undertaken to investigate whether increased functional stress caused 
by rapid pacing is able to elicit areas of structural abnormalities not otherwise identifiable. 
The susceptibility of the preparations to arrhythmias due to the introduction of fibrosis 
and/or conduction slowing was evaluated to investigate the hypothesis that fibrosis and 
reduced conduction velocity are pro-arrhythmic.  
7.2 Methods 
7.2.1 Isolation and culture of neonatal rat ventricular myocytes (NRVM) and 
fibroblasts 
Neonatal Sprague-Dawley rat pups (post-natal day 0-2) were sedated with isofluorane then 
sacrificed by manual cervical dislocation and death was confirmed by cessation of circulation. 
This was performed in accordance to Schedule 1 within the guidelines of the EU Directive 
2010/63/EU. Sternotomy and lateral thoracotomy incisions were made and the hearts 
dissected and collected in cold calcium and magnesium free Hanks’ balanced salt solution 
(HBSS).  The ventricles were isolated from the great vessels and atria, and cut into 1-2mm3 
cubes. Samples were transferred to gentleMACS C tube along with preheated neonatal 
enzyme mix (Miltenyi Biotec GmbH). The tissue and enzyme mix was incubated without 
agitation for 15mins at 37oC, and subsequently attached to the gentleMACS dissociator for 
gentle agitation. This process if further repeated twice.   Cell culture medium with 10% 
serum was added to the cell/ enzyme mix and applied to 70µm pre-separation filter then 
centrifuged at 1000g for 5 minutes. Following supernatant aspiration, cells were re-
suspended in M199 medium (supplemented with 10% neonatal calf serum (NCS) M19910%), 
50U/ml penicillin, 0.05mg/ml streptomycin, 2mg/ml vitamin B12 and 0.68mM L-Glutamine) 
and pre-plated in T75 flasks for 1hr. Subsequent cell suspension was passed through 70µm 
pre-separation filter, to provide myocytes alone (90% myocyte count). Cells retained within 
the T75 flask consist of mesenchymal cells, primarily fibroblasts. In this study, cells obtained 
prior to pre-plating in T75 flask (pre-plate), were considered to be a ‘natural composition’ of 
cells (NC). 
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7.2.2 Fibroblast culture 
Fibroblasts obtained during pre-plating stage were cultured for later experimental use. Cells 
were cultured under an atmosphere of 1% CO2 and 99% air in M19910% medium, changed 
every 48-72 hours. Fibroblasts were allowed to proliferate until confluent and then split as 
necessary by addition of trypsin (without EDTA) for 15-20 minutes. Trypsin activity was 
blocked by trypsin inhibitor (soya bean) at a ratio of 10µL per 1 cm2 of cells. The dissociated 
cells were plated or used for experimentation.   
7.2.3 MEA Electrical recordings 
Extracellular unipolar electrogram recordings of the co-cultured NRVM and fibroblast 
monolayers were measured using a microelectrode array (MEA) system. The MEA system  
(Multichannel Systems, Reutlingen, Germany) is a system for stimulation, recording and data 
acquisition. The MEA contains 60 gold electrodes (diameter - 100µm with inter-electrode 
spacing - 700µm) arranged on an 8x8 matrix set on glass (corner electrodes removed) 
allowing simultaneous stimulation and recording (total recording area - 4.9 x 4.9mm). One 
electrode acts as an internal reference resulting in the recording of 59 unipolar electrograms. 
 
Figure 7.1 Microelectrode array (MEA) system 
The MEA contains 60 gold electrodes (diameter - 100µm with inter-electrode spacing - 
700µm) arranged on an 8x8 matrix set on glass (corner electrodes removed). 
 
Using a dissection microscope, an inert polymer (Polydimethylsiloxane-PDMS) ring was 
positioned to encircle recording electrodes. 200, 000 cells of each experimental group 
(according to trypan blue-negative cell count using a haemocytometer), suspended in 150µL 
M19910% medium, were seeded within the polymer ring which had been pre-coated with 
100µL collagen (0.2mg/ml).  Cells were left to attach for 30 minutes before polymer ring 
removal and the plate flooded with 850µL of M19910% medium. Medium was changed to 
M199 supplemented with 5% NCS 24 hours post seeding, then changed every 12-24 hours. 
Recordings were made when the cells reached their previously determined maximum 
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conduction velocity of above 20cm/s (3-4 days post-seeding) in HBSS supplemented with 
1.5mM CaCl2 and 1mM MgCl2. 
7.2.4 Model of cellular scar: co-culture of NRVM and fibroblasts 
As a model of cellular scar, co-cultures of NRVMs and fibroblasts were seeded into 4 
experimental groups: ‘myocyte only’ (MO) (after pre-plate) ‘natural composition’ (NC) of 
cells (before pre-plate) and a combination of myocytes + 20 %(+20%FB) or 40%(+40%FB) 
fibroblasts (% by cell number) after pre-plate with specific fibroblast numbers added (Table 
7.1). Fibroblasts obtained from previous NRVM isolations were mixed as appropriate with 
myocytes from fresh isolations prior to seeding onto the MEA plates. The total number of 
cells within each MEA preparation across the experimental groups was similar 
(approximately 200, 000 cells).  
Table 7.1 Co-culture of NRVM and fibroblasts: experimental groups 
Experimental group Number of NRVMs Number of fibroblasts 
Natural composition (NC) 200, 000 cell total 
Myocyte only (MO) 200, 000 0 
+20% fibroblasts (+20%FB) 160, 000 40, 000 
+40% fibroblasts (+40%FB) 120, 000 80, 000 
 
 
7.2.5 Electrical stimulation of monolayer preparations: Pacing protocol 
Stimulation was carried out using a STG stimulus generator programmed by the 
MC_Stimulus II software (version 3.4.4, MultiChannel systems MCS GmbH). Cell 
monolayers were stimulated using biphasic voltage pulses +/-1000mV for 2 ms at 2Hz, or 
just above the intrinsic rate (cycle length = 500ms)(125% of the threshold) from two to four 
extra-cellular electrodes at the edge of each array. Pacing rate was increased incrementally 
in 1Hz steps until loss of capture or fibrillation was induced. A monolayer was classed as 
fibrillating if the intrinsic cycle length was ≤250ms and ‘overdrive’ pacing was not possible. 
Plates were subsequently paced in orthogonal directions (North/South & East/West) at each 
rate. Ten second recordings of the extracellular field potentials of each electrode were 
acquired, with a sampling frequency of 25kHz using MC-Rack software (version 4.6.2 
MultiChannel systems MCS GmbH). When fibrillation was seen, a 30s recording was 
acquired to analyse fibrillation stability. 
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7.2.6 Pharmacological slowing with carbenoxolone 
If there was no fibrillation following pacing the pacing rate was returned to 2Hz, and 
incremental additions of carbenoxolone, a gap-junction uncoupler was added (10-100µM), to 
slow conduction velocity. The pacing protocol was repeated at each carbenoxolone 
concentration, unless fibrillatory activity was seen (Figure 7.1). 
 
Figure 7.2 Summary of experimental protocol 
(1) 200,000 cells from each experimental group were seeded directly onto the MEAs, 
allowing cells to stabilize and achieve confluence for 3-4 days before electrical recordings 
were made in a 2hr long experimental protocol. (II) Monolayers were stimulated 
incrementally (2-5Hz) until loss of capture from orthogonal directions. (III) Incremental 
doses of carbenoxolone were administered, with the pacing protocol repeated at each dose, 
unless fibrillatory activity ensued. 
 
7.2.7 Electrogram analysis 
Analyses of extra-cellular recordings were made using associated propriety software, MC-
rack, and data subsequently exported into MatLab (MatLab R2014b; 8.4.0.150421, The 
Mathworks Inc., Natick, MA) for measurements of specific electrogram characteristics. The 
central 36 electrodes were analysed in a semi-automated manner with the aid of an in-house 
custom written graphical user interface (GUI).  
Electrogram depolarization duration was defined as the duration of the “QRS complex” of 
the electrogram. Field potential durations (FPD), defined as the time between the most 
negative peak of depolarisation and the maximum positive peak of repolarisation, has been 
shown to correlate with action potential duration to 90% repolarisation (APD90)339. FPD 
was calculated for each electrode and averaged for each array (Figure 7.2).  
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Figure 7.3 MEA recordings, and electrogram measurements 
(Left) The output screen of a MEA recording in MC_Rack demonstrating the 60 electrodes.  
The stimulation electrodes in this example are from the top row of electrodes on the MEA, 
evident from the prominent stimulation artifact. (Right) A representative example of the 
extracellular unipolar electrogram with illustration of the measurements of the electrogram 
depolarization (QRS complex) duration, amplitude and field potential duration (FPD). NB: In 
this example, Electrode 15 was utilized as the reference (or indifferent) electrode. 
 
Electrograms were considered fractionated if they contained one or more peaks ≥25% of 
the amplitude of the primary deflection (Figure 7.3). The electrogram fractionation index (FI) 
was calculated as an average number of peaks (considered significant if only ≥25% of the 
amplitude of the primary deflection) at each electrode. Global fractionation burden of plate 
was measured as the number of fractionated electrograms as a proportion of the total 
number of electrograms recorded, i.e. number of fractionated electrograms/total number of 
electrograms*100).  
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Figure 7.4 Classification of fractionated electrograms  
Electrograms were classified as fractionated if they contained one or more peaks ≥25% of 
the amplitude of the primary deflection, i.e. amplitude of secondary deflection/amplitude of 
primary deflection*100 ≥25%.  
 
7.2.8 Measurement of conduction velocity across each MEA 
The calculation of conduction velocity with the acquired MEA data and the generation of 
isochronal maps for the demonstration of wave propagation were implemented in a custom 
in-house MatLab code, and the analysis performed off-line using Matlab software package 
(MatLab R2014b; 8.4.0.150421, The Mathworks Inc., Natick, MA). The conduction velocity 
across each array was calculated using electrode activation times (maximum-dV/dt) at each 
electrode, and its neighbouring four electrodes (N: S/E: W) to create conduction vectors, 
identifying the direction of wavefront propagation as described by Salama et al.305 (Figure 7.4) 
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Figure 7.5 Conduction velocity measurement across MEA 
(Left) The MEA is arranged in a series of grids with stable inter-electrode distance. Hence, 
the calculation of the average conduction velocity can be performed using the activation 
time of each electrode and its neighbours. (Right) Isochronal activation map for the 
demonstration of wavefront propagation. 
  
7.2.9 Fibroblast and myocyte immuno-labelling 
Following electrical recordings monolayers were fixed and permeabilised with methanol pre-
cooled at -20°C. Preparations were washed in phosphate buffered solution (PBS) and 
blocked with 5% horse serum (HS) for 30 minutes at room temperature. Preparations were 
incubated for four hours at room temperature with primary antibody Vimentin (Invitrogen-
PA1-16759, ThermoFisher Scientific Massachusetts, USA) against fibroblast (raised in 
chicken) and α-actinin (A7811-.2ml SIGMA-Aldrich, Missouri, USA) against myocyte (raised 
in mouse) at 1:5000 and 1:1000 dilutions in 5% HS block respectively. Following three 
washes in PBS, the MEA plates were incubated for one hour with fluorescent goat anti-
chicken 568 IgG antibody (Alexa Fluor 568-ThermoFisher Scientific, Massachusetts, USA) 
and donkey anti-mouse 488 IgG (Alexa Fluor 488-ThermoFisher Scientific, Massachusetts, 
USA) antibody at 1:400 dilution in 5% HS block at room temperature. After washing three 
times in PBS, the slides were mounted in Vectashield (Vector Labs) with DAPI nuclear stain, 
cover-slip mounted, and stored at 4°C in the dark to preserve fluorescence (Figure 7.6).  
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Figure 7.6 Fibroblast and myocyte immuno-labelling 
Florescence microscopy of co-cultured neonatal rat ventricular myocytes (NRVMs) with 
fibroblasts. (A) Vimentin staining of fibroblasts in red, (B) α-actinin staining of NRVMs in 
green, (C) DAPI nuclear staining of all nuclei in blue, and (D) overlaid images of immuno-
labelled fibroblasts and NRVM, with DAPI nuclear staining.  
 
7.2.10 Quantification of fibroblasts 
Images of immune-labelled cell monolayers were acquired using a ZeissAxioVert200M, at 
10X magnification. Using ZEN software, 25 individual images covering entire array area were 
acquired and stitched together to form a single image (Figure 7.7). The Facility for Imaging by 
Light Microscopy (FILM) at Imperial College London is part supported by funding from the 
Wellcome Trust (Grant P49828) and BBSRC (Grant P48528).  
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Figure 7.7 Immuno-staining for fibroblasts in quantification of fibrosis 
MEA plates immunostained for vimentin following electrical recordings to accurately quantify 
fibroblast burden. This is a representative of the different burdens of fibroblast in each 
experimental group, the red representing the vimentin staining of fibroblasts.  
 
Fibroblast coverage was quantified using FIJI (FIJI is Just ImageJ, NIH. Observers were blinded 
to the groups and the fluorescence threshold was adjusted subjectively to binarise regions 
into red, and non-red which allowed quantification of fibroblast coverage in each MEA 
preparation. Electrode tracks were removed from image during analysis (due to auto-
fluorescence affecting quantification) and percentage of fibroblast coverage of subsequent 
area (i.e. MEA – electrode tracks) was then calculated.  
Additionally, individual electrode surfaces were segmented using a custom made macro on 
FIJI, and the area over each individual electrode covered by fibroblasts was quantified (Figure 
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7.8).  Myocyte and nuclear fluorescence were analysed qualitatively for even cell coverage 
across each MEA.  
 
Figure 7.8 Area of coverage of fibroblasts per electrode 
This image represents the 60 electrodes on a single MEA plate. Each circle represents one 
electrode, with the red area representing vimentin stain of fibroblasts. The area of coverage 
by fibroblasts over each electrode was quantified. 
 
7.2.11 Statistical analyses 
All data is presented as mean±SEM. A one-way ANOVA with Bonferoni post-test analysis 
was used unless otherwise stated. A value of p<0.05 was considered significant (*=p<0.05, ** 
=p<0.01, ***= p<0.001). NS denotes no significance. 
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7.3 Results 
7.3.1 Quantification of fibroblast burden 
Quantitative comparisons were made between each experimental group with fibroblast 
burden measured as a percentage of each MEA covered by fibroblasts (Figure 7.9). Fibroblast 
burden was significantly higher in both the +20%FB (13.7±0.5%) and +40%FB (20.7±4.5%) 
groups compared to MO (5.5±0.8%). Similarly, fibroblast burdens were significantly higher in 
the +40%FB compared to +20%FB co-cultured cell monolayer preparations. Although no 
significant differences were observed between MO and NC (10.2±0.9%), or NC and +20%FB 
preparations, they trended towards an increase in each group (p=0.06 and p=0.07 
respectively).  
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Figure 7.9 Fibroblast burden in various preparations 
Quantification of fibroblast burden in each experimental group as a percentage of total area 
of MEA plate covered by fibroblasts. Myocyte only (MO) (n=5), Natural Composition (NC) 
(n=4), +20%FB (n=3), +40%FB (n=4). (**=p<0.01, ***= p<0.001, NS denotes no significance) 
   
 
The quantification of fibroblast burden was only carried out for a sub-group of preparations. 
However due to the small standard-deviation (SD) for each group, we assumed a similar 
trend throughout and as such, the preparations remained grouped as MO, NC, +20%FB and 
+40%FB for subsequent analyses.  
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7.3.2 Global fibroblast burden (MEA plate) and electrogram morphology 
7.3.2.1 Electrogram fractionation 
The proportion of fractionated electrograms within each plate was expressed as a 
percentage of the total number of electrograms (Figure 7.10). Each group was further 
categorised into fractionated >2 peaks, and fractionation ≤2 peaks as a marker of the degree 
of fractionation. A significant increase in fractionation was seen between +40%FB vs. MO 
(35.34±5.31% vs. 8.00±4.78%; p<0.01) and +40%FB vs. +20%FB (35.34±5.31% vs. 6.99 
±2.52%; p<0.05). No significant difference was observed between the NC preparations 
(13.35± 5.7%) and any of the other groups apart from that with +40%FB (35.34±5.31%; 
p<0.05).  
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Figure 7.10 Extent of fractionation in each monolayer preparation 
Percentage of fractionated electrograms on each MEA preparation, subdivided to illustrate 
degree of fractionation (number of peaks) MO (n=5), Natural Composition (N=3), +20%FB 
(N=3), +40%FB (N=5). (*=p<0.05, ** =p<0.01) 
 
 
7.3.2.2 Electrogram amplitude 
There was no significant difference was seen in mean electrogram amplitudes across all the 
electrodes of each individual MEA between the various groups (MO: 1202±65µV, NC: 
1395± 84µV, +20%FB: 1016±100µV, +40% FB: 1289±99µV)(Figure 7.11).  
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7.3.2.3 Conduction velocity anisotropy 
Conduction velocity anisotropy was measured as the percentage difference in average 
conduction velocity (across each MEA plate) when the monolayers were paced from two 
orthogonal directions. There was no observed significant difference between any groups 
(MO: 1.731±1.15m/s, NC: 1.11±1.84m/s, 40%FB: 1.03±1.97m/s; p=NS) (Figure 7.11). 
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Figure 7.11 Amplitude and conduction velocity anisotropy across cell 
preparations 
(Left) Average electrogram amplitude in each monolayer preparation - MO (n=168), NC 
(n=123), +20%FB (n= 103), +40%FB (n=173). (Right) Percentage difference in conduction 
velocity when paced in orthogonal directions in each group - MO (n=36), NC (n=16), 
+40%FB (n=9). Both indices did not show any significant differences across all monolayer 
preparations. (NS denotes no significance) 
 
 
7.3.3 Local fibroblast burden (electrode) and electrogram morphology  
The proportion of individual electrodes covered by fibroblasts was determined as described. 
Classification by pre-determined experimental group was blinded, and electrogram 
morphology was characterised based solely on individual electrode fibroblast coverage and 
categorised into low (0-20%), medium (20-50%) and high (>50%) burden in accordance to 
the percentage of the total surface area of each electrode occupied by fibroblasts. The total 
numbers of electrodes with low, medium and high burden of fibroblasts were 91, 194 and 
111 respectively, i.e. low: 0-20% (N=91), medium: 20-50% (n=194), high: >50% (n=111).  
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7.3.3.1 Electrogram fractionation 
Fractionation was assessed as a fractionation index (FI)(average number of peaks on each 
electrode). Electrodes with high fibroblast burden (1.36±0.06 peaks) had a significantly larger 
FI than compared to those with medium fibroblast burden (1.15±0.03 peaks); p <0.001, and 
low fibroblast burdens (1.14±0.04); p<0.01 (Figure 7.12). 
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Figure 7.12 Electrogram fractionation and fibroblast burden per electrode 
Electrograms were more fractionated over electrodes with a higher degree of fibroblast 
burden, measured as the percentage area of electrode covered by fibroblasts. Lo: 1.14±0.04 
peaks (n=91); Med: 1.15±0.03 peaks (n=194) and Hi: 1.36±0.06 peaks (n=111).  
(***= p<0.001, NS denotes no significance) 
 
 
7.3.3.2 Electrogram amplitude 
A trend for lower amplitude electrograms on electrodes with higher fibroblast burdens was 
observed, but this did not reach statistical significance (Low: 1502±147µV, Medium: 1504± 
93µV, High 1374±115µV, p=ns) (Figure 7.13). 
7.3.3.3 Electrogram duration 
The electrogram durations were statistically significantly longer with higher burden of 
fibroblasts over the electrodes (Low: 0.0071±0.0004s, Medium: 0.008640±0.0003s and High: 
0.01014±0.0006s) (Figure 7.13). 
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Figure 7.13 Electrogram amplitude and duration, and fibroblast burden 
over each electrode 
(Left) No significant difference was seen in the amplitude of electrograms across all 3 
burdens of fibroblasts over each electrode. (Right) Higher burden of fibroblasts over each 
electrode resulted in longer duration of electrograms. (*** =p<0.01, ***= p<0.001, NS 
denotes no significance) 
 
 
7.3.4 Pacing rate and electrogram morphology 
As no significant difference in electrogram morphologies were observed between the MO, 
NC and +20%FB monolayer preparations during incremental pacing in preliminary 
comparisons, all subsequent analysis were performed involving only the MO and +40%FB 
groups. Paired T-tests were performed on MEA plates paced at different rates. Paired two-
way Anovas were then performed to elicit overall differences between the 2 groups.   
7.3.4.1 Plate fractionation  
The extent of fractionation across each MEA plate was compared during low (2Hz, i.e. cycle 
length 500ms) and high (4Hz, i.e. cycle length 250ms) rate pacing. There was no significant 
difference in the percentage of fractionated electrograms with increased pacing rate in MO 
group (2Hz: 8.04±3.40% vs. 4Hz: 8.01±4.78%), however higher pacing rates in +40%FB 
group elicited a significant increase in plate fractionation (2Hz: 31.18± 5.07% vs. 4Hz: 
35.34±5.31%) p<0.05. There was a significantly increased plate fractionation at both low and 
high pacing rates in the +40%FB group compared to the MO preparations (2Hz pacing MO: 
8.04±3.40% vs. +40%FB: 31.18± 5.07%, and 4Hz pacing MO: 8.01±4.78% vs. +40%FB: 
35.34±5.31%; p<0.001)(Figure 7.14). 
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Figure 7.14 Plate fractionation and pacing 
The extent of fractionated electrograms across the MEA plates increased at high rate pacing 
in the +40%FB preparation only. However, there was higher extent of fractionated 
electrograms in the +40%FB preparations (n=4) at both high and low rate pacing, when 
compared to the MO (n=8) preparations. (*=p<0.05, ***= p<0.001, NS denotes no 
significance) 
 
 
7.3.4.2 Electrogram amplitude 
There was no significant difference in electrogram amplitude during high rate pacing in both 
MO (2Hz: 1178±61.75µV, 4Hz: 1202±65.39µV) and +40%FB (2Hz: 1349±123.4µV, 4Hz: 
1418±116.3µV) preparations. Electrograms in the +40%FB preparations had significantly 
higher amplitudes compared to those in the MO preparations at both high and low pacing 
rates (p<0.05) (Figure 7.13). 
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Figure 7.15 Electrogram amplitude and pacing 
No significant difference was observed with higher rate pacing in both the MO and +40%FB 
preparations, but electrogram amplitudes were higher in the +40%FB preparations at both 
low and high rate pacing compared to MO preparations. (*=p<0.05, NS denotes no 
significance) 
 
 
7.3.4.3 Electrogram field potential duration 
Assessment of FPD showed significantly shorter durations with increased pacing rates, in 
both the MO (2Hz: 71.9±32ms vs. 4Hz: 55.6±0.17ms; p<0.001) and +40%FB preparations 
(2Hz: 63.3±2.77ms vs. 4Hz: 49±2.30ms; p<0.001). Two-way Anova testing demonstrated 
that the FPD was significantly shorter in the +40%FB compared to MO monolayer 
preparations at each pacing rate (p<0.01)(Figure 7.14). 
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Figure 7.16 Electrogram field potential duration and pacing 
Electrogram FPD shortened with pacing rates in both MO and +40%FB monolayer 
preparations, and FDPs in +40%FB were significantly shorter than in MO groups at both low 
and high rate pacing. (** =p<0.01, ***= p<0.001) 
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7.3.4.4 Electrogram depolarization duration and pacing 
Electrogram duration, in both MO and +40%FB monolayer preparations were increased 
faster pacing rates, although was only statistically significant in the +40%FB group (2Hz: 
0.007±0.0004ms vs. 4Hz: 0.01±0.0006ms; p<0.001). Electrograms were significantly longer in 
duration in the +40%FB group (2Hz: 0.007±0.0004ms and 4Hz: 0.01±0.0006ms), compared 
to the MO group (2Hz: 0.0068±0.0003ms and 4Hz: 0.0077±0.00035ms), at both low and 
high rate pacing (Figure 7.15).  
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Figure 7.17 Electrogram duration and pacing 
Faster pacing rates resulted in increased electrogram durations in both MO and +40%FB 
monolayer preparations, and electrogram durations were longer in +40%FB groups 
compared to MO groups, at both low and high rate pacing. (***= p<0.001, NS denotes no 
significance) 
 
 
7.3.4.5 Conduction velocity restitution 
Average conduction velocity across the MEA was calculated during pacing at progressively 
shorter cycle lengths (CL) to determine conduction velocity restitution (500 to 250ms). 
Significant conduction slowing was observed at progressively shorter cycle lengths when the 
MO and +40%FB preparations were grouped. A trend for lower conduction velocity was 
seen in +40%FB (CL200ms: 27.30±1.74ms, CL250ms: 28.59±1.07ms, CL333ms: 
31.67±0.98ms, CL500ms: 31.43±0.78ms) compared to MO at each pacing rate MO 
(CL200ms: 33.76±1.41ms, CL250ms: 35.09 ±2.07ms, CL333ms: 34.99±2.11ms, CL500ms: 
35.53±1.93ms, although statistical significance was not reached (Figure 7.13). 
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Figure 7.18 Conduction velocity restitution 
Average conduction velocity across MEA when paced at progressively shorter cycle lengths 
in both the MO (n=8) and +40%FB (n=4) preparations. (***= p<0.001, NS denotes no 
significance) 
 
 
7.3.5 Effect of gap-junction uncoupling (carbenoxolone) on electrogram 
morphology 
Analysis of electrogram morphology was performed on preparations treated with 50µM 
carbenoxolone (CBX) compared to that at baseline (unpublished data have demonstrated 
conduction slowing, but not block at this concentration of carbenoxolone). 
7.3.5.1 Electrogram fractionation 
There was a significant increase in the electrogram fractionation index with the addition of 
carbenoxolone, both in MO (Baseline: 1.14±0.047 vs. CBX: 1.53±0.08; p<0.001) and 
+40%FB MEA preparations (Baseline: 1.629±0.10 vs. CBX: 2.08±0.12; p<0.001).  There was 
a significantly higher fractionation index in the +40%FB compared to the MO groups, 
with/without the treatment of carbenoxolone (Figure 7.17).  
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Figure 7.19 Effect on CBX on electrogram fractionation 
CBX, in both MO (n=91) and +40%FB (n=62) MEA preparations, resulted in increased 
electrogram fractionation. There was also a higher degree of fractionation in the +40%FB 
compared to the MO groups with/without CBX treatment. (***= p<0.001) 
 
 
7.3.5.2 Electrogram amplitude and depolarization duration 
Electrogram amplitude significantly reduced on carbenoxolone administration in both MO 
(Baseline: 1113±100.5µV vs. CBX: 308.7±36.64µV; p<0.001) and +40%FB groups (Baseline: 
2242±233.6µV vs. CBX: 288.6±35.28µV). Electrogram duration was significantly lengthened 
by 50uM carbenoxolone administration in the MO preparations (Baseline: 6.87±0.35ms vs. 
CBX: 12.13±0.32ms). However no significant difference was seen in +40% FB group 
(Baseline: 9.00±0.57ms vs. CBX: 10.89± 0.88 ms) (Figure 7.18). 
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Figure 7.20 Effect of CBX on electrogram amplitude and duration 
CBX, in both MO (n=98) and +40%FB (n=68) preparations resulted in a statistically 
significant decrease in electrogram amplitude (Left), and prolongation of the electrogram 
(Right), although this did not reach statistical significance during pacing at 4Hz. (*=p<0.05, 
***= p<0.001, NS denotes no significance) 
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7.3.6 Effect of carbenoxolone on conduction velocity 
There was significant decrease in conduction velocity in both the MO (33.2±1.3 mm/s to 
8.36 ±0.86 mm/s p<0.001) and +40% FB preparations (29.00 ±2.7mm/s to 7.43 ±3.05mm/s 
p<0.001).  No significant difference was observed in conduction velocities between MO and 
+40%FB preparations, at both baseline and with carbenoxolone (Figure 7.19). 
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Figure 7.21 Effect of CBX on conduction velocity 
Conduction velocities in both the MO (n=3) and +40%FB (n=3) preparations decreased 
significantly with CBX administration during 4Hz pacing. (***= p<0.001, NS denotes no 
significance) 
  
 
7.3.7 Effect of fibroblasts and carbenoxolone on propensity to fibrillation 
Out of 18 plates (MO n=5, NC n=4, +20%FB n=4 and +40%FB n=5), only 6 plates fibrillatory 
activity. Figure 8b demonstrates after which point during the pacing and carbenoxolone 
treatment protocols each MEA preparation began to demonstrate fibrillatory activity. No 
plates fibrillated with increased pacing rate without gap-junction uncoupling (no CBX). Only 
1 out of 4 +20%FB plates, fibrillated with 10µM carbenoxolone, while the remaining 3 plates 
did not fibrillate, even at the maximum carbenoxolone concentration of 100µM. 2 out of 5 
+40FB% plates fibrillated with 10µM of carbenoxolone, with the remaining 3 plates 
fibrillating at the maximum carbenoxolone concentration of 100µM. None of the MO or NC 
preparations fibrillated at any point.   
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Figure 7.22 Fibrillatory activity with increasing conduction slowing with 
CBX 
Proportion of MEA plates free of fibrillatory activity after incremental conduction slowing 
with increasing doses of carbenoxolone. Myocyte only (n=8), NC (n=7), +20%FB (n=4) and 
40%FB (n=5).  
 
7.3.8 Fibrillatory activity and baseline electrogram fractionation and amplitude 
Retrospective analysis of baseline pacing data in the MEA plates with and without fibrillatory 
activity was performed. MEA plates which fibrillated (n=6) showed significantly higher 
baseline fractionation compared to MEA plates which did not fibrillate (n=11) (30.49±6.51% 
vs. 9.83 ±2.97 %; p<0.001). There was also a higher proportion of low voltage electrograms 
(≤25% of the maximum amplitude within respective MEA plates) at baseline in MEA plates 
that fibrillated compared to those which did not (26.28 ± 5.17% vs. 48.5 ± 8.76 %; p <0.05) 
(Figure 7.20). 
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Figure 7.23 Electrogram fractionation and voltage, and fibrillatory activity 
There was a higher proportion of fractionated and low voltage electrograms in MEA 
preparations which demonstrated fibrillatory activity (n=6) as compared to those with no 
fibrillatory activity (n=11). Electrograms were classified as low voltage if it is <25% of the 
maximum amplitude was observed in the same array. (***= p<0.001) 
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7.4 Discussion 
We sought to investigate how fibroblasts and/or conduction slowing affects electrogram 
morphology and susceptibility to arrhythmia in a 2D cellular model of scar. Increased fibrotic 
burden led to greater electrogram fractionation without changes to its amplitude. Increased 
fibroblast burden reduced FPD. High rate pacing caused increased fractionation in plates 
with increased fibroblast burden, but not in myocyte only plates. Carbenoxolone both 
slowed conduction down and increased electrogram fractionation. Increased fibroblast 
burden with conduction slowing increased the likelihood of observing fibrillatory conduction.   
Fibrillating plates demonstrated more fractionation and low voltage electrograms at baseline. 
7.4.1 Effect of fibroblasts 
This model confirms the hypothesis that greater fibroblast burden increases electrogram 
fractionation, with a higher proportion of fractionation seen in the +40%FB group compared 
to all other experimental groups. Similar results were seen both at both the global MEA and 
electrode level. Computational models of fibrosis have demonstrated similar findings, 
revealing discontinuous conduction and electrogram fractionation.128 Jaquemet et al 
introduced microfibrosis via collagenous septa (30 to 945 µM size) in a computation model 
of a cardiac monolayer demonstrating that increased septal length increased fractionation.340 
Our model suggests that increasing the global burden of fibroblasts, intermingled amongst 
myocytes, is sufficient for increased fractionation. Similar to Jaquemet, fractionation in our 
model is also likely to be a result of discontinuous propagation, tortuous conduction paths, 
and conduction delays across electrodes, as a result of the more heterogeneous substrate in 
the co-cultured monolayer preparations.  
Of note, no increase in electrogram fractionation was seen in any of the other groups 
compared to myocyte only, suggesting insufficient structural abnormalities to result in 
discontinuous conduction, suggesting a dose-dependent or a threshold effect of the burden 
on fibroblasts. The lack of fractionation in the NC MEA monolayer preparations was 
expected. NRVM’s isolated from control animals (pre-plate) are unlikely to contain 
pathological fibrosis, so although they may have a higher fibroblast composition compared to 
myocytes alone, if recoupled sufficiently, conduction would be expected to be relatively 
homogenous. There was no difference in the +20%FB group compared to NC group, both in 
terms of fractionation, and fibroblast area. This suggests that presence of the indigenous 
fibroblast population in the NC MEA monolayer preparations (~20% fibroblasts) were 
insufficient to lead to abnormal conduction and electrogram fractionation. 
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Conduction velocity anisotropy was not seen in any groups confirming the absence of either 
longitudinal or transverse orientations of myocytes in the monolayer preparations. Spach et 
al demonstrated heterogeneity of conduction velocity in canine cardiac muscle when muscle 
fibers were paced longitudinally compared to when paced transversely. This is primarily due 
to the anisotropic shape of myocardial cells, with preferential low resistance gap-junction 
distribution at intercalated disks in the longitudinal aspect,229,341 resulting in faster 
propagation in this direction. Neonatal cells in cultures (and monolayer preparations) adopt 
a circular configuration, and have a more even gap-junctional distribution around its 
circumference,342,343 and therefore will inherently have less conduction anisotropy. Fibrosis 
modelled by collagenous septa between myocardial bundles would also result in great 
conduction anisotropy as a result of more discontinuous conduction in the transverse 
direction.340 
Contrary to our hypothesis, increased burden of fibroblasts demonstrated no difference in 
electrode amplitude when compared to the MO group. This contradicts the observations in 
our in vivo clinical findings  (Chapters 4 and 5) which suggest an inverse relationship 
between endocardial voltage, during both pacing and AF, and the degree fibrosis, as 
determined by late gadolinium enhancement CMRI.266 This model of fibrosis being due to 
fibroblasts only could explain this discrepancy. This cellular model of scar does not mimic 
tissue fibrosis in vivo, where fibrotic tissue is characterised by both an increase in 
extracellular matrix (ECM), e.g. collagen, surrounding myocytes, as well as an increase in the 
fibroblasts content.344 It is possible that increased acellular ECM in the form of collagen 
deposition is the principle reason for low amplitude electrograms. The area under the 
electrogram represents total ion exchange,223 therefore, fewer cells where ion exchange 
occurs,  co-localised to an electrode may result in a lower electrogram amplitude. This is 
supported by our clinical data, where endocardial voltages were lower in regions of the left 
atrium with “dense scar” as determined by LGE-CMRI, as apposed to regions of “patchy” 
and “healthy” regions. These findings have also been observed by Jadidi et al utilising AF 
voltage only.203  
The lack of change in electrogram amplitude with increased fibroblast burdens in this cellular 
model of scar may be attributable to two factors. Firstly, it has been noted that the role of 
fibroblasts in cardiac electrophysiology extends beyond that of acting as passive electrical 
insulators.301,344 Fibroblasts could electrotonically contribute to the electrogram by 
fibroblasts and myocyte coupling and hence contribute to the extracellular electrogram 
amplitude by virtue of its ion flux. Secondly, diffuse seeding of the fibroblasts in the 
homogenously seeded NRVM monolayer, may mean sufficient myocytes are present on each 
electrode, despite the increased fibroblast concentration, to maintain electrogram amplitude. 
 280 
The latter explanation would appear more likely, as individual electrode analyses 
demonstrated a trend to reduced electrogram amplitude when there was a greater area of 
the electrode covered by fibroblast i.e. fewer myocytes, although this did not achieve 
statistical significance. 
The field potential duration (FPD), a surrogate of action potential duration (APD) to 90% 
restitution (APD90)339 was used to evaluate the relationship between electrogram 
fractionation and cellular ion exchange. FPD was shorter in +40%FB groups, compared to 
the MO monolayer preparations, suggesting the coupling of fibroblasts and myocytes leading 
to faster repolarisation. Isolated fibroblasts can form functional gap-junctional channels in 
vitro344,345, leading to entrainment of rhythm between two myocytes only connected by 
fibroblasts over 300 µm in distance.300 Heterogeneous coupling of fibroblasts to myocytes 
may lead to APD dispersion. The separation by fibroblasts may also lead to enhancement of 
the natural variability in APDs in myocytes as a result of reduced coupling. These 
phenomena can act as a substrate for heterogeneous conduction, which promotes functional 
conduction blocks and abnormal wave propagation,346 which may manifest as electrogram 
fractionation.  
Increased electrogram fractionation was observed in the +40%FB cell monolayer 
preparations at higher pacing rates, but this was not seen in the MO group. In line with 
previous studies,112,347,348 conduction restitution was seen at faster rates, with significant FPD 
shortening. Functional stress and conduction slowing as elicited by high rate pacing, has been 
shown clinically to identify areas of structurally abnormal tissue, when structural 
abnormalities alone may not be sufficient for identification by baseline electrogram 
morphology.349 The greater heterogeneity of the fibroblast monolayers (+40%FB) may have 
led to conduction slowing induced by fast pacing, exaggerating an already disordered wave-
front leading to greater fractionation. Conversely conduction slowing of the homogenous 
wavefront in the myocyte only monolayer (MO), was insufficient to induce abnormal 
propagation, and hence electrogram fractionation.  
7.4.2 Effect of conduction slowing via gap-junction uncoupling 
Conduction slowing via gap-junction uncoupling with carbenoxolone resulted in concomitant 
increase in electrogram fractionation in not only on the +40%FB, but also in the MO 
monolayer preparations. This observation demonstrates that slowing conduction velocity via 
gap-junctional uncoupling alone, without underlying structural abnormalities (“fibrosis”) is 
sufficient for electrogram fractionation. However, computational models slowing conduction 
via uniform cellular uncoupling, prolongs electrograms and reduces amplitude, but did not 
lead to increased fractionation.340 We have previously demonstrated that in our in vitro 
 281 
model, carbenoxolone mediated GJ-uncoupling was not homogenous as in computer 
simulations, therefore may have led to a more discontinuous wavefront of propagation and 
subsequent electrogram fractionation. We also observed that sufficient cellular uncoupling, 
may lead to individual cellular action potentials contributing independently to the overall 
extracellular electrogram, creating fractionation. The reduction in electrogram amplitude 
and trend to prolonged electrogram duration, were likely as a result of the slower 
wavefront activation crossing the electrodes.  
In addition, the higher degree of electrogram fractionation with 50µM carbenoxolone in the 
+40%FB preparations compared to the MO group, confirms that a combination of “fibrosis” 
and conduction slowing leads to electrogram fractionation in a cumulative manner. The 
structural abnormalities due to increased fibroblast burden are likely to have been 
exaggerated by the conduction slowing, similar to that observed during higher pacing rates, 
resulting in greater electrogram fractionation. This demonstrates how functional and/or 
structural abnormalities can cumulatively affect the extra-cellular electrogram and result in 
increased electrogram fractionation.  
7.4.3 Increased fibroblast burden and/or conduction velocity slowing and 
propensity to arrhythmogenesis 
As predicted combination of increased fibrotic burden in addition to conduction slowing was 
arrhythmogenic, as measured by the number of plates with fibrillatory activity. A 
combination of structural and functional factors may have increased arrhythmia susceptibility. 
Structurally, increased fibroblast burden provided a greater anatomical substrate which 
could act passively to obstruct propagating wavefronts, promoting-re-entry, or providing 
anchorage sites for rotor formation, but also via electrotonic myocyte-fibroblasts 
interactions affecting myocyte excitability.300  
Notably, no plates fibrillated without conduction slowing regardless of fibroblast burden, 
demonstrating the need for an excitable gap [Path length>Wavelength (CV X ARP)] to allow 
re-entry to be sustained. Bian and Tung demonstrated re-entry was readily inducible in 
NRVMs when structural heterogeneity was created in a ‘zig-zag’ pattern as first described by 
Spach at el in healed infarct models, demonstrating structural abnormalities may manifest as 
arrhythmias.350   
In addition to structural heterogeneities, functional changes resulting from introducing 
fibroblast to the myocyte population must be considered. Fibroblasts have a less negative 
resting membrane potential than myocytes, and lack the depolarising voltage gated Na+ or 
Ca2+ channels, therefore may act as a current sink and affect myocyte excitability.344 The 
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+40%FB group had a shorter APD. This may be a result of the fibroblast resting membrane 
potential causing a faster repolarisation to reach threshold for myocyte excitation. This 
shorter APD may promote re-entry. Computational models suggest the resting membrane 
potential of fibroblasts may increase mono-layer automaticity, by causing a depolarising leak 
of current from myocytes to fibroblasts.301 Arrhythmias may have been easier to induce, due 
to the monolayer being held at a resting membrane potential closer to the Na+ channel 
activation threshold.  
As was “fibrosis” alone was not sufficient to results in fibrillatory activity, conduction slowing 
along via gap-junction uncoupling, in our model, was insufficient to lead to fibrillation. The 
small area of the mono-layer (4900 m X 4900 m), in addition to the rapid conduction 
velocities of NRVMs (~50cm/s), could mean that conduction slowing via carbenoxolone was 
insufficient to provide a long enough wavelength to allow for re-entry to occur. While 
conduction velocity was not slower in the fibroblast group, the additional heterogeneities 
introduced provided an additional arrhythmogenic substrate.  
Retrospective observation of baseline paced data fibrillating against that of non-fibrillating 
plates showed a higher degree of fractionation and proportion of low amplitude 
electrograms. This suggests baseline paced data can be used to identify MEA preparations 
which were more likely to develop fibrillatory activity with rapid pacing.  
7.5 Limitations  
However it is necessary to remember that in vitro models do represent a simplification and 
their limitations must be kept in mind. Protein expression and biophysics may be different 
between in vivo and in vitro models, leading to different biochemistry and physiology. 
Nevertheless, it is still useful to take advantage of in vitro models and compare with in vivo 
animal models and humans, which we have done here.  
The use of neonatal rat ventricular, as apposed to atrial, myocytes was as a result of 
practical issues surrounding harvesting of adequate numbers of cells requiring for the plating 
of MEAs for experimentation. Although electrophysiological characteristics such as 
conduction velocities are similar, there remain differences in ion channel expression in atrial 
and ventricular myocytes which need to be taken into consideration when extrapolating our 
findings to atrial fibrillation. The use of fibroblasts as a model for fibrosis does not take into 
account the influence of the extracellular matrix and collagen deposition. However it does 
provide information of the effect of structural heterogeneities on wave propagation and 
electrogram morphology. With immuno-staining, it was evident that the fibroblasts may 
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situate themselves on top or beneath the myocytes, suggesting that our preparations were 
not a monolayer in certain areas.  
This model does not consider the effect of the 3D complex architecture and physiological 
stressors that are seen in animal or human myocardium. Point stimulation is likely to have 
created a concave wave front of propagation. Wave front curvature can create areas of 
source-sink mismatch and slowing of conduction velocity.301,351 We have demonstrated that 
conduction velocity affects electrogram morphology and therefore this may have affected 
the degree of fractionation seen.   
7.6 Conclusion 
In this 2D cell model of fibrosis, we found that increased structural abnormalities in the form 
of higher fibroblast burdens, and increased functional abnormalities in the form of 
conduction slowing and cellular uncoupling with CBZ, lead to increased electrogram 
fractionation and are pro-arrhythmic. These findings suggest that baseline levels of 
fractionation in sinus/paced rhythm may be used to identify tissue at greater risk of 
arrhythmia. 
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8 Conclusions and future work 
 
8.1 Summary of key findings 
The manner in which the underlying structural topology of the atrial myocardium affects its 
electrophysiology is crucial in understanding the mechanisms of the persistence of AF. In this 
thesis, we studied how fibrotic change in the atrium results in changes in routinely utilized 
electrophysiologic metrics, with the use of late-gadolinium enhanced cardiac magnetic 
resonance imaging (LGE-CMRI).  
The use of LGE-CMRI to visualise left atrial structural remodelling in the form of fibrotic 
change is a relatively new imaging modality, initially used to study ablative scar following 
catheter ablation, and more recently, de novo fibrosis to understand how such structural 
remodelling relates to the AF phenotype, affect clinical outcomes following catheter ablation 
and guide catheter ablation of persistent AF. There has been little systematic investigational 
work on its influence on basic atrial myocardial electrophysiology.  
This technique is plagued by its limitations of resolution, reproducibility and the lack of 
histomorphological validation in humans, compounded by the non-uniformity of MRI 
sequences across centres and more importantly, post-processing algorithms and scar-
thresholding, which can result in significant changes in the distributions of left atrial 
enhancements as a result of their inaccurate detection and assignment. Using techniques 
which we have utilized in visualizing the more apparent post-ablative scar, we have adjusted 
and optimised post-processing algorithms to ensure accurate visualisation of de novo intrinsic 
left atrial fibrosis in patients with persistent AF. Atrial segmentation using the late-gadolinium 
imaging sequences minimised registration errors allowing more accurate representation of 
left atrial enhancements, and exclusion of extra-cardiac enhancing structures. As an indirect 
form of validation of our technique, the extent of left atrial enhancements in patients in 
persistent AF correlates to well-accepted clinical parameters which promote structural 
remodelling such as the CHADS2 score, left atrial dimensions and persistence of AF. The 
distribution of late-gadolinium enhancements also corroborates to that observed by other 
centres (independent findings utilising a variety of LGE-CMRI methodologies) – a 
predilection of fibrosis on the posterior wall which has been thought to be an important 
arrhythmogenic site.  
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Despite these optimistic findings, LGE-CMRI remains a complex imaging modality, with due 
diligence required in laborious post-processing steps required to ensure accurate 
representation of left atrial scar. This continues to hamper its routine clinical use outside 
specialist centres.  
We subsequently investigated the electrophysiologic changes associated with late-gadolinium 
atrial enhancements. Utilising a novel correlative assessment of structure (fibrosis in the 
form of atrial enhancement) and function (electrophysiology) with the Kernel as a unit of 
measure to overcome limitations of resolution of LGE-CMRI and electroanatomic mapping, 
and registrations errors, electrophysiologic changes consistent with fibrosis were observed 
with reduced endocardial voltage (during the paced-rhythm and AF) and conduction 
velocities in left atrial regions with atrial enhancements. Counter-intuitively, we observed an 
inverse relationship of late-gadolinium enhancement to electrogram fractionation in AF 
suggesting and re-affirming the dominant functional contribution of fractionation during AF.  
The spatio-temporal variability of electrical activity during AF, explains in part, the 
complexities involved in understanding the underlying mechanisms of AF persistence. 
Although various metrics, in both the time and frequency domain have been utilised to 
characterise these electrograms in AF, the majority of them have not yielded any sustained 
clinical usefulness. We systemically characterised the time course of the mean peak-to-peak 
AF bipolar voltage over vary time sampling windows, and observed the stability of the mean 
AF voltage only at and beyond 4 sec of sampling, and crucially, stable spatial distribution of 
mean AF voltage over multiple epochs of AF separated in time. Most interestingly, low mean 
AF voltage regions (0.35mV) correlates well with LGE-CMRI defined fibrosis, and intriguingly, 
better that that of sinus rhythm voltage. Mean AF voltage, when adequately sampled, allows 
for a meaningful spatial differentiation of the AF substrate and may be a potential novel 
marker of fibrosis, and will form the basis of a randomised controlled study involving 
catheter ablation of low voltage regions mapped in AF and discussed in 8.2.3.  
Along similar lines of mapping the spatio-temporally disorganized rhythm of AF, we 
performed comparative assessment of the electrophysiologic properties of the paced-
rhythm and native disorganized rhythm of AF. The mean AF voltage over 8 sec correlated 
with mean paced voltages, and consistent with findings with correlative assessment of 
regions of atrial enhancements and electrogram fractionation, we observed electrogram 
fractionation corresponding to areas of higher voltages, both in AF and the paced-rhythm. 
These findings suggest that the electrophysiologic substrate of AF can be interrogated in the 
paced-rhythm, and could provide crucial insights into the underlying mechanisms of AF.  
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Utilising endocardial voltage as a surrogate marker of fibrosis has been a long and widely 
held concept, but our observations affirms the voltage discordance phenomena and 
emphasizes the importance of the description and characterisation of voltage maps in the 
context of the rhythm, and tools utilised (electrode size and spacing). This comes at a time 
where newer mapping technologies with higher resolution mapping tools have been 
introduced, and caution needs to be taken in interpreting “historical” electrophysiological 
data and extrapolation to more contemporaneous clinical mapping studies especially with 
respect to scar-thresholding.  
Finally, reverse translational basic science work was carried out to further elucidate the 
functional and structural determinants of the electrogram morphology through the co-
culture neonatal rate ventricular myocytes (NRVM) with fibroblasts on multi-electrode array 
(MEA) in AF and the paced-rhythm. The introduction of fibroblasts leads to increased 
intrinsic fibrillation and fibrillation is associated with the presence of rotors and low peak-to-
peak voltage electrograms. This model suggests that voltage may have a more dominant 
functional rather than a structural basis in AF, consistent with the characterisation of the 
human in vivo AF peak-to-peak voltages and its favourable relationship with atrial 
enhancements. Increased fibroblast burden also led to an increase in electrogram 
fractionation, and conduction slowing via cellular uncoupling with carbenoxolone amplified 
this. This model validates clinical findings that electrogram fractionation may predict 
arrhythmia vulnerability, and may prompt the re-visiting of ablation of fractionated 
electrograms, but specificity of electrogram fractionation may still be problematic.   
This body of work attempts to marry the structure, and function of atrial myocardium and 
its electrophysiology, utilising the newly established state-of-the-art imaging modality of LGE-
CMRI and correlating to both traditional and novel markers of the arrhythmic substrate of 
AF, with hope of generating tools and concepts in further understanding the mechanisms of 
the persistence of AF, and translating to more effective treatment for our patients.  
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8.2 Future directions 
Wavefront activation patterns and interactions are crucial components of electrogram 
morphology, and future work stemming from this thesis aims to focus on delineating this on 
a multi-scale level using data and models established during the period this research but 
which have not been fully tested.  
8.2.1 In vivo human AF activation 
Utilising the data acquired during AF on a per Kernel basis (with the high density double 
spiral AFocusII catheter), regional activation mapping can be performed and represented as 
AF propagation or “wavelet” maps. These localised electroanatomic maps in AF at various 
regions of the left atrium are created on the EnsiteTM Velocity system, obtained from data 
acquired as part of the work in characterisation of spatiotemporal stability of bipolar peak-
to-peak AF voltage. Unipolar electrograms from each of the 20-poles of the AFocusII 
catheter are annotated (peak negative dV/dt) referenced to a dummy-pacing electrode set at 
the average AF cycle length during acquisition of AF data (usually measured from the 
decapolar catheter in the coronary sinus taking an average of 10 AF cycles). This may allow 
the visualisation of wavefront activations and identification of potential AF drivers with 
repetitive rotational activity, and also “track” planar activation patterns which may aid the 
understanding of whole atrium activation without the physiological impact of dispersion of 
refractoriness. However, this work-flow involved in the generation of isochronal maps on 
the EnsiteTM Velocity system, a highly laborious process which requires accurate annotation 
of often fractionated and low voltage unipolar electrograms with significant intra- and inter-
observer variability, compounded by limitations of current 3D mapping systems which does 
not allow the flexibility of varying the windows of interest, making this technique currently 
unfeasible during real-time AF mapping (Figure 8.1). 
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Figure 8.1 AF wavelet propagation maps 
(Top panel) Bipolar electrograms (orange) acquired using the AFocusII catheter 
demonstrating both organised (boxed) and disorganised periods of AF during mapping of the 
posterior left atrial wall using the AFocusII catheter. (Bottom panel) Localised activation 
isochronal maps (utilising unipolar electrograms) can be created during organised periods of 
activity demonstrating planar activation patterns which can change directions when AF 
mapped over different epochs. The creation of these activation maps proved challenging, if 
not impossible, when electrograms are fractionated as illustrated in between the 2 periods 
of more organised AF.  
 
 
400ms 400ms 
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We are currently developing a novel technique to rapidly detect planar wavefronts in AF, 
and build a composite map of preferential directions without any operator guided annotation 
on the basis of our observations that repeated, and seemingly consistent direction of planar 
activations across the mapped atrial surface. This will test the hypothesis that there are 
preferential directions of activation of planar wavefronts in AF that indicate the underlying 
mechanism perpetuating AF, and forms the basis of a successful British Heart Foundation 
Clinical Research Training Fellowship to which I am a co-supervisor.  
Further, parallel to the work above, in conjunction with the ElectroCardioMaths programme 
in Imperial College, and part of the BHF Centre of Excellence, we are developing, and 
optimising, a semi-automated algorithm to determine wavefront propagation patterns 
determined using both activation and phase mapping from the exported data during AF 
across multiple left atrial sites over at least 30 sec (Figure 8.2).  
 
Figure 8.2 Export of data during clinical mapping of AF in the left atrium 
 
 
(A) Mapping of the left atrium with the 
AFocusII catheter in multiple positions (>30 
sec at each location) with EnsiteTM Velocity 
(B) Data exported with re-constructed left atrial 
geometry with locations of catheter electrogram 
recordings 
(C) Representative examples of 
unipolar ( top) and bipolar 
electrograms (bottom) 
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Figure 8.3 Methodology used to determine wavefront direction from 
phase and to determine suitable time windows to construct activation 
time maps. 
(A) Isophase maps with lines of isophase 0 (white dots). Mid-point of each wavefront is 
indicated as a black dot. (B) Mid-points are joined and smoothed to mark wavefront path 
over time from blue to red. (C) Times corresponding to the start and end of this path define 
the time window for constructing activation time maps for bipolar and unipolar phase. 
 
 
Figure 8.4 Wavefront activation patterns over a single Kernel 
A representative example of wavefront activation patterns generated from 30 sec of AF data 
acquired over a single mapped left atrial site, with each map representing a single AF cycle 
length. 
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8.2.2 Ex vivo canine left atrial preparation 
The limitations of human in vivo work was sought to be overcome using an ex vivo canine 
preparation in an acetyl-choline (ACh) induced AF model to allow for more controlled 
structure-function correlation utilising clinical mapping catheters used in the clinical work 
presented in this thesis. We have adapted and optimised a coronary-perfused left atrial 
model from donor dog hearts donated to our institution by pharmaceutical industry, and 
hence, only a minimal number of data sets have been acquired at the time of writing of this 
thesis. This model can be studied during pacing and cholinergic AF, and has the advantages of 
allowing global mapping of the endocardial surface of the left atrium in AF and also the 
examination of the role of anatomical structures (e.g. pulmonary veins) on fibrillatory 
dynamics not possible in smaller animal models of AF. The similarity in size of canine hearts 
to human hearts also allows for the use of clinical EP catheters in this model.  
 
 
 
Figure 8.5 Ex vivo canine preparation 
Contact mapping with the clinical AFocusII catheter, and optical mapping during pacing and 
ACh-induced AF, and subsequent histomorphometric correlation to electrophysiology.  
 
Contact mapping 
Histomorphology 
Activation 
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Figure 8.6 Contact electrograms from AFocusII catheter 
Pilot electrogram data obtained during pacing from North-South (Left) and South-North 
(Right) with electrogram fractionation observed during high rate pacing predicting 
continuous electrogram fractionation in AF.  
 
8.2.3 Randomised controlled study on targeting low AF voltage regions 
With current enthusiasm of fibrosis guided ablation, our systematic and robust 
characterisation of the time-course of the spatio-temporal variability of mean peak-to-peak 
AF voltage which correlates well with LGE-CMRI defined scar, forms the backdrop of our 
planned randomised controlled clinical study of ablation of low-voltage regions in AF. This 
strategy is supported by observations in basic science, computer modelling and human 
clinical investigative work which has drawn interest and focus on fibrosis providing the 
underlying structural substrate for AF drivers. As mentioned, studies, which have adopted 
similar ablation strategies, are inadequate due to the flawed methodologies of AF voltage 
mapping, and failing in taking into account the obvious variability of electrical activity in AF.  
We plan to test the original hypothesis that low voltage areas mapping in AF represents a 
novel marker of the AF substrate and ablation of these areas improves clinical outcomes. 
Seventy-four patients with persistent AF will be recruited and randomised to either 
pulmonary vein isolation (PVI) alone or PVI plus ablation of low voltage regions (<0.35mV) 
mapped in AF over 8 sec, with primary end points of acute AF termination and 12-month AF 
recurrence. As part of the mechanistic component of the study, off-line analysis will include 
wavefront propagation analysis utilising EnsiteTM Velocity’s updated Research module which 
incorporates a vector based algorithm which “averages” direction of wavefront activation 
using triangulation of adjacent electrodes of the multipolar mapping catheter which allows 
visualisation of wavefront propagation.  
Paced&and&induced&AF&EGMs&(PV34)&
600ms 
AF 
300ms 
160ms 
Paced&and&induced&AF&EGMs&(PV9,10)&
600ms 
300ms 
160ms 
AF 
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Figure 8.7 EnsiteTM Velocity vector based mapping 
Electroanatomic mapping of an atrial tachycardia – localised re-entry around a region of scar 
on the anterior left atrial wall. Arrows demonstrate direction of wavefront activation with 
the thickness of the arrows representing the degree of certainty of the algorithm. (Left) 
Voltage map superimposed on the wavefront propagation map delineating the region on scar 
on the anterior wall. (Right) A conventional isochronal activation map demonstrating the re-
entrant circuit around the anterior wall. Ablation at the site marked with the green dot 
terminated the AT to sinus rhythm.  
 
We have validated this functionality on atrial tachycardias (Figure 8.7), which also allows 
tracking of wavefront activation over a superimposed voltage map. This presents an exciting 
opportunity to study wavefront activations over the mapped low voltage regions, and 
crucially, signatures of electrical activity at sites of AF termination or organisation.  
In the clear absence of a widely accepted strategy for substrate modification in patients 
undergoing catheter ablation for persistent AF, this study will assess the efficacy of the use 
of not only a novel, but electrophysiologically relevant, index of the substrate, in targeting 
areas of the left atrium for catheter ablation. This may provide a new paradigm in the 
assessment and modification of the AF substrate in catheter ablation of patients in persistent 
AF. 
 
 
 
 
 
VOLTAGE ACTIVATION 
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